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SUMMARY
The rate of postprandial fat clearance from the circulation has long been implicated as a 
risk factor for coronary heart disease. The extent and duration of postprandial lipaemia 
is regulated by LPL. LPL activity is known to be affected by the dietary fatty acid 
content of the habitual diet. We therefore hypothesised that feeding frequency and 
habitual fatty acid intake would modulate LPL activity and may affect gene expression.
The level of this control was investigated initially by studying the effects of
/
gastrointestinal hormones on rat adipose tissue LPL activity.
In explants of rat adipose tissue GIP (4nM), insulin (2nM) and GLP-1 (7-36) amide 
(4nM) were found to stimulate heparin-releasable LPL activity. Similar concentrations 
of GLP-1 (7-37), GLP-1 (1-36) amide or GLP-1 (1-37) produced no effect on LPL 
activity. Melatonin significantly increased LPL activity at a concentration of 8 nM but 
not at 4nM. Since gastrointestinal hormones are stimulated by the dietary intake of fat 
and carbohydrates, the action of insulin, GIP and GLP-1 (7-36) amide on LPL activity 
provides a direct link between dietary intake and postprandial nutrient metabolism.
Under normal physiological conditions meal frequency has been shown to affect fasting 
triacylglycerol, cholesterol and GIP levels (Wolever, 1990; McGrath & Gibney, 1994). 
Few effects on postprandial lipid metabolism were found as a result of altering meal 
frequency in young healthy women which suggested that diet composition was a more 
important determinant of postprandial lipaemia.
Alterations in maternal nutrition during pregnancy may irreversibly affect aspects of 
physiological and biochemical functions in the offspring (Barker et al. 1993). A rat 
study was performed to investigate the effects of a high n-3 PUPA intake in the 
maternal diet on postprandial hormone and nutrient metabolism in the offspring. Most 
of the changes exhibited during this study were due to developmental changes with 
age. Increasing the mixed oil intake of pregnant rats increased LPL mRNA levels in
the offspring -  an effect which persisted into later life. This study therefore confirms 
that maternal and early diet do affect LPL gene expression and therefore possibly risk 
of atherogenesis in adult life.
There is strong evidence that dietary fatty acid composition influences LPL activity. 
However, there is little understanding of whether the level of control is hormone or 
substrate driven. A technique to measure human LPL mRNA was developed to enable 
the assessment of the level of control of LPL in adipose tissue. The level of LPL 
expression in humans was found to be 6 % of that in rats.
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1. INTRODUCTION
The central theme of this research project was the enzyme lipoprotein lipase (LPL) -  
its activity and gene expression. To this end, the effects of diet and gastrointestinal 
hormones on LPL activity and gene expression have been studied, along with the 
programming effects of dietary changes on LPL and lipoprotein metabolism, both 
during development and in adulthood.
This chapter examines the physiology and pathophysiology of LPL and factors such as 
gastrointestinal hormones which alter its activity and gene expression. The chapter 
begins with an overview of lipoprotein metabolism, in which LPL is of central 
importance, especially in the postprandial period.
1.1 LIPOPROTEIN METABOLISM
This section discusses the current knowledge of dietary lipid metabolism in humans. 
Lipids circulate in plasma as a number of different forms of lipoproteins. Very low 
density lipoproteins and chylomicrons are the major lipoproteins carrying 
triacylglycerol both from endogenous and exogenous sources. During the postprandial 
period -  defined as the time from ingestion of food and up to ten hours later -  the fat 
component of the meal is absorbed. Postprandial lipaemia is the appearance of lipid 
particles in the bloodstream as a result of meal ingestion. Postprandial lipoproteins 
have been implicated in the pathogenesis of atherosclerosis so there is increasing 
interest in dietary and other factors which may determine the extent and duration of the 
rise in lipoprotein concentrations following a meal. This section therefore studies the 
factors affecting, and the mechanisms of, postprandial lipaemia in man.
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1.1.1 D ig e s t io n  &  a b s o r p t io n  o f  d ie t a r y  l ip id
Dietary lipid mostly enters the body as triacylglycerol (TAG) and a small fraction as 
cholesterol ester and phospholipid. These must be broken down into di- and mono- 
acylglycerols and fatty acids by pancreatic lipase in the small intestine before full 
absorption is possible. Hydrolysis of TAG occurs sequentially, one of the end fatty 
acids being removed^t^^time to yield diacylglycerols and then sn- 2  monoacylglycerol. 
The enzymes involved in this hydrolysis are lipases and phospholipases whose secretion 
are under hormonal control by cholecystokinin (Hunt & Groff, 1990). Dietary 
cholesterol is in the form of cholesterol ester and is hydrolysed in the intestinal lumen 
by pancreatic cholesterol esterase to yield free cholesterol and fatty acids. The end 
products of intestinal lipid hydrolysis are therefore free fatty acids, glycerol, mono- and 
diacylglycerol, cholesterol and lysophospholipids. These products are then absorbed 
into the gastrointestinal tract. The entry of fat into the duodenum stimulates the 
release of bile which in turn stimulates émulsification until micellar stabilisation is 
reached. The micellar contents can then move into the mucosal cells, which they enter 
by passive diffiision (Patsch, 1987).
Once inside the enterocyte the fate of fatty acids is dependent on their length. Fatty 
acids of less than 1 0 - 1 2  carbon atoms pass directly from the mucosa by passive 
diffusion without being re-esterified. They are then bound to the carrier protein, 
albumin, and are transported in the portal vein as non-esterified fatty acids (NEFA) to 
the liver and other tissues. Fatty acids of over 12 carbon atoms, and the absorbed 
cholesterol, are re-esterified to TAG and cholesterol esters within the enterocyte. 
Chylomicrons (CM) are particles formed at this stage within the intestinal epithelial 
cells to carry re-esterified TAG and cholesterol around the body. Chylomicrons consist 
of a hydrophobic core of TAG, cholesterol esters, monoacylglycerol and free fatty 
acids, all covered by a surface layer of apoproteins and phospholipids, arranged so that 
the outer surface is hydrophilic.
Within the enterocyte free fatty acids are bound to fatty acid binding protein which has 
a high affinity for long chain fatty acids and prevents the accumulation of potentially 
toxic free fatty acids in the cell. Resynthesis of TAG occurs in the endoplasmic
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reticulum of the enterocyte from the CoA-activated absorbed free fatty acids and 
glycerol (Sethi et al 1993). The sn-2 monoacylglycerols formed by pancreatic lipase in 
the intestinal lumen are absorbed into the enterocyte where they are acylated to sn-1 ,2 - 
diacylglycerols or sn-2,3-diacylglycerols and eventually to triacylglycerols. The 
enzymes involved in these processes are long chain fatty acidiCoA ligase, 
monoacylglycerol transferase and diacylglycerol transferase. These are located on the 
smooth endoplasmic reticulum of the enterocyte.
Phosphatidylcholine (lecithin) is the main phospholipid associated with chylomicrons. 
This can be made in the enterocyte by acylating lysophosphatidylcholine which is 
absorbed from the lumen after the digestion of phosphatidylcholine itself or it may 
originate from hepatic production where it is secreted into the intestine via bile (Carey 
et a l 1983).
The main apolipoprotein associated with chylomicrons is apo B48 but apo AI, apo 
AJV, apo Cl, CII, c m  and apo E may also be present at some time during the 
postprandial period. Apohpoproteins involved in the formation of the chylomicron 
(apo B48, AI and AIV) are synthesised in the enterocyte. However, the 
apohpoproteins associated with the chylomicron in circulation (apo CII, CIII and apo 
E) appear to be acquired after release by the enterocyte. Apo B48 is synthesised in the 
rough endoplasmic reticulum, transferred to the smooth endoplasmic reticulum and 
incorporated into nascent chylomicrons. These move to the Golgi body and are 
glycosylated prior to exocytosis from the cell membrane. The apolipoprotein B48 
remains with the chylomicron from its production in the smooth endoplasmic reticulum 
until removal of the chylomicron from the circulation by the hver and its measurement 
has therefore been used as a marker of chylomicron number in the circulation.
1.1.2 P o s t p r a n d ia l  c h y l o m ic r o n  m e t a b o l is m
The healthy individual absorbs over 98% of the dietary fat ingested. Therefore the 
level of intestinal chylomicron formation depends on the quantity of dietary TAG 
ingested (Norum, 1992). The size and composition of chylomicrons also depend on
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the amount and type of fat ingested. A high fat meal results in large, low density 
chylomicrons; polyunsaturated fatty acid intake results in larger chylomicrons than 
when saturated fats are eaten. Postprandially, chylomicrons are secreted into the 
lymphatic vessels and enter the jugular vein via the thoracic duct. Chylomicrons are 
the largest lipoprotein species, being 80 -  500nm in diameter and having a density less 
than 0.96g/ml. Chylomicrons appear in the circulation within 60 minutes of fat 
ingestion and peak levels occur around six hours postprandially.
Following secretion from the enterocyte and entry into the systemic circulation, 
chylomicrons acquire apo CII, CIII and apo E. The apolipoproteins surrounding 
lipoproteins help to solubilize the fatty components, confer specificity on the 
lipoproteins and determine the way in which they are metabolised. The apoproteins 
recognise and interact with specific receptors on cell surfaces, following which 
receptor-mediated endocytosis occurs to clear the lipoprotein from the bloodstream. 
For example, apo E on the chylomicron surface is involved in targeting the 
chylomicron remnant for a receptor located on the liver and is therefore a ligand for 
remnant removal by the liver. The apo CII, CIII and apo E are transferred onto 
chylomicrons in the circulation from high-density lipoprotein (HDL), along with free 
and esterified cholesterol and phospholipids. At the same stage, apo AI and AIV are 
transferred to HDL from the chylomicrons. The roles of individual apolipoproteins are 
given in Table 1.1.
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Table 1.1 Characteristics of the human apolipoproteins
Name Function Sites of synthesis
AI Activates LCAT Liver and intestine
AH Activates hepatic lipase Liver
AIV Activates LCAT Intestine
B48 Cholesterol clearance Intestine
BlOO Cholesterol clearance Liver
Cl Activates LCAT? Liver
CII Activates LPL Liver
CIII Inhibits LPL? 
Activates LCAT?
Liver
E Cholesterol clearance and 
chylomicron clearance
Liver, brain, muscle, spleen, 
ovary and kidney
1.1.3 C h y l o m ic r o n  h y d r o l y s is  a n d  LPL
Once the chylomicrons have acquired apo CII they are capable of activating the 
enzyme lipoprotein lipase (LPL) on the epithelial surfaces of blood vessels (Eckel, 
1989). This enzyme mediates in the removal of TAG from the chylomicron, resulting 
in chylomicron remnants. LPL is the rate-limiting enzyme in TAG hydrolysis and its 
activity determines the extent and duration of postprandial lipaemia (see Section 1.2). 
Since LPL initiates the uptake of TAG fatty acids by tissues, it also determines cellular 
fuel availability. LPL is located on the vascular endothelium of tissues with a high fatty 
acid requirement such as cardiac and skeletal muscle, adipose tissue and mammary 
glands. The hormone insulin stimulates LPL activity in adipose tissue by increasing its 
synthesis and release (Spooner et al. 1979). Insulin decreases skeletal muscle LPL, 
therefore skeletal muscle LPL activity increases postabsorptively when insulin levels 
have decreased to fasting levels (Cryer et al. 1976). The hydrolysis of TAG from the 
chylomicron results in small, relatively protein-enriched particles known as remnants. 
The surface phospholipids, cholesterol, apo CII and apo CIII are transferred to HDL to
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maintain chylomicron stability. The transfer of apo CII to HDL, and the increasing 
inaccessibility of TAG for the active site results in the cessation of TAG removal.
1.1.4 C h y l o m ic r o n  r e m n a n t  c l e a r a n c e
Chylomicron remnant removal occurs via a receptor-mediated process in the liver. 
Apo B48 and apo E remain with the remnant, allowing recognition by the hepatic apo 
E receptor. Evidence suggests that the remnant receptor is a specific one and is 
separate fi"om the LDL receptor (Chen et al. 1991; Herz et al. 1988). The removal of 
the remnants is affected by the apo E phenotype of the individual, the activity of 
hepatic triacylglycerol lipase and the presence of apo CIII. There are three iso forms of 
apo E: E2, E3 and E4. The most common phenotype is E3/E3, which predominates in 
approximately 60% of the population. The avidity of binding to receptors is widely 
thought to be E4>E3>E2. Hence, subjects with the E2/E2 phenotype have increased 
chylomicron remnant levels in the bloodstream and consequently an increased risk of 
coronary artery disease (Utermann, 1987). One controversial paper this year has 
however reported young men with the apo E4/3 phenotype to have higher remnant 
levels postabsorptively compared to an E3/E3 group of men (Bergeron & Havel, 
1996). Remnant receptor binding relies on the prior removal of apo CIII onto HDL 
and therefore explains the close interaction between the pathways of metabolism of 
HDL and other TAG-rich lipoproteins.
1.1.5 R e v e r s e  c h o l e s t e r o l  t r a n s p o r t  &  l ip o p r o t e in  in t e r a c t io n s
The rate of transport of LDL cholesterol to peripheral tissues is normally greater than
the tissue requirements except during active growth periods or tissue repair (Sethi et
al. 1993). Most cells are unable to oxidise cholesterol so it goes back to the liver for
elimination in the bile. This process is known as reverse cholesterol transport. HDL
plays a central role, being converted to HDL3 by the enzyme lecithin:cholesterol
acyltransferase (LCAT) during the transfer. Cholesterol initially transferred Jfrom
peripheral cells to HDL eventually returns to the liver via chylomicrons and very low
density lipoprotein (VLDL) remnants and HDL becomes enriched with TAG. Free
cholesterol is acquired by nascent HDL fi*om the peripheral cells and is esterified by
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LCAT, which, together with surface materials from chylomicrons and VLDL, forms 
HDL3 . LCAT activity rises postprandially leading to an increase in the HDL2 iHDL3 
ratio. LCAT activity is affected by dietary factors (Abbey et al. 1990), for example, 
the intake of n- 6  polyunsaturated fatty acids (PUTA) decreases LCAT activity and 
leads to an accumulation of the n3-PUFA acyl moiety in the sn-2 position of lecithin. 
This may explain the unexpected decrease in plasma HDL-cholesterol seen following 
the intake of dietary fish oils (Norum, 1992). The reciprocal crossing over of 
cholesteryl esters and TAG is catalysed by the enzyme complex cholesteryl ester 
transfer protein (CETP). Any remaining free cholesterol is transferred to VLDL and 
chylomicron surfaces, mediated by CETP. CETP activity increases when primates 
receive a high saturated fat diet (Abbey et al. 1990). This could in turn lead to 
decreased levels of HDL cholesterol and increased levels of cholesterol in VLDL and 
LDL. This may also be of significance in humans.
The secretion of chylomicrons into the circulation and their metabolism affect the 
whole lipid transport system. Chylomicrons contribute apolipoproteins to the plasma 
pools, which are then used by other lipoproteins, contributing to their structure and 
mass. This interaction between TAG-rich lipoproteins and HDL is therefore important 
in cholesterol metabolism and is thus a prime consideration when proposing 
mechanisms involved with coronary artery disease. Chylomicrons also compete with 
VLDL for hydrolsis by LPL and may displace VLDL from heparin binding sites. A 
schematic representation of the interlocking processes involved in lipoprotein 
metabolism are shown in Figure 1.1.
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Figure 1.1 Lipoprotein metabolism. A schematic overview showing the 
interrelationships between exogenous (dietary) and endogenous (hepatic) TAG- 
rich lipoproteins.
1.1.6 Other LIPOPROTEINS
This section will provide a brief overview of the lipoproteins shown in Figure 1.1. 
Very low density lipoproteins (VLDL) are formed in the liver: their production is 
dependent on TAG synthesis in the liver. Their function is to transport TAG and 
cholesterol around the body. Diets high in saturated fatty acids increase VLDL 
synthesis but high PUFA diets lower VLDL production (Drevon, 1992). VLDL are 
metabolised into VLDL remnants, otherwise known as intermediate density 
lipoproteins (IDL) which are removed by hepatic LDL receptors.
Low density lipoproteins (LDL) contain only one apolipoprotem - apo BlOO, which is 
formed in the liver. LDL is produced from VLDL via IDL by a delipidation cascade 
produced by the action of lipoprotein lipase and hepatic lipase both in the lining of 
peripheral blood vessels and in the liver. LDL may then be modified by oxidation and 
may be taken up in liver and other cells by scavenger receptors. Saturated fatty acids 
cause an increase in LDL because they suppress hepatic LDL receptor activity and 
cause impaired LDL removal. Conversely, PUFA may increase the secretion o f bile
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acids and cholesterol in bile which leads to an up-regulation of hepatic LDL receptors. 
LDL has three major subclasses - LDL I, LDL II and LDL III. The predominance of 
LDL III has been associated with a three fold higher risk of myocardial infarction in 
young men (Austin et al. 1988). Small dense LDL is removed more slowly by 
receptors than larger LDL and therefore has prolonged residence time in the circulation 
(Griffin & Zampelas, 1995). It also has a tendency to oxidation and is then associated 
with the atherosclerotic plaque (de Graaf er al. 1991).
High density Hpoproteins (HDL) are secreted from the liver or gut, or are formed in 
plasma during the lipolysis of TAG-rich lipoproteins. They are composed of apo Al 
and/or apo AH, phospholipids and unesterified cholesterol. Their main function is 
reverse cholesterol transport as described in the previous section. Low HDL levels are 
associated with an increased risk of coronary heart disease because this represents a 
compromised pathway for the excretion of cholesterol. There are five subclasses of 
HDL; 2a, 2b, 3a, 3b and 3c. The HDL2  fractions have lower densities and are 
inversely linked with coronary heart disease risk (Hamsten et al. 1986).
1.1.7 Factors affecting postprandial lipaemia
Cell culture studies have confirmed that TAG-rich lipoproteins and especially
chylomicron remnants that are found in abundance in the postprandial phase promote
the rapid accumulation of cholesterol within arterial cells (Ellsworth et al. 1986).
! well-fed
These findings, and the fact that mostj^individuals are in a postprandial state for at least 
16 hours a day, may provide a coherent mechanistic basis to explain how diet, 
especially dietary fatty acids, exerts a significant influence on lipoprotein-mediated 
CHD risk through postprandial events. The study of postprandial lipaemia in 
individuals as a predictor of their disease risk is therefore of paramount importance.
In general terms, the consumption of fat is followed by a monophasic rise in TAG-rich 
lipoproteins. However, several authors have reported a biphasic or triphasic response 
to fat ingestion (Olefsky et al. 1976; Cohn et al. 1989). The early peaks have been 
suggested to be a result of secondary influxes of undigested TAG from previous meals
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(Williams et al. 1992; Fielding et al. 1996). The multi peaks may be provoked by the 
ingestion of fluid during a postprandial study day. Therefore, previous meal fi-equency 
may affect postprandial lipoprotein clearance. Some of the other main factors affecting 
postprandial Hpaemia have been divided into three categories below;
1.1.7.1 Macronutrient composition
As might be expected, increasing the fat content of a standard test meal results in more 
marked postprandial lipaemia. Cohen et al. (1988) gave three test meals of 40g, 80g 
and 120g fat to 12 normotriacylglycerolaemic men. The three meals produced 8  hour 
postprandial TAG concentrations of 2.8, 5.7 and 8  mmol/1 respectively. Similarly in 
our laboratory we have shown increases in area under the time-response concentration 
curves following the consumption of a 20g, 40g or 80g fat load (213, 236 and 260 
min.mmol 1'^  respectively) in young healthy men (Murphy et al. 1995).
1.1.7.2 Fatty acid composition
There is strong evidence to suggest that altering the fatty acid content of a standard 
test meal or habitual diet can influence the size and duration of postprandial lipaemic 
responses. Dietary PUFA attenuate both the duration and magnitude of postprandial 
lipaemia compared with highly saturated diets (Harris et al. 1988; Weintraub et al. 
1988; Demacker et al. 1991). Specifically n-3 PUFA, found in fish oils, can decrease 
postprandial TAG by up to 60% (see Chapter 5). The acute and chronic consumption 
of n-3 PUFA leads to decreased chylomicron and chylomicron remnant levels in the 
circulation. This may be by altering the size and fatty acid composition of 
chylomicrons which increases their ability to compete with large VLDL as substrates 
for LPL (Levy et al. 1991). Alternatively it could be the PUFA increasing postheparin 
LPL activity after acute fish oil intake (Zampelas et al. 1994), though studies looking 
at the long term effects disagree with these results (Weintraub et al. 1988; Nozaki et 
al. 1991). Research into the effects of mo no unsaturated fatty acids (MUFA) on 
lipoprotein metabolism has been limited. Studies which have compared the effects of 
acute test meals enriched with MUFA or PUFA have shown no significant effects of 
MUFA on postprandial lipaemia (de Bruin et al. 1993; Lichtenstein et al. 1993).
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1.1.7.3 Phvsiolosical factors
Women of all ages have lower postprandial lipid responses than men and younger 
subjects have lower responses than older subjects (Cohn et al. 1988). Physical exercise 
conditioning decreases postprandial lipaemia and increases postheparin LPL activity 
(Weintraub et al. 1988; Cohen et al. 1989). The main effects of exercise are a faster 
rate of lipid clearance from plasma and increasing the plasma LPL activity. Weintraub 
et al. (1987) showed significantly raised plasma LPL in young subjects (1 9 -2 8  years) 
compared with older subjects (40 - 72 years). The same research team showed a 
tendency in women to have higher plasma LPL activities, but this was not significant. 
More recent work has reported no significant sex dimorphism in postheparin plasma 
LPL and HL although adipose tissue LPL activities were higher in women. However 
young premenopausal, healthy women had a higher HDL-cholesterol : LDL-cholesterol 
ratio than young healthy men (Stamand et al. 1995).
1.2 LIPOPROTEIN LIPASE
Lipoprotein lipase (LPL) {EC 3.1.1.34) is the major, rate-limiting enzyme responsible 
for the hydrolysis of triacylglycerol in chylomicrons and very low density lipoproteins 
(see Section 1.1.3) and thus has a pivotal role in total body lipid metabolism. The 
enzyme is located on the luminal surface of the capillary endothelium of extrahepatic 
tissue, including cardiac and skeletal muscle, adipose tissue and lactating breast tissue. 
LPL is activated by apolipoprotein CII which is present on the surface of chylomicrons, 
very low density hpoproteins (VLDL) and high density lipoproteins (HDL) (Wang et 
al. 1992). In contrast, apolipoprotein CIII acts as an inhibitor of LPL activity in vitro 
(Eckel, 1989) -  also relevant in vivo.
1.2.1 Functions
In the body, LPL has a directive role; NEFA produced by the action of LPL are re- 
esterified for the storage of energy as triacylglycerols in white adipose tissue, are 
oxidised to provide an energy source in the heart and are used to regulate 
thermogenesis in brown adipose tissue. LPL therefore has an important functional role
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in controlling energy production from TAG-fatty acids, and in turn ensures the 
peripheral tissues have their energy requirements fulfilled in a tissue specific manner.
LPL catalyses the initial step in the catabolism of TAG-rich lipoproteins. It hydrolyses 
the sn-1 and -3 position of tri-, di- and monoacylglycerols. It demonstrates a 
preference amongst TAG-rich lipoproteins such that chylomicrons are a much better 
substrate than VLDL and LDL (Potts et al. 1992). In addition to the primary function 
of TAG-rich lipoprotein hydrolysis, LPL also facilitates the transfer and uptake of 
chylomicron and chylomicron remnant cholesterol esters (cited by Garfinkel & Schotz, 
1987). At the endothelial surface, surface-bound LPL is thought to be essential for 
cholesterol ester internalisation, by acting as a ligand (cited by Garfinkel & Schotz, 
1987). LPL therefore has a catabolic role in chylomicron metabolism, by converting 
them into remnants which can be removed by receptor-mediated endocytosis.
Sex differences in the distribution of fat in humans are well-documented. Women have 
greater adipose tissue thickness and larger subcutaneous fat cells in the femoral and 
gluteal regions while men readily gain fat in the abdominal region. A central (‘male’) 
fat distribution has been associated with increased risk of obesity-associated disorders 
such as diabetes, hypertension and cardiovascular disease (Bjomtorp, 1990; Allawi & 
Jarrett, 1990). LPL, because of its role in controlling the uptake of circulating 
triacylglycerols into fat cells, has been hypothesised to play a role in the regulation of 
fat cell size (Schwartz & Brunzell, 1981). LPL activities have been reported to be 
higher in those regions where fat is most readily deposited. For example, women have 
higher LPL activity in the gluteal region than men (Bosello et al. 1984). Also, in both 
gluteal, subcutaneous and abdominal adipose tissue, LPL mRNA levels were found to 
be significantly higher in women than in men (Arner et al. 1991). Thus, LPL may play 
a role in regional fat deposition which has important implications in terms of obesity- 
related morbidity and mortality.
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1.2.2 Production
Although the physiological site of action for LPL is the luminal surface of blood vessels 
where endothelium-bound enzyme can interact with circulating lipoproteins, vascular 
endothelial cells do not synthesise LPL. LPL is synthesised in parenchymal cells 
(Olivecrona et al. 1987). Thus, it appears that the metabolic requirements of the 
parenchymal cell govern the production of LPL. Firstly, an inactive proenzyme is 
synthesised in the endoplasmic reticulum which is then activated in the Golgi body by 
progressive N-linked glycosylation. An intermediatory with a high mannose content is 
then formed. The N-linked carbohydrate of LPL undergoes a series of modifications as 
the enzyme is transported through a sequence of distinct intracellular compartments. 
The three terminal glucose residues are removed first by glucosidases I and II in the 
endoplasmic reticulum, followed by removal of one mannose to give a high-mannose 
structure which is then transferred to the Golgi complex. This form of LPL 
accumulates in the trans Golgi body where it is protected until it is secreted into 
vesicles and transported to the endothelial surface.
Each subunit of LPL contains a glycosaminoglycan binding site and an apo CII binding 
site (Gotto, 1987). As a glycoprotein, LPL must be synthesised on membrane-bound 
ribosomes and translocated into the lumen o f the endoplasmic reticulum (Bensadoun,
1991). Several animal experiments have shown that inhibition of the N-glycosylation 
process inhibits cellular LPL activity (Chajek-Shaul et al. 1985; Bensadoun, 1991). 
The requirement for glycosylation in human LPL has been narrowed to the N-linked 
oligosaccharide at asn43 (Semenkovich et al. 1990).
In the Golgi, LPL is sorted for (i) delivery to the lysosomes; (ii) incorporation into 
secretory vesicles; (iii) delivery to the plasma membrane (Braun & Severson, 1992). 
Only a small fraction of LPL actually reaches the cell surface of adipocytes, suggesting 
extensive intracellular degradation either by lysosomes or in the endoplasmic reticulum. 
This degradation is stopped in vitro by the addition of heparin to the medium 
(Bensadoun, 1991). This intracellular degradation occurs less in the vascular 
endothelium. The LPL receptor at the endothelial surface is a 220kDa proteoglycan.
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Secretion of active LPL occurs biphasically. The first phase, which is independent of 
protein synthesis, represents the secretion of a pre-existing pool of intracellular 
molecules. The second phase, during which secretion occurs at a lower rate, 
corresponds to a ‘constitutive’ secretion of the enzyme. ‘Constitutive’ refers to a 
process in which proteins are secreted as they are synthesised, without any intracellular 
accumulation. At the endothelial cell surface, positively-charged LPL is probably 
bound ionically to the glycosaminoglycan part of heparan sulphate proteoglycans which 
are anchored in the basement membrane of the endothelium (Eckel, 1989). 
Glycosaminoglycans are long, unbranched polysaccharide chains of repeating 
disaccharide units. They are highly negatively charged due to the presence of sulphate 
and carboxyl groups on the sugar residues, they contain heparan sulphate and are 
specific LPL receptors. Binding to the heparan sulphate stabilises the enzyme but does 
not activate LPL into its functional state (Gotto, 1987). The mechanisms by which 
LPL is released in vivo fi*om parenchymal cell surface binding sites are currently 
unclear. It is known, however, that heparin displaces LPL bound to cellular heparan 
sulphate proteoglycan binding sites, forming soluble heparin-LPL complexes in the 
medium (Bensadoun, 1991).
As mentioned earlier, LPL requires apolipoprotein CII for its full activity. This is 
transferred to the surface of the TAG-rich lipoprotein from HDL, to which it returns 
after TAG has been depleted by LPL action. The activation of LPL by apo CII is 
thought to be through the binding between the two molecules. Apo CII then binds to 
the lipid substrate, thus enabling substrate hydrolysis (Gotto, 1987). The negatively 
charged -COOH terminal of apo CII apparently reacts with the positively charged 
region of LPL whilst the positively charged -NH2  terminal of apo CII reacts with the
lipid substrate (Gotto, 1987). The end point of LPL activity is probably determined by 
the loss of apo CII from the surface of the TAG-rich particle back to HDL (Vance & 
Vance, 1985).
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1.2.3 Regulation OF LPL
The central role of LPL in triacylglycerol metabolism suggests that the enzyme is finely 
regulated and that several levels of co-regulation exist. The activity of LPL can be 
regulated at the transcription, translation or glycosylation level, or even through release 
from cells, although much of the regulation occurs post-transcriptionally (Ranganathan 
et al. 1995). LPL activity depends on the metabolic state of the tissue and the role of 
LPL within that tissue. Expression of LPL varies between different tissues 
(Ranganathan et al. 1995) and between different sites of the same tissue. Since much 
of the work on LPL in this thesis has been performed on adipose tissue, this will be the 
major focus of attention in this section. Along with many other proteins produced in 
more than one tissue, the molecular processes that lead to tissue-specific regulation of 
LPL are numerous and relatively poorly understood.
Peterson et a l, whilst studying the possibility of fatty acid feedback control of LPL in 
vivo, observed a positive correlation between plasma free fatty acids and plasma LPL 
activity in humans during an infusion of a triacylglycerol emulsion (Peterson et al.
1990). Displacement of fiinctional LPL from endothelial binding sites by free fatty 
acids, the product of the LPL reaction, would prevent the over-supply of fatty acids to 
tissue parenchymal cells under conditions of excessive lipolysis and complement other 
regulatory mechanisms whereby free fatty acids inhibit endothelial LPL activity, such as 
product inhibition and a reduction in apo CII activation (Olivecrona & Bengtsson, 
1984). More recently, Karpe et al. (1992) reported good evidence for the fatty acid 
feedback control of LPL at the vascular endothelium when they showed a high degree 
of parallelism between the fluctuations of chylomicron-derived free fatty acids and 
plasma LPL activity in 44 subjects following an oral fat load. LPL activity changes in 
various tissues in response to energy requirements. Adipose tissue LPL activity is 
relatively high in fed animals and low during fasting, whereas the opposite is the case in 
heart and skeletal muscle (Bensadoun, 1991). Tissue LPL activity is also affected by 
physical implications such as lactation, ageing, development or exercise level. These 
changes are generally under direct and/or indirect hormonal control.
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Various studies have supported the view that diet can alter LPL through direct effects 
on LPL gene expression. For example, in adult rats, a high fish oil diet led to 
significantly higher LPL mRNA levels in epididymal adipose tissue when compared to a 
high maize oil diet (Murphy et al. 1993). However, although changes in LPL mRNA 
contribute to the nutritional regulation of adipose tissue LPL, posttranslational 
mechanisms are also important. A 12 hour fast resulted in a reduction in LPL catalytic 
activity in rat fat pads with no change in LPL mass so that LPL specific activity was 
decreased in one study (Doolittle et al. 1990). This must be the result of redistribution 
of fiinctional (endothelium-bound) enzyme to the inactive (high-mannose) pool in 
adipocytes (Braun & Severson, 1992). In 1988 Ong & Kern concluded, by measuring 
changes in LPL activity, immunoreactive mass and mRNA levels in response to a 
carbohydrate-rich meal, that the mechanism was through posttranslational activation of 
a previously inactive LPL precursor. Enerback et al. showed both adipose tissue LPL 
activity and mRNA levels to be lower in overnight-fasted guinea pigs when compared 
to those animals in the fed state (Enerback et al. 1988) and this was confirmed the 
following year by a separate group of workers (Semb & Olivecrona, 1989). The 
degree of saturation of fat intake has also been shown to stimulate LPL activity in 
different ways. Rats fed on diets containing highly unsaturated fats have shown 
decreased circulating triacylglycerol levels and increased plasma LPL activity (Groot et 
al. 1988; Levy et al. 1991). There have also been numerous reports of high dietary n-3 
PUFAs intakes lowering plasma TAG levels which, in the fight of the current evidence, 
would suggest an increase in plasma LPL activity alongside. However, the literature is 
conflicting and incomplete and to date there have been few reports of dietary changes 
on LPL mRNA levels.
A comprehensive review by Semenkovich and colleagues (1989) documented many 
changes in tissue expression of LPL and hepatic lipase during rat development. 
Adipose tissue has not been found in prenatal rats and is difficult to find in the early 
postnatal period. Postnatally, adipose cells accumulate in the inguinal region, then 
regress at this depot while other regions, such as epididymal fat pads, increase in size 
with age. LPL mRNA levels in epididymal fat pads measured at 24 days old were high
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and remained at the same level subsequently. This finding was also reflected in 1977 
by Heitanen and Greenwood when they did not find changes in LPL activity in 
epididymal fat after day 21 (Heitanen & Greenwood, 1977). Other sites of LPL 
measurement such as heart, liver, lung and muscle also varied widely with increase in 
age (Semenkovich et al. 1989). One study has reported age differences in how LPL is 
activated. Older animals regulate LPL activity changes by a relatively slow change in 
LPL mRNA, whereas younger animals show a more rapid regulation exerted on the 
transport and turnover of the enzyme (Semb & Olivecrona, 1989).
Insulin might play a role in developmental LPL regulation since rat insulin levels are
known to peak at birth and at weaning, and as mentioned earlier, LPL activity rises on
feeding which could well be linked to the postprandial rise in insulin. Insulin has also
been shown to affect LPL mRNA levels in rat adipocytes in vitro (Ong & Kern, 1989).
The insulin action on LPL may be ascribed to a direct effect on transcription or
posttranslational processes (Eckel, 1987; Doolittle et al. 1990; Raynolds et al. 1990).
Actinomycin D (a protein synthesis inhibitor) did not inhibit the insulin effect on LPL
stimulation in rat epididymal adipose tissue explants, therefore suggesting the effect is,
J.M.E.
certainly in part, a posttranslational one (Knapper^ unpublished observations). Insulin 
appears to be a major determinant of adipose tissue LPL activity in both human and 
animal studies. Plasma insulin and LPL activity correlated well in obese women and 
both reduced when caloric intake was reduced (Bosello et al. 1984). Insulin seems to 
act on the rate of enzyme synthesis in the adipocyte and changes in LPL activity during 
modifications of nutritional status such as calorie restriction can be attributed, in part, 
to changes in plasma insulin levels. In conclusion then, insulin can act at many stages 
of LPL synthesis and activation.
Other hormonal regulators of LPL include glucocorticoids, thyroxine, glucagon, GIP 
and other hormones affecting intracellular cAMP. Certain drugs affect LPL activity. 
Fibrates have been used as cholesterol-lowering drugs in hypertriacylglycerolaemic and
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hypercholesterolaemic patients for many years. They act by promoting TAG-rich 
lipoprotein catabolism by stimulating LPL activity (Grundy & Vega, 1987).
In addition to the nutritional, developmental and hormonal control of LPL, there is a 
genetic component to LPL regulation. Most studies concerned with genetic regulation 
have looked at the clinical implications of LPL deficiency. Type I 
hyperlipoproteinaemia is an uncommon, familial autosomal recessive disease in which 
LPL activity is low or non-existent. This complaint has wide manifestations on the 
body and its metabolism such as severe hypertriacylglycerolaemia, high numbers of 
chylomicrons and VLDLs and low levels of HDL early in life (Eckel, 1989). The site 
of the genetic mutation which results in LPL deficiency has not been conclusively 
identified. However, many other alterations in DNA sequence that cause LPL 
deficiency have been identified. The majority of these alterations are missense 
mutations, mostly in exons 4, 5, and 6  (Hayden et al. 1993). The symptoms of these 
mutations are given in section 1 .2 .6 .
1.2.4 Measurement OF LPL
Postheparin lipase measurements are the most commonly used assessment of activity 
because they are quick and easy to perform and the method is very reproducible. The 
method involves the administration of a bolus dose of heparin intravenously. Heparin 
then strips off potentially active lipase fi’om the capillary endothelium into the 
circulation. Peak lipase activity occurs between 5 and 15 minutes after the heparin 
injection. One disadvantage of this method is that it is not specific to LPL. Heparin 
acts on both hepatic lipase and LPL and releases them fi'om all sites in the body. 
Postheparin LPL measurements are not site-specific because LPL is released fi"om 
muscle and adipose tissue. Postheparin LPL measurement also has the disadvantage of 
being a single measurement only which means it is impossible to obtain information 
about any physiological regulation of LPL. Chronic heparin-mediated release of tissue- 
bound LPL is probably associated with some loss of tissue activity and integrity from 
which it takes time for the tissue to recover (Persson et al. 1987; Chevreuil et al. 
1993). Also, the release of lipolytic activities into plasma results in substantial
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intravascular lipolysis which perturbs lipid levels and may therefore alter lipase 
activities (Eckel et al. 1988; Weintraub et al. 1995). Postheparin plasma LPL 
measurement therefore gives a one-shot global picture of LPL in the body.
Once total plasma lipase activity has been obtained, LPL is measured using a selective 
assay designed to measure the release of free fatty acids from a labelled triolein source 
(see Chapter 2 for detail). This method utilises the known physico-chemical properties 
of LPL, such as its inhibition at IM NaCl concentration and its activation by 
apolipoprotein CII, in order to distinguish LPL activity from total lipase activity. This 
technique is also employed to measure LPL in preheparin blood samples. Preheparin 
measurements provide an estimate of actual circulating levels of LPL. They have the 
advantage over other methods of allowing frequent sampling and therefore giving a 
continuous measurement. For example the fluctuations in LPL following a standard 
test meal can be measured on a postprandial study. However, because these levels are 
low, there are problems of sensitivity using the current method of measurement and it 
is for this reason that they were not measured on the studies described in this thesis.
Recently, more detailed analysis of LPL has been made possible by the availability of 
antibodies against LPL (Goers et al. 1987). Plasma immunoreactive (IR) LPL mass 
can be measured by ELISA. This employs the use of monoclonal antibodies raised 
either against human milk LPL or bovine milk LPL (Ikeda et al. 1990). This 
measurement of IR-mass correlates well with postheparin plasma LPL measurement 
(Ong et al. 1988) but requires the production of specific antibodies which becomes 
both time consuming and expensive. Estimations of IR mass give values which 
encompass active and inactive LPL.
diethyl
Acetone^ther preparations of adipose tissue delipidate the tissue and are extracts of 
tissue LPL. The LPL can then be assessed by simple weighing, by running on an SDS- 
PAGE gel and quantifying by densitometry to give an estimate of the size and purity of 
the LPL, or enzyme activity can be measured using the activity assay previously 
described. These preparations can be freeze dried and stored for at least 6  weeks at - 
70°C. LPL protein synthesis in tissue can also be measured by measuring rates of
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translation or synthesis. This entails radio labelling LPL with ^^S-methionine, 
immunoprécipitation of LPL and measurement of labelled LPL protein by 
electrophoresis on an SDS-polyacrylamide gel. Protein synthesis measurements give 
an impression of how much LPL is actually being made at a specific time.
Less quantitative methods of assessing LPL include in situ hybridisation. This 
technique involves hybridisation of a radio labelled probe to cell slices and visualisation 
under a microscope. These techniques have largely been left behind because all LPL 
was found in the Golgi body and secretory vesicles as expected and the method cannot 
now provide new information. The semi-quantitative method of measuring LPL 
mRNA by Northern blot analysis has replaced in situ hybridisation. The improvement 
of measuring LPL gene expression is ongoing and is discussed further in Chapter 6 .
1.2.5 Molecular BIOLOGY
The complete amino acid sequence of LPL has been deduced fi*om the cloning and 
sequencing of LPL fi-om a number of species. The human cDNA is characterised by a 
long 3’-untranslated region, which has two polyadenylation signals. In man, two 
mRNA species of 3750 and 3350 bp are produced by alternative 3’ terminal 
polyadenylation sites (Wion et a l 1987). The preprotein contains 475 residues which 
includes about 175 nt upstream of the translation initiation codon, a region 1425 nt 
long coding for the preprotein, a termination codon TGA, and an untranslated 3’ region 
of 1557 nt or 1952 nt followed by a poly A tail (Bensadoun, 1991). From this a 
hydrophobic 27 amino acid signal peptide is removed and the mature 448 amino acid 
LPL is formed which has a molecular weight of approximately 55, 000. Mature LPL 
contains 8  -  12% carbohydrate. The amino acid sequence is highly conserved between 
species, with mouse, cow, guinea pig and human sharing about 90% identity. The 
human LPL gene is located at position 22 on the short arm of chromosome 8  (Sparkes 
et a l 1987). The gene spans approximately 30 kb and contains 10 exons and 9 introns.
Based on the primary sequence and on the homology to pancreatic lipase, for which the 
three-dimensional crystallographic structure has been determined, structural domains 
have been proposed in LPL. For example, ser 132, asp 156 and his 241 are present in
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the central conserved region and are essential for the enzyme's catalytic properties. 
Another series, between amino acids 125 and 142, functions as the lipid binding 
domain. In the first 314 amino acids of the LPL molecule, a region responsible for the 
interaction with its co factor apo CII, is situated. This region is rich in positively
charged amino acids around ^^^lys and ^^^lys (Yang et al. 1989). The interaction of 
LPL with heparin is dependent on its tertiary structure, and is likely to be associated 
primarily with the -COOH terminal part of LPL, and also missense mutations far 
outside this site.
1.2.6 LPL AND Disease
This section reviews the clinical manifestations of LPL activity. It has been suggested 
earlier in this review that LPL is a central enzyme in lipoprotein metabolism. The 
intention of this section is to study more closely the role of LPL in insulin resistance 
and CHD. Kissebah et al. proposed twenty years ago that changes in adipose tissue 
metabolism underlie these clinical conditions (Kissebah et al. 1976). Since then, 
further evidence has accrued which supports this belief.
Classic autosomal recessively inherited LPL deficiency is the most common type of 
LPL deficiency. It usually becomes apparent in childhood, but may present in 
adulthood. The symptoms are;
Pancreatitis 
Abdominal pain 
Dementia 
Depression 
Dyspnoea 
Eruptive xanthomas 
Hepatomegaly 
Retinopathy 
Recent memory loss
LPL deficiency is typically characterised by massive hypertriacylglycero laemia, 
chylomicronaemia, high VLDL levels and low HDL levels. There are three main
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causes of LPL deficiency; apolipoprotein CII mutation, LPL mutation or the presence 
of a circulating inhibitor. This circulating inhibitor is very rare and is inherited as an 
autosomal dominant gene. The clinical manifestations of this disorder do subside with 
dietary fat restriction and drug treatment.
1
Low postheparin plasma LPL activity and insulin-deficient diabetes were linked 
together as early as 1968 (Bagdade et al. 1968). Postheparin plasma LPL activity has 
been reported to be reduced in both Type I and Type II diabetes since that time 
(Nikkila et al. 1977; Howard, 1987; O’Looney & Vahouny, 1987). The 
hypertriacylglycero laemia associated with insulin-dependent diabetes mellitus (IDDM) 
is, in part, due to decreased degradation of circulating triacylglycero 1-rich lipoproteins 
because of changes in the apoprotein content of lipoprotein particles and decreased 
adipose tissue LPL activity (Howard, 1987). In general, the more severe the insulin 
deficiency or resistance, the greater the likelihood that decreases in LPL contribute to 
the hypertriacylglycerolaemia, as opposed to increases in VLDL synthesis (Eckel, 
1989). Insulin treatment has been shown to increase postheparin plasma LPL activity 
(O’Looney & Vahouny, 1987). Low postheparin LPL activities seen in diabetic 
patients are increased with fibrate treatment (Sethi, 1995; Grundy & Vega, 1987).
Table 1.2 describes work principally investigating tissue and postheparin plasma LPL 
activity. Heparin-releasable LPL in tissues represents all the active LPL and may also 
reflect some intracellular enzyme secreted during the incubation period. There is 
therefore a clear advantage of measuring tissue LPL mRNA levels alongside tissue 
activity because this represents both the functional and residual LPL, therefore giving 
an estimate of the overall tissue stores of LPL. Reports of the effects of disease states 
on LPL mRNA have been sparse to date and those that have been published have been 
conflicting (Ong & Kern, 1989; Fried et al. 1992). The work in this thesis studies both 
LPL activity and mRNA levels with the aim of clearing up some of the discrepancies in 
our knowledge at present.
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Table 1.2 Literature summary on LPL and disease.
Authors Subiect Description Results
Pykalisto et al. 
1975
8  untreated diabetics 
Age 45+8 years 
15 male controls 
Age 39+9 years.
Heparin-releasable LPL activity significantly 
hi^er in controls (P < 0.001).
1 0 - 1 2  weeks insulin treatment increased heparin- 
releasable adipose tissue LPL (P < 0.025).
Nikkila et al. 
1977
60 Diabetic (IDDM 
and NIDDM) patients 
Age 16 -  56
Postheparin plasma LPL activity correlated with 
basal plasma insulin levels in IDDM patients. 
Insulin treatment increased postheparin plasma 
LPL activity in ketotic diabetics.
Sadur et al. 
1984
Normal weight subjects 
19 women, 8  men
Adipose tissue LPL activity responsiveness to 
insulin infusion decreased following IV fat 
infusion.
Bosello et al. 
1984
2 2  obese, 18 non-obese 
women, age 35+12
Adipose tissue LPL activity (in heparin eluates) 
correlated with plasma insulins at baseline and 
after calorie restriction.
Fried & Krai, 
1986
26 women, age 
37.7+6.6 & 14 men, 
age 39.3+7.6 -  all 
morbidly obese
Heparin-releasable adipose tissue LPL activity 
(LPLA) was;
=> higher in women than men
higher in lower-body subcutaneous sites in 
women
An enlargement of intra-abdominal fat cell size 
not associated with increased LPLA
Laakso et al. 
1987
Female; 12 IDDM, 11 
NIDDM, 16 controls
No difference in postheparin plasma LPL between 
the three groups. LPL significantly correlated 
with HDL cholesterol in all diabetics but not 
controls (P<  0.001).
Ong & Kern, 
1989
15 obese, 6  lean Heparin-releasable LPL activity higher in obese 
subjects.
No difference in IR LPL mass between the two 
groups.
In the lean, 2.2 fold increase in total adipose tissue 
LPL activity - no increase from LPL IR mass.
In the obese, no significant increase in LPL 
activity, IR mass or specific activity in response to 
feeding.
No change in LPL mRNA levels in response to 
feeding.
Kern et al. 
1990
9 very obese subjects 
Age 44+2.6
After weight loss;
Heparin-releasable adipose tissue LPL activity 
increased.
LPL immunoreactive (IR) protein increased.
LPL mRNA levels increased.
Coppack et al. 
1992
8  obese, age 34-57 
10 controls, age 29-64
Postprandial increase in in vivo adipose tissue 
LPL was blunted in the obese.
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The connection between insulin and LPL is not only important in insulin-resistance 
itself, but it has also been linked to abnormal adipose tissue metabolism seen in obesity. 
The major effects of insulin on adipose tissue are, as in other tissues, anabolic. For 
example, insulin stimulates glucose uptake and lipogenesis, it suppresses fat 
mobilisation and stimulates and/or activates LPL (reviewed by Frayn & Coppack, 
1992). Insulin suppresses the release of NEFA from adipose tissue by two 
mechanisms: direct inactivation of the intracellular enzyme hormone-sensitive lipase 
(HSL), and increased re-esterification of the fatty acids liberated by HSL. Loss of 
sensitivity to this insulin suppression of fat mobilisation has been demonstrated in 
obesity (Pykalisto g/ al 1975), NIDDM and IDDM. Impaired suppression of fat 
mobilisation causes an increase in supply of fatty acids to the liver and other tissues. 
This in turn causes an increase in VLDL production, and thus insulin resistance itself 
could cause hypertriacylglycero laemia.
Central obesity is known to be associated with increased cardiovascular disease risk 
(Bjomtorp, 1990). Levels of LPL in adipose tissue affect the maintenance of fat cell- 
size, body weight and obesity. Upper body fat distribution represents an accumulation 
of intra-abdominal fat, with which insulin resistance is particularly associated (Kissebah 
& Peiris, 1989). Glucocorticoid hormones increase LPL activity, particularly in the 
central, intra-abdominal region, which has a high density of a specific glucocorticoid 
receptor. Therefore, certain adipose tissue sites are more sensitive to lipolysis and 
hormonal control of LPL and this leads to differences in regional fat distribution. Both 
genetic and diet-induced obesity are associated with increases in LPL levels in human 
and rat adipose tissue following an overnight fast (Eckel, 1987). Increased LPL 
mRNA and activity have been observed in obese rats (Fried et a l 1992) and in obese 
humans (Ong & Kem, 1989).
Another related consequence of impaired LPL activity, and particularly of impaired 
postprandial activation of LPL by insulin, is a prolonged residence time of remnants in 
the circulation produced by the hydrolysis of TAG-rich lipoproteins. These remnant 
particles may well be responsible for atherogenicity (Zilversmit, 1979). The links 
between insulin-resistance, heart disease and adipose tissue are therefore clear.
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In summary, impairment of normal suppression by insulin of fatty acid release from 
adipose tissue results in increased NEFA delivery to the liver and accelerated VLDL 
production. When LPL activity and response to insulin are low, such as in obesity and 
insulin resistance, there is reduced VLDL-TAG clearance, impaired cholesterol transfer 
to HDL and possibly prolonged residence time of atherogenic remnant particles.
1.3 GASTROINTESTINAL HORMONES
Gastrointestinal hormones are low molecular weight polypeptides with chain lengths 
generally of less than 50 amino acids. Gut peptides may have endocrine (secretin, 
glucagon-like peptides and glucose dependent insulinotropic polypeptide [GIP]), 
paracrine (motilin, somatostatin) or neurocrine (CCK, somatostatin, vasoactive 
intestinal peptide (VIP)) fimctions. They are distributed in endocrine and neural 
elements of the gut and throughout the central nervous system. This review will 
concentrate on some of the secretin family of hormones, since there is a considerable 
structural homology and overlap in the biological activities within this group and many 
play a major role in the enteroinsular axis. The major members of the secretin family 
are secretin, GIP, VIP, peptide histidine jnethionine, and the glucagon-like peptides. 
These hormones have a role in insulin secretion via the enteroinsular axis and therefore 
have effects on carbohydrate metabolism. More recently evidence has built up 
supporting the finding of specific receptors for some of these hormones in adipose 
tissue, therefore suggesting their role in lipid metabolism also.
1.3.1 GIP
Glucose dependent insulinotropic polypeptide (GIP) contains 42 amino acid residues 
in the porcine, human and bovine forms of the hormone (Jomvall et a l 1981 ; Moody et 
al 1984). The human GIP gene spans 10 kb and is located on the long arm of 
chromosome 17. It is derived from a 153 amino acid precursor protein that is encoded 
in exons 2, 3 and 4. Most of the sequence for mature GIP is in exon 3. Pro-GIP is 
processed to one main biologically active end product, GIP 1-42 (Brown & Dryburgh, 
1971). The N-terminal of GIP is important for biological activity. GIP 3-42, for
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example, has no insulin-releasing activity (cited by Fehmann et al. 1995). GIP is 
secreted in the k-cells of the small intestine, specifically the duodenum and upper 
jejunum in man (Bloom & Polak, 1981). In rodents, k-cells are also distributed along 
the duodenum, jejunum and ileum (Solcia et al. 1989). Specific receptors for GIP have 
been isolated in a number of tissues including pancreas, stomach, duodenum, proximal 
small intestine, adipose tissue, adrenal gland and brain (Usdin et al. 1993). The rat 
receptor is comprised of 455 amino acids and contains three potential glycosylation 
sites before the first transmembrane domain. Functions of GIP in all these tissues are 
not yet known but those which are known are discussed later. In humans typical 
circulating levels of GIP in plasma are between 0.05 -  0.1 nM.
GIP is secreted in response to the absorption of nutrients. On an energy basis, fat is a 
more potent stimulus for GIP secretion than glucose in man (Jorde et a l 1983). GIP 
release stimulated by sugars has been shown to depend upon the active transport of the 
monosaccharide into the enterocyte (Sykes et al. 1980). Also, the rate of GIP 
secretion is proportional to the rate of glucose absorption fi-om the gut (Ellis et al. 
1995). So GIP release is clearly triggered by the absorption of monosaccharides rather 
than merely by their presence in the intestine (Sykes et al. 1980). As with sugars, fatty 
acid absorption is a necessary prerequisite for their effect on GIP secretion. Long 
chain unsaturated fatty acids enhance GIP release more than shorter chain saturated 
fatty acids (Kwasowski et al. 1985). For example, fish oils are very potent stimuli of 
GIP release in human subjects (Lardinois et al. 1988).
Only fatty acids re-esterified in the enterocyte and incorporated into chylomicrons 
stimulate GIP secretion and it may be the energy requiring re-esterification process that 
is the signal for GIP secretion (Thomson & Dietschy, 1981). However, there is a close 
correlation between plasma TAG and plasma GIP levels postprandially, so it may be 
chylomicron release from the enterocyte, rather than reesterification of TAG, that 
stimulates GIP release. Protein is a poor stimulus for GIP secretion, with only high 
amounts of amino acids being GIP secretagogues (Penman et al. 1981) and protein 
itself not showing stimulatory properties (Elliott et al. 1993). In a more physiologically 
realistic situation, where a mixed meal is ingested, the interpretation of effects of
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individual macro nutrients on GIP release is confounded by the volume and physical 
form of the meal exerting changes on gastric emptying (Low, 1990). In an attempt to 
overcome this, recent work has studied intraduodenal fat and carbohydrate infusions in 
pigs (Knapper et al. 1995a). In contrast to human subjects, carbohydrate was the most 
potent stimulus for GIP secretion. However, a dual infusion of fat and carbohydrate 
together provided the strongest overall effect.
1.3.2 GLP-1
Glucagon-like peptide-1 (GLP-I) contains 30 amino acid residues and is secreted in 
mucosal L-cells from proglucagon (Varndell et al. 1985). The human GLP-1 gene is 
located on the long arm of chromosome 2  and spans lOkb in length.
lys arg 
70 71
GRPP GLUCAGON GLP- Sp2 GLP-2
3132 6263 109 110 124 125 159 160 
arg lysarg arg arg arg arg
POSTTRANSLATIONAL PROCESSING
PANCREAS A cell SMALL INTESTINE L cell
122 126107 I158
Sp-2GLP-1 GLP-2MPGFGLUCAGONGRPP
Figure 1.2 Diagrammatic representation of the structure of proglucagon and its
tissue specific processing.
(GRPP = Glicentin-related pancreatic peptide; MGPF = Major proglueagon fragment)
Proglucagon is an 160 amino acid peptide precursor. It consists of an N-terminal 
which is homologous to glicentin-related pancreatic peptide (GRPP), the glucagon 
sequence (proglucagon 33 - 61), glucagon-like peptide-1 (78 -107 amide) and
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glucagon-like peptide-2 (126 - 158). The GLP-1 and GLP-2 are separated by an 
intervening sequence of 13 amino acids, the so-called spacer peptide (Sp-2) (111 - 122 
amide) (0rskov et a l 1989). Although glucagon, GRPP, GLP-1 and GLP-2 all come 
from the same precursor, they are cleaved differently in the pancreas and small intestine 
to produce the individual hormones (Mosjov et a l 1986) as shown in Figure 1.2. 
GLP-1 closely resembles glucagon at the N-terminal end -  the first 1 0 - 1 5  residues 
being identical when position 7 (histidine) of GLP-1 is aligned with position 1 
(histidine) of glucagon. This highly homologous sequencing is conserved between 
species (hamster, man, cow, rat and guinea pig), suggesting significant biological 
functions of GLP-1. The presence of a histidine residue at position 7 of GLP-1 as a 
free N-terminal amino acid is very important in the insulinotropic activity and 
glucagonostatic effect of GLP-1. C-terminal amidation and the presence of three C- 
terminal amino acids are less important for its activity (Suzuki et a l 1989).
Cleavage of an N-terminal hexapeptide produces GLP-1 (7 .3 7 ) which, along with GLP- 
1 (7 .3 6 ) amide, are the major circulating forms of GLP-1 and are the biologically active 
forms of the peptide. GLP-1 (7 .3 6 ) amide is produced by further C-terminal truncation 
(Fehmann et a l 1995) and represents approximately 90% of the circulating forms of 
the peptide in humans. The N-terminal part of the molecule is responsible for the 
receptor binding and activation, and both peptides, amidated or not, are thought to 
possess identical insulin-releasing potencies in equimolar concentrations (0 rskov et a l 
1993; Adelhorst et a l 1994; Hjorth et a l  1994). The highest concentrations of this 
peptide are found in the distal ileum and colon. The cell number of GLP-1 positive 
cells increases from the duodenum to the distal jejunum and ileum and again, from the 
proximal to the distal colon, reaching maximum cell density in the rectum (Eissele et a l
1992).
The GLP-1 receptor consists of 463 amino acids and there is a 90% homology between 
rat and human receptors. The human GLP-1 receptor gene is localised on the long arm 
of chromosome 6  (Stoffel et a l 1993). It has recently been shown that glycosylation 
of the receptor is a necessary prerequisite before full activity of the receptor is possible
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(Gôke et al. 1994). The distribution of the receptor is discussed more fully in 
Chapter 3.
The nature and mechanism of nutrient stimulus for GLP-1 secretion remain unclear, 
mainly due to the low circulating levels of this hormone and different cross-reactivities 
of antisera with the various biologically active and inactive forms of GLP-1 (Knapper 
et al. 1996). Despite its location in the gut, rises in GLP-1 have been observed in 
response to nutrient ingestion. It has been suggested that small amounts of nutrients 
reach the distal small intestine rapidly after digestion and this is supported by studies of 
patients with accelerated gastric emptying rates (Miholic et al. 1991). Alternatively, a 
novel inter-endocrine loop between GIP and GLP-1 has been proposed in animals, as 
intravenous infusion of GIP leads to an increase in plasma GLP-1 (7-37), the 
biologically active unamidated form of GLP-1 (Roberge & Brubaker, 1993). In 
humans, it is the presence of food in the upper gut which is the most likely trigger of 
GLP-1 release. Glucose stimulates GLP-1 secretion in pigs (0rskov et al. 1986) and in 
humans (Kreymann et al. 1987). It appears to be the presence of glucose in the 
intestine rather than its digestion which stimulates GLP-1 secretion (Shima et al. 1990; 
Fukase et al. 1992). A monocomponent fat test meal produced a small, significant rise 
in circulating GLP-1 (7-36) amide in humans (Elliott et al. 1993), but the mechanism 
behind this is unknown. In the same study, a purely protein meal only slightly 
increased GLP-1 (7-36) amide levels in plasma. When Knapper et al. (1995a) 
performed single nutrient infusion studies in pigs, fat was the most potent stimulus of 
GLP-1 (7-36) amide secretion but maximal GLP-1 secretion was achieved by a mixture 
of fat and carbohydrate.
1.3.3 F u n c t io n s  o f  GIP a n d  GLP- 1
1.3.3.1 Pancreatic Functions
The most widely reported function of GIP and GLP-1 is that of stimulating glucose- 
mediated insulin secretion via the enteroinsular axis. The term enteroinsular axis (EIA) 
was adopted by Unger & Eisentraut in 1969 to encompass all the gut factors which 
contribute to enhanced insulin secretion after the consumption of a meal.
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Gastrointestinal peptides potentiate insulin secretion via both neural and endocrine
pathways, but in man the endocrine role of the gut hormones (collectively known as the
incretins) is considered to be quantitatively more important (Clark et al. 1989). GIP
secretion
and GLP-1 stimulate insùlihjÿià adenylate cyclase activation (Rasmussen et al. 1990; 
Shimizu et al. 1986) and can also enhance proinsulin gene expression. Both hormones 
enhance intracellular cAMP production. During the process, their receptors undergo 
rapid and reversible homologous receptor desensitisation which is typical of G protein- 
coupled receptors. Signal transduction after GIP or GLP-1 receptor binding occurs via 
an increase of Ca^  ^ influx through voltage-dependent Ca^  ^ channels. This rise in free 
cytosolic Ca^  ^ is necessary for GLP-1 and GIP to potentiate glucose-induced insulin 
release. GIP only stimulates insulin secretion at elevated glucose levels and glucose 
metabolism of the B cell must occur before GIP-stimulated insulin secretion occurs.
Another role of GIP and GLP-1 is in the control of glucagon and somatostatin, a 
hormone which regulates gastric acid and gastrin secretion. The actions of GIP and 
GLP-1 on glucagon release are strongly dependent on glucose concentrations. For 
example, GIP only stimulates glucagon secretion fi*om the perfused rat pancreas at low 
glucose levels. In contrast, GLP-1, but not GIP, caused a release of insulin and 
lowered plasma glucagon levels in patients with type II diabetes mellitus (Nauck et al.
1993). GIP is only a weak stimulator of somatostatin secretion in rats because the D 
cells seem to be less sensitive to GIP than the B cells (cited by Fehmann et al. 1995).
GLP-1 has a direct effect on the pancreatic D cells and its effects on somatostatin 
secretion are not glucose dependent. GLP-1 releases somatostatin secretion from 
human islets, and the inhibitory effect of GLP-1 on glucagon secretion negatively 
balances the somatostatin release. Therefore, glucagon secretion might be suppressed 
by the stimulation of B and D cells (Fehmann et al. 1995). GLP-1 and GIP also 
stimulate proinsulin biosynthesis, demonstrating that they not only stimulate insulin 
secretion but also help to replenish the intracellular insulin pool (Fehmann et al. 1995). 
Neither GIP nor GLP-1 have any reported exocrine function in the pancreas (Fehmann 
et al. 1995).
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1.3.3.2 Extrapancreatic functions
The isolation of specific receptors for both GIP and GLP-1 in many tissues outside the 
pancreas has confirmed these extrapancreatic functions and provide a possible 
mechanism for their action. The central role of GIP and GLP-1 in insulin secretion via 
the enteroinsular axis may be affected by diet. Therefore it is likely that these 
hormones may have a role in the pathogenesis of diseases such as diabetes and obesity, 
both of which are associated with insulin deficiency or excess and in which dietary 
factors are also implicated. This section therefore includes evidence for the potential 
clinical roles of these hormones.
In adipose tissue, GIP stimulates the release and activity of lipoprotein lipase (see
Section 1.2.5). GIP also augments the insulin-stimulated triacylglycerol synthesis in rat
epididymal adipose tissue and increases the clearance of chylomicrons in dogs, but not
man (Dupre et al. 1976). Both GIP and GLP-1 have been shown to increase de novo
fatty acid synthesis (Oben et al. 1991) in rat epididymal adipose tissue explants.
Exogenous and endogenous GIP increases plasma triacylglycerol disposal in rats (Ebert
: investigated
et al. 1991) and dogs (Wasada, 1981) but has not b e e n -^ ô w m  man. GIP may also 
modulate the effects of insulin by directly altering target tissue sensitivity to insulin 
(Starich er «/. 1985).
Hormonal control of LPL can occur at any stage in the synthesis, processing, secretion, 
or degradation of the enzyme. GIP and GLP-1 (7-36) amide show direct anabolic
effects on adipose tissue (Morgan et al. 1992) and both stimulate insulin secretion in 
the postprandial hyperglycaemic state (Kreymann et al. 1987). Eckel and colleagues 
showed GIP stimulating the activity of LPL in cultured mouse preadipocytes (Eckel et 
al. 1979). Rebuffé-Scrive (1990) showed adipose tissue LPL activity to be influenced 
by both insulin and steroid hormones. When GIP and insulin are added simultaneously, 
an additive effect on stimulation of LPL activity in rat adipose tissue explants is 
observed (Knapper et al. 1995b).
GIP was originally thought to exert its effects on LPL through its action on the 
pancreatic B-cell. However, attention now focuses on other direct anabolic functions
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of this hormone which are described in detail in Section 1.3.1. GLP-1 (7-36) amide is 
very similar to GIP in its structure and the way it acts on the pancreatic B-cell. GLP-1 
(7-36) amide circulates in the plasma at lower concentrations than GIP, being present 
at levels of only 0.006 - 0.04nM in healthy individuals.
GLP-1 has been shown to exert a histamine-like effect in parietal cells of the stomach 
and is a potent inhibitor of the cephalic phase of acid secretion in man (Wettergren et 
ah 1994). In 1992, 0rksov compared the effects of GIP and GLP-1 (7-36) amide and 
GLP-1 (7-37) on gastrin secretion in isolated, perfused rat stomachs. Both GIP and 
GLP-1 increased somatostatin secretion at a threshold of 50 pmol/1, but each had a 
different maximal effect. GIP increased gastrin secretion but GLP-1 (7-36) amide and 
GLP-1 (7-37) suppressed its release. These results were confirmed in 1994 by Jia and 
colleagues. However, these results are fi'om in vitro culture work and at 
supraphysiological levels so more work is required to elucidate the true effects in man.
GIP reduces glucagon-stimulated hepatic glucose production, especially at high insulin 
concentrations but to date there has been no firm evidence for a hepatic role of GLP-1. 
GLP-1 has been found in the hypothalamus and brain stem, indicating a role as a 
central neurotransmitter in the brain, probably involved in autonomic and 
neuroendocrine regulations. New work on the role of GLP-1 as a clinical tool suggests 
that GLP-1 may have a role in the central regulation of feeding. GLP-1 receptors are 
present on the hypothalamus which is a brain area known as an integral centre for 
feeding regulation. Research has involved intracerebroventricular (ICV) injection of 
GLP-1 (7-36) amide with and without its antagonist exendin. Following a 24 hour fast 
rats which had received a GLP-1 injection had significantly lower food intake in the 
first 3 hours of refeeding. This did not recover during the ensuing 3 hours, resulting in 
an overall reduction in the cumulative food intake (Schick et al. 1994). ICV injection 
of the specific GLP-1 receptor antagonist, exendin, blocked the inhibitory effect of 
GLP-1 on food intake and augmented the feeding response to the appetite stimulant 
neuropeptide Y (Turton et al. 1996).
32
Chapter 1
Glucagon has been shown to produce a slight but significant rise in blood pressure in 
normal individuals but this work was done thirty years ago and a mechanism for this 
effect has not been discovered. As GLP-1 and its receptors are present in the nucleus 
tractus solitarius, which is involved in the central control of cardiovascular function, it 
may be that GLP-1 is involved in blood pressure change. A recent study in rats found 
that GLP-1 (7-36) amide induced a concentration-dependent increase in both systolic 
and diastolic blood pressures fi'om physiological to pharmacological doses, with 
lOOOng dose having the most significant effect (Barragân et al. 1994). Surprisingly, 
GLP-1 (1-37) produced a moderate but significant increase in both diastolic and 
systolic blood pressures and GLP-2 had no effect.
Plasma GLP-1, and sometimes plasma GIP levels, have been found to be high in non­
insulin dependent diabetics. GLP-1 infusion reduces meal-related insulin requirements, 
perhaps through delayed gastric emptying and/or enhanced insulin sensitivity due to 
suppression of glucagon (Gutniak et al. 1992). In patients with poor glycaemic 
control, normoglycaemia was achieved by a single subcutaneous injection of GLP-1 
(Gutniak et al. 1993). GLP-1 has recently been shown to have direct effects on tissues 
involved in glucose disposal since it enhanced glucose tolerance in healthy subjects by 
significantly stimulating insulin release and increasing insulin-dependent glucose 
disposal (D’Alessio et al. 1994). GLP-1 may therefore have therapeutic properties in 
the treatment of NIDDM.
Obesity is often associated with hyperinsulinaemia. This hyperinsulinaemia could be 
due to a number of factors, one of which could be an overactive enteroinsular axis, 
thus causing hyperstimulation of insulin release. Both high fasting GIP levels and 
exaggerated GIP responses to oral glucose have been measured in obese individuals 
(Creutzfeldt et al. 1978; Mazzaferri et al. 1985) but other investigators have failed to 
show any differences (Ranganathan et al. 1996). The elevated GIP levels have not 
always been mimicked by increased insulin secretion. GIP has been shown to increase 
deposition of adipose tissue, increase lipoprotein lipase activity (Eckel et al. 1978; 
Knapper et al. 1995b) and stimulate fatty acid synthesis de novo (Oben et al. 1991). 
Therefore it is reasonable to suggest that GIP may either have a direct effect on the
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hyperinsulinaemia of obesity or may have a direct metabolic role in the disease in the 
light of the factors listed above. GLP-1 secretion following oral glucose is reduced in 
obesity (Ranganathan et a l 1996), providing fiirther evidence for a possible role for 
GLP-1 in satiety.
1.4 INSULIN
1.4.1 Structure OF INSULIN
Insulin exists as 2 polypeptide chains linked by disulphide bridges. The ‘A’ chain 
contains 2 1  amino acid residues with an intrachain disulphide bridge between amino 
acids 6  and 11. The ‘B’ chain consists of 30 amino acids. The secondary structure 
involves helical regions within both the A and B chains and an extended loop region 
exists in the A chain. A large proportion of the B chain is in extended conformation, 
but this can assume helical conformation under certain conditions (Wood & Mcleod,
1991).
1.4.2 Production OF INSULIN
Insulin is produced in the B cells of the pancreatic islets. These cells are the most 
numerous type of islet cell and are positioned in the centre of the islet, surrounded by 
the other cells -  the A, D and PP cells. The B and A cells are interconnected by tight- 
and gap-junctions (Orci, 1976). Within the B cell, the initial insulin precursor is 
preproinsulin -  an ll.SkDa polypeptide. This is then rapidly discharged into the 
cisternal space of the RER where it is cleaved by proteolytic enzymes to pro insulin, a 
9kDa polypeptide consisting of the A and B chains positioned at opposite ends of a C- 
peptide molecule. Pro insulin is transported by microvesicles to the Golgi apparatus 
where it is folded and aligned by disulphide bridges. The conversion of pro insulin to 
insulin is initiated in the Golgi complex and continues in secretory granules. Mature 
insulin is produced during a critical drop in pH. It has a lower solubility than pro insulin 
and so precipitates with zinc to form micro crystals within the secretory granule.
34
Chapter 1
1.4.3 Secretion OF INSULIN
The major secretagogue for insulin is glucose. The secretion of insulin in response to a 
mixed meal in vivo occurs in three stages; a cephalic phase under the control of 
acetylcholine, an early enteric phase under cholecystokinin (CCK) regulation, and a late 
enteric phase which is influenced by glucose, GIP and CCK (Rasmussen et a l 1990). 
Glucose must be metabolised before it acts as a stimulus for insulin secretion and it is in 
conjunction with other extracellular and intracellular stimuli that most insulin secretion 
occurs. These stimuli arise at different times and fi'om different sources and create a 
complex picture which is too detailed to describe fially in this review. However, in 
brief, the extracellular stimuli include acetylcholine, released by parasympathetic nerves 
at the B cell itself, and cholecystokinin (CCK), secreted at the synapses of nerves 
which supply the B cells. These two stimuli act by stimulating phosphoinositide- 
specific phospho lipase C. Other extracellular stimuli include GIP and GLP-1 which act 
by stimulating adenylate cyclase. The consequence of both these pairs of stimuli acting 
through different intracellular messengers is unclear, but there is potential for additive 
or synergistic effects (Rasmussen ûf/. 1990).
Calcium and cAMP serve as two important intracellular messengers during the actions 
of glucose on insulin stimulation. Glucose itself does not generate these intracellular 
messengers, but rather the products of glucose metabolism such as ATP (Ashcroft et 
a l 1973). cAMP exerts its action by activating protein kinases. Calcium alters B cell 
membrane potential and stimulates protein kinase C which is important in regulating 
the insulin response caused by neurotransmitters. The interrelationship of insulin 
secretion and regulation is shown in Figure 1.3.
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Figure 1.3 Diagram showing interactions between stimuli (eg. glucose), 
potentiators (eg. GIP) and neurotransmitters (eg. acetylcholine) in the regulation 
of insulin secretion (Howell, 1988).
Levels of insulin are maintained by insulin-receptor interactions at the target cell 
surface. The insulin receptor consists of 2 a-subunits and 2 (3-subunits joined by 
disulphide bonds. The (3-units contain the trans-membrane sequence and it is thought, 
although it is not certain, that the insulin binding domain is in a cysteine-rich region of 
the a-subunit. At the plasma membrane surface insulin binds to the receptor and 
triggers either signal transmission by second messengers or internalisation. The 
isolation and classification of second messengers of insulin is an ongoing area of 
research and the precise nature of the second messengers have still not been fully 
identified. The most popular theory is that insulin promotes phosphorylation or 
dephosphorylation of proteins such as glycogen synthetase, pyruvate dehydrogenase, 
hormone sensitive lipase and acetyl CoA carboxylase, alongside the generation of 
second messengers (Saltiel, 1990). The structures of specific second messengers have
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not been discovered, but they are reported to regulate the activities of several insulin- 
sensitive enzymes.
Receptor-mediated endocytosis accounts for approximately 85% of insulin clearance in 
vivo, mostly by hepatic insulin receptors. The occupied receptors are internalised into 
endocytotic vesicles. The excess insulin is then degraded by lysosomes and the 
receptors are processed by the Golgi complex before recycling to the cell surface. 
Insulin receptor numbers can change under various conditions such as 
hyperinsulinaemia and obesity. Insulin can down-regulate its own receptor by 
increasing receptor internalisation and turnover. This may explain the reduced overall 
insulin sensitivity in hyperinsulinaemia. In obesity, an impairment in hepatic insulin 
extraction after oral glucose might be caused by the reduction of receptor-dependent 
insulin degradation (Eaton et a l 1984). It may therefore be reasonable to expect a 
relationship between fasting insulin and the degree of reduction in hepatic insulin 
extraction after oral glucose (Bonora et a l 1984).
1.4.4 Insulin IN DISEASE
In 1988, Reaven listed the typical pathological signs for the insulin resistant syndrome 
as (1) resistance to insulin-stimulated glucose uptake (2) glucose intolerance (3) 
hyperinsulinaemia (4) increased VLDL-TAG concentration (5) decreased HDL- 
concentration and (6) hypertension. He called this ‘Syndrome X’ or ‘Reaven’s 
syndrome’ (Reaven, 1988). There are several suggested ways in which insulin 
resistance is thought to affect cardiovascular disease risk. Firstly, insulin resistance 
leads to a raised plasma glucose level (Reaven, 1988). This in turn leads to an 
increased rate of non-enzymic glycation of proteins. Glycation of apolipoproteins may 
affect the postprandial clearance and hence atherogenicity of these particles (Duell et 
a/. 1990).
Insulin has direct effects on adipose tissue which may link heart disease and insulin 
resistance. Insulin has an anabolic effect on adipose tissue: stimulation of glucose 
uptake and lipogenesis, suppression of fat mobilisation, and stimulation of LPL.
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Insulin suppresses the release of NEFA from adipose tissue by two mechanisms: direct 
inactivation of hormone-sensitive lipase (HSL), and increased re-esterification of the 
fatty acids liberated by HSL. In obesity and type II diabetes, patients lose the 
sensitivity to insulin-suppression of fat mobilisation and this results in over-delivery of 
fatty acids to the liver and other tissues. Increased fatty acids to the liver result in 
overproduction of VLDL, a lipoprotein whose role in hypertriacylglycerolaemia is 
well-defined. Where insulin stimulation of LPL is low, this results in 
hypertriacylglycerolaemia by decreased rates of clearance of chylomicron-TAG (see 
section 1.1.7) and hence prolonged residence time of potentially atherogenic particles 
in the circulation.
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1.5 AIMS AND SCOPE OF THIS RESEARCH PROJECT
This literature survey stresses the importance of the metabolic role of LPL. LPL may 
affect cardiovascular disease risk because it is the rate-limiting step in the clearance of 
dietary TAG from chylomicrons and VLDL. Also, LPL has a pivotal role in regional 
fat deposition and thus may play an integral part in the development of obesity. The 
effects of gastrointestinal hormones and diet on LPL activity may therefore indirectly 
affect risk of cardiovascular disease and its associated complications and play a part in 
the development or maintenance of obesity.
Therefore the aims of this research project were:
1) To investigate the in vitro effects of insulin, GIP and the glucagon - related 
family of peptides on adipose tissue lipoprotein lipase activity.
2) To investigate the in vivo effect of dietary manipulation in humans on 
postprandial gastrointestinal and pancreatic hormone secretion, LPL activity 
and lipoprotein metabolism.
3) To investigate the effects of changes in dietary fatty acid intake on hormone 
secretion, LPL activity and gene expression in rats at different stages of 
development.
4) To investigate how changes in diet affect LPL gene expression as well as 
activity in rats and humans.
In pursuing these aims, the following experimental work was performed;
1) Previous work studying the effects of gastrointestinal hormones and insulin on
explants of rat epididymal adipose tissue was first substantiated (Beety, 1994;
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Knapper et al. 1995b). The effects of other gastrointestinal hormones and 
insulin on in vitro lipoprotein lipase activity were then investigated further in 
explants of rat epididymal adipose tissue.
2) The effect of previous meal frequency on postprandial lipoprotein metabolism 
and plasma levels of insulin, GIP and GLP-1 was investigated in human 
subjects. A dietary intervention study was performed, comparing normal food 
intake as 2 meals a day with 12 meals a day. At the end of each manipulation 
period, changes in postprandial responses to a standard test meal were 
measured.
3) A developmental study was performed in Wistar Albino rats to investigate the 
effects of changes in maternal dietary fatty acid intake on postprandial 
lipoprotein metabolism in the offspring. This work was designed to elucidate 
further the mechanisms behind Barker’s hypothesis which states that maternal 
diet during pregnancy and early diet of the offspring have important effects on 
disease status in later life (summarised by Barker et a l 1993a). A comparison 
was made between a mixed oil diet, designed to mimic the typical U.K. intake 
of fatty acids, and a fish oil diet. The offspring were sacrificed at different ages 
to investigate any changes in circulating hormones and metabolites or LPL gene 
expression that carried through to adult life.
4) Work was performed to develop the method of Northern blot analysis for the 
measurement of mRNA and to produce a specific cDNA probe for LPL. The 
question of whether diet alters LPL mRNA levels directly was addressed -  both 
in rat and human adipose tissue samples.
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2. MATERIALS AND METHODS
2.1 MATERIALS
All general laboratory chemicals were supplied by Fisons, Loughborough or BDH, 
Poole and were AR grade unless otherwise stated. Specific chemicals ordered include:
Radiochemicals
'^^I-sodium iodide 
'""I-Insulin 
^^ P-dCTP 
Hormones
Supplier
ICN, Thame
Amersham International, Buckinghamshire 
ICN, Thame
Sigma Chemical Company Ltd., Poole 
Peninsula Laboratories, St. Helens 
Peninsula Laboratories, St. Helens 
Peninsula Laboratories, St. Helens 
Peninsula Laboratories, St. Helens 
Peninsula Laboratories, St. Helens 
Peninsula Laboratories, St. Helens 
Peninsula Laboratories, St. Helens 
Sigma Chemical Company Ltd., Poole
GIP (porcine)
GIP (human)
GLP-1 (7-36) amide 
GLP-1 (1-36) amide (human)
GLP-1 (7-37)
GLP-1 (1-37) (human)
GLP-2 (human)
Glucagon (human)
Insulin (porcine)
Molecular Biology Grade Products
Sodium chloride Sigma Chemical Company Ltd., Poole
Guanidium isothiocyanate Gibco BRL (Life Technologies), Paisley
Sarkosyl BDH, Poole
2-Mercaptoethanol Sigma Chemical Company Ltd., Poole
Ethidium bromide (Aqueous solution) Sigma Chemical Company Ltd., Poole 
Diethyl pyrocarbonate Aldrich, Gillingham, Dorset
Lauryl sulphate Sigma Chemical Company Ltd., Poole
Isoamyl alcohol Sigma Chemical Company Ltd., Poole
Hybaid mesh Hybaid Ltd., Teddington, Middlesex
Hybond N+ membrane Amersham International, Buckinghamshire
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Bromophenol blue 
Others
BSA (Fraction V, RIA Grade) 
BSA (Essentially fatty acid free) 
HS A Fraction V 
Medium 199
(containing 25mM HEPES buffer, 
Earles salts and L-glutamine) 
Aprotinin (from bovine lung) 
Bacitracin
Heparin (porcine, sodium salt)
Straight iris scissors
Sac-Cel
Nick Columns
LP3 and LP4 tubes
Cannulae ( Y -CAN 19g)
14ml sterile Falcon tubes 
5ml and 10ml lithium heparin tubes 
Kodak X-OMAT AR5 
autoradiography film 
Sephadex G-15 
Chloramine-T 
Sodium metabisulphate 
Affinity purification columns 
Nonidet P40
Folin-Ciocalteu Phenol Reagent 
Coomassie Brilliant Blue G-250 
Xylene cyanole FF 
Hypoxanthine 
Superoxide dismutase 
(From bovine erythrocytes)
Sigma Chemical Company Ltd., Poole
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Gibco BRL, Paisley
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Downs Surgical Ltd., Mitcham, Surrey 
IDS Ltd., Tyne & Wear 
Pharmacia, St. Albans 
Lip Services, Shipley
H.G. Wallace Ltd.
Greiner Labortechnik Ltd., Dursley
Lip Services, Shipley
Sigma Chemical Company Ltd., Poole
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Cliffrnar Associates Ltd., Guildford 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole
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Xanthine oxidase (From Buttermilk) 
Cytochrome C 
Imidazole Buffer
Titanium oxysulphate sulphuric acid 
complex hydrate
Flavin adenine dinucleotide (disodium 
salt)
Oxidised glutathione 
NADPH (Tetrasodium salt)
Cobas Mira Analysis Kits 
TAG Analysis Kit
Cholesterol Kit
Glucose Kit
Paracetamol Kit
NEFA Kit
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Sigma Chemical Company Ltd., Poole 
Aldrich, Gillingham, Dorset, U.K.
Sigma Chemical Company Ltd., Poole
Sigma Chemical Company Ltd., Poole 
Boehringer Mannheim GmbH, Germany
Roche Diagnostic Products Ltd., Welwyn
Garden City, Hertfordshire
Roche Diagnostic Products Ltd., Welwyn
Garden City, Hertfordshire
Roche Diagnostic Products Ltd., Welwyn
Garden City, Hertfordshire
Cambridge Life Sciences, Ely,
Cambridgeshire
WAKO Chemicals (Alpha Laboratories, 
Eastleigh, Hampshire)
2.2 METHODS
2.2.1 Lipoprotein LIPASE assay
Lipoprotein lipase activity was measured by a modified method described by Nilsson- 
Ehle and Schotz (1976). The method uses the detection of ^ H-labelled fi*ee fatty acids 
fi'om a labelled triolein substrate emulsion, according to the equation below;
Glycerol ^H-trioleate —> ^H-oleic acid + glycerol
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3 ■ "2.2.1.1 Preparation o f H- triolein emulsion
triolein (50pl), triolein (250p,l) and phosphatidyl choline (50pl) were placed in a 
sonicating vial and blown down under nitrogen in the dark for 1 - 2 hours. Glycerol
(5ml) was added and the emulsion mixed using a vortex mixer. The emulsion was kept 
on ice throughout this preparation stage. The emulsion was sonicated at 20 minute 
intervals at room temperature using a Soniprep probe for 10 - 20 second bursts for 2- 3 
hours until no visible oil droplets remained on the surface of the glycerol. The 
emulsion was then stored at room temperature in glass tubes wrapped m foil and was 
stable for up to 5 weeks. The linearity of each emulsion was checked by a dose- 
response curve, using standards prepared from fresh unpasteurised cow’s milk which 
were stored at -80°C.
2.2.1.2 Preparation o f milk standards and apo CII source
The milk was first decreamed by centrifuging at 463 x g for 10 minutes to bring the 
cream to the surface. The cream layer was then scraped off and the remaining milk 
passed through glass wool three times to remove any other fat. The standards were 
either a 1 in 10 dilution or a 1 in 4 dilution of the decreamed milk, diluted using 0.2M 
NaCl-Tris buffer (pH 8.1). Heat activated serum was used in each assay to provide 
apo CII. Venous blood was taken from a group of volunteers and collected into tubes 
without anticoagulant. The blood was left to clot at room temeprature for 2 hours and 
centrifuged at 3000rpm for 10 minutes in a benchtop centrifuge. The plasma was 
removed, pooled and incubated at 65°C for 15 minutes before being aliquoted into 
500pl aliquots and stored at -80°C.
2.2.1.3 Assay vrotocol
The protocol described below is for LPL activity in explant medium. Variations in the 
assay according to the sample being analysed are described below the protocol. The 
assay tubes were kept on ice whilst all the reagents were added to prevent the reaction 
occurring before the incubation stage. Explant medium (lOOpl) was placed in a 
disposable 14ml centrifuge tube and substrate emulsion (lOOpl) was added. The 
substrate emulsion was prepared by adding 0.2M NaCl-Tris buffer (pH 8.1, containing 
0.3% BSA), human serum and ^H-triolein emulsion together in the ratio 4:1:1. The 
mixture was then vortex mixed and incubated at 37°C for 10 minutes before being
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added to the reaction tubes. Once the substrate emulsion had been added to the 
reaction tubes, they were capped and incubated at 37°C for 45 minutes. At the end of 
this period, 3.25ml organic solvent (ie. chloroform, methanol and heptane in the ratio
1.25:1:1.41) and 1.05ml O.IM K2CO3 (pHlO.5) were added to all tubes to stop the 
reaction and the free fatty acids were extracted into the upper, methanolic phase. The 
tubes were then vortex mixed vigorously to aid extraction and centrifuged at 1852 x g 
for 10 minutes. Part of the aqueous (top) phase (500pl) was then removed and added 
to a scintillation vial containing 4ml Optiphase ‘Safe’ and glacial acetic acid (75pi). 
Once the tubes had been shaken and stood for one hour in the dark they were counted 
for radioactivity on a Wallac 1410 beta counter. Each tube was counted for five 
minutes using a preset programme.
The LPL activity was calculated using the following expression:
Enzyme activity (pmol oleate.min'^) at 37°C =
(DPM -  blank) x -  x  ^ ---------;— — x 3 x 4.9 x
t specific activity of triolein 0.76
Where;
t = incubation time (minutes)
radio-
Specific^ctivity of triolein = 2170584.8 DPM/pmol
(varies with each batch)
3 = 3  frtty acids released for each triacylglycerol ' 
hydrolysed 
4.9 = dilution factor
0.76 = partition coefficient for oleate into the 
aqueous phase.
The results were expressed as % change in activity per gram of tissue per minute for 
the explant work or as milliunits (mU) for plasma samples, where one milliunit 
represents Inmol oleate released per ml plasma, per minute at 37°C.
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2.2.1.4 Assay protocol for postheparin plasma
Only 20pl postheparin plasma were added to the assay mixture, the total volume being 
kept at lOOpl by adding 80pl of Tris-buffer. The incubation time at 37°C was only 30 
minutes because of the relatively high LPL activity in these samples compared to 
explant medium. The assay was run in the presence of 0.2M NaCl and 4M NaCl in the 
Tris buffers. Hepatic lipase is still active in the presence of 4M NaCl but LPL is not, so 
the LPL activity is calculated as the difference between the results from each NaCl 
concentration.
The intraassay coefficients of variation (CVs) were 4.9% at 70 mU and 5.6% at 270 
mU and the inter-assay coefficient of variation (CV) was 8.7% at 260 mU (plasma 
samples).
2.2.2 Isolation of RNA from adipose tissue
This technique is based on a method reported by Chomczynski & Sacchi (1987). 
Autoclaved, DEPC-treated water was used to prepare all the solutions described. The DEPC
(diethyl pyrocarbonate) treatment involved adding 1ml DEPC per litre of R.O. water, 
holding the water at 37°C overnight and then autoclaving. All the glassware used was 
baked overnight at 80°C to eradicate RNAses and all procedures were carried out in 
sterile conditions.
Reasents
Denaturing solution C D l Phenolic solution
250g Guanidium isothiocyanate lOOpl 2M Sodium acetate, pH 4
293ml DEPC water 1ml phenol (fresh, water saturated)
17.6ml 0.75M Sodium citrate, pH 7 200pl Chloroform.dsoamyl alcohol
26.4ml 10% Sarkosyl (24:1)
These were held at 65°C to fully These quantities were added per ml
disso Ive the GTC. ‘ D ’.
Fresh rat adipose tissue was homogenised in solution ‘D’ (3ml) plus p-mercaptoethanol 
(7.2pFml D). The phenolic solution was added and the mixture was shaken vigorously
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for 20 seconds in a sterile centrifuge tube. The tubes were then left on ice for 15
minutes before being centrifiiged at 6595 x g for 20 minutes at 4°C in a Camlab
refrigerated high speed centrifuge. The upper aqueous phase was then removed and an
equal volume of isopropanol added. The samples were then left at -20°C for 1 hour.
centrifiiged
Following this, the tubes were then at 6595 x g for 20 minutes at 4°C. The 
supernatant was decanted off and discarded and the pellet dissolved in 300pl solution 
D. The samples were transferred to a microcentrifuge tube and 600pl ethanol was 
added. The contents were left to precipitate at -20°C for 1 hour. The tubes were then 
respun for 20 minutes at 4135 x g at room temperature. The remaining pellet was 
washed with lOOpl 75% ethanol and the tubes were spun again at room temperature 
for 20 minutes at 4135 x g. The supernatant was discarded and the tubes left upside 
down for 30 minutes to dry. Lauryl sulphate (50pl, 0.5%) was added to each sample 
and the pellet redissolved at 65°C for 5 minutes. The extracted RNA was stored at 
-80°C until an aliquot (5 pi sample and 495 pi water) was scanned 
spectrophotometrically at 260nm to quantify the sample. From this, the amount of 
RNA needed to load lOpg onto a gel was calculated according to the equation below;
Amount of RNA to load = 7-----   7  x 10
(A260 X  1 0 )
2.2.2.1 Northern Blot A nalvsis 
Reagents
lOxMOPs lOxSSC
21.8 g 3-[n-morpholino]propanesulphonic acid 87.5g sodium chloride
3.12% EDTA 44.1 g sodium citrate
4.1 Og sodium acetate 400ml DEPC water 
900ml DEPC water
Both the above solutions were adjusted to pH 7, made up to 1 litre with DEPC water 
and autoclaved. MOPs solution was kept at room temperature in the dark to prevent 
yellowing. The denaturing agarose gel (1.5% w/v) was made by dissolving 2.45g 
agarose in 152ml DEPC water and boiling this in a microwave for 2 minutes. The gel
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was left to cool to 60°C before the addition of 17.5ml 10 x MOPs, 5.25ml 
formaldehyde and 2pl ethidium bromide (2.5 mg/ml). The gel was then poured and left 
to set at room temperature. Meanwhile the samples were prepared by adding Ipl 10 x 
MOPs, 1.75pl formaldehyde and 5pi formamide to lOpg of each RNA sample. The 
samples were then incubated at 65°C for 15 minutes and 2pl of loading buffer was 
added to each. The loading buffer, described below, was previously made up in DEPC 
water, aliquoted and stored at -20°C.
Loading Buffer 
0.25% bromophenol blue 
0.25% xylene cyanole FF 
30% glycerol 
lOmM EDTA
The samples were loaded onto the gel and the gel was run for 134-2 hours at 120V. 
The running buffer was 1 x MOPs and the system was cooled by standing the gel tank 
on ice. On completion of the run, the gel was washed three times for 5 minutes in 
250ml DEPC water and then for 30 minutes in 300ml 10 x SSC. The gel was then 
blotted onto positively charged Hybond N+ membrane for 24 hours by the system 
shown in Figure 2.1. At the end of this time, the membrane was dried for 2 minutes at 
80°C and then crosslinked for 3 minutes under UV light. The membrane was baked at 
80°C for 2 hours to bind the samples permanently to the membrane. The blots were 
then wrapped in foil and stored damp in the reft'igerator at 4°C.
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Figure 2.1 The Northern Blot System
Hybridisation Conditions
The blots to be probed were placed between two sheets of hybaid cloth and soaked 
with 1 X SSC. They were then rolled up, placed in hybaid bottles and the excess SSC 
poured off The blots were prehybridised in 25ml Church Buffer at 65°C for 2 hours in 
a Hybaid rotating oven (Church & Gilbert, 1984).
Church Buffer 
0.5M Na2HP04 
0.5MNaH2PO4
The two above components were added to one another until the pH reached 7.4 then 
lauryl sulphate (70g) and 2ml 0.5M EDTA were added per litre whilst stirring on a 
hotplate.
The cDNA probe was produced by subcloning at the EcoRl site of the plasmid 
pUSlOOO. It was then transformed and amplified and a 1.8Kb portion excised using 
the restriction endonuclease EcoRl (details in Chapter 6).
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Random Primer Labelling of the cDNA Probe
The specific probe was labelled with ^^ P using a kit called the ‘Megaprime Kit’ 
(Amersham) in a designated controlled radiochemical area behind perspex screens. 
Random mongpier primers in aqueous solution (5 pi) were added to 25ng of the 
template cDNA in a micro centrifiage tube and the tube contents were denatured by 
boiling for 5 minutes m a water bath. The tube was spun briefly in a micro centrifuge to 
bring the contents to the bottom of the tube before labelling buffer (lOpl) was added at 
room temperature. The labelling buffer supplied in the kit consisted of dATP, dGTP 
and dTTP in Tris-HCl (pH 7.5), 2-mercaptoethanol and magnesium chloride. The 
Klenow enzyme (2pl) was spotted on to the side of the tube and 23 pi water were 
added to wash the enzyme to the bottom of the tube. Next, 1.85MBq ^^P-dCTP label 
(5 pi) was carefully added. The enzyme solution contained lunit/pl DNA polymerase I 
Klenow fi-agment (cloned). The contents were then mixed gently by pipetting up and 
down and the tube capped. The tube was centrifiiged briefly in a microcentrifuge to 
bring the contents of the tube to the bottom. The reaction was then incubated at 37°C 
for 10 minutes in a water bath. The reaction was stopped immediately by the addition 
of 0.2M EDTA (5pi) and the tube was then heated to 100°C in a water bath for 5 
minutes to denature the labelled DNA prior to hybridisation. The labelled probe was 
then chilled on ice until required.
Before hybridisation, the probe was purified using a Sephadex G-50 DNA ‘Nick’
column (Pharmacia) to remove unincorporated ^^P-labelled nucleotides and thus reduce
the background produced by the probe during hybridisation. This process involved
passing the label through the column once the column had been prewashed with Nick
column buffer. This buffer contained lOmM Tris-HCl and ImM EDTA, pH 7 J .^ iv e
most radioactive
aliquots (400pi) of the eluent were collected, the second aliquot being the one
containing the purified probe. The second tube was therefore boiled for 5 minutes to 
denature the probe into single strands that can bind to the appropriate mRNA on the 
blots.
At the end of the prehybridisation period, the Church Buffer was tipped off into a 50ml 
sterile falcon tube and 50pl of lOmg/ml denatured salmon sperm DNA was added.
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along with the purified ^^P-labelled probe. The blots were then hybridised at 65 °C 
overnight. Following hybridisation, the blots were washed 2 - 3  times with 25ml 
Church Wash for 20 minutes at 65°C, the level of radioactivity remaining on the blot 
being checked between washes with a hand-held p-counter.
Church Wash
5.8m llM NaH 2P04
19.2ml lM N a 2HP0 4
lOg lauryl sulphate
Made upto 1 litre with R.O. water.
The blots were placed into a cartridge with an intensifying screen with Kodak X- 
OMAT AR5 film for 5 days at -80°C. The autoradiograph was then developed and the 
bands of mRNA were quantified at 550nm on a Shimadzu CS-9100PC scanning 
densitometer.
Assav Validation and Normalisation of the results
The assay validation is summarised in Chapter 6. Normalisation of the expression
results was checked by stripping the blots and reprobing with the constitutively
expressed protein, mouse P-actin. The results were then expressed as a ratio of LPL
expression to actin expression. I Actin expression is unaffected by diet and hence 
remains constant with cell number despite alterations in LPL 
expression with diet (cited by Hennessey a/. 1993).
2.2.3 Adipose TISSUE EXPLANTS
This method was adapted fi'om that described by Dils & Forsyth (1981). Epididymal 
adipose tissue was obtained fi'om 250-300g male Wistar Albino rats. The rats were 
killed immediately prior to use by cervical dislocation, the fat pads excised carefully 
without being pulled or torn and placed into prewarmed (37°C) medium 199. All 
equipment was also prewarmed to 37°C. Explants of the adipose tissue were cut under 
a dissecting microscope to approximately Imm^ using straight iris scissors. The cut 
explants were regularly transferred to a petri dish containing warm medium and held at 
37°C on a dry block heater. After two hours of cutting, 15 - 2 0  explants were placed
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in each well of a multiwell plate containing 1 ml fresh medium 199. The explants were 
rested for 90 minutes and washed with 1 ml fresh medium prior to the addition of test 
hormones. The stock hormones were made up using 0.4M phosphate buffer, pH 7.4 to 
a high concentration and frozen at -20°C until required. At the time of the assay the 
test hormones were diluted to the appropriate concentrations using medium 199 
containing 0.1% bacitracin. Test hormone (0.5ml) was added and the explants were 
incubated for two hours prior to the addition of 5pi heparin (2U/5pl) for a further 40 
minutes to release the LPL from the tissue into the medium. At the end of the 
incubation period the LPL-containing medium was removed and frozen in LP3 tubes at 
-20°C. The remaining explants were weighed wet. The LPL activity of the medium 
was measured by the assay previously described in Section 2.2.1.3 and the activity 
expressed as % change in LPL activity from basal per mg tissue per minute at 37°C.
2.2.3.1 Assav validation
Validation work had previously been carried out by other investigators (Beety, 1994; 
Knapper, 1995b). The optimal time for demonstrating hormone activation was 
checked before commencing experimental work. Following the resting period of 90 
minutes, the incubation time in the presence of the test hormone was altered to 1, 2 and 
3 hours and the results showed that two hours incubation with the test hormone was 
the optimum time to demonstrate hormone activation. These results agreed with and 
confirmed previous work.
During early experiments, large variations in LPL activity between wells were found 
despite the fact that the explants in each well were treated similarly. The variations 
were thought to be due to expressing the LPL activity against wet weight of tissue. To 
study whether these variations could be reduced, expression of the LPL activity against 
the protein content of the explants was investigated. A method to determine the 
protein content of the tissue, developed from the Bradford method (Bradford, 1976) 
was therefore investigated.
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Protein Determination
The total content of adipose tissue expiants present in each well was 15 -  20mg and of 
this only 1 -  2% would be expected to be protein (Christophe & Wodon, 1963). 
Ramsay et al. (1992) reported a method to measure the total protein content of polar 
bear adipose tissue which was developed specifically to detect small quantities of 
protein. The assay involves the binding of Coomassie Brilliant Blue-G250 to protein 
and this binding causes a shift in absorption from 494nm to 595nm. The binding of the 
dye to protein occurs rapidly (within 2 minutes) and the protein-dye complex remains 
dispersed for up to an hour.
Bradford Reagent
0.01% (w/v) Coomassie Blue G-250
4.7% (w/v) ethanol
8.5% (w/v) phosphoric acid
Coomassie Blue G-250 (lOOmg) was dissolved in 95% ethanol (50ml) and 85% 
phosphoric acid (100ml) was added. The resulting solution was then made up to a final 
volume of 1 litre with distilled water.
A range of standards were prepared by dissolving HSA (Fraction V) in 0.15M NaCl to 
final protein concentrations of 0 -  2mg/ml. Standard or sample (lOOpl) was pipetted 
into test tubes and 1ml protein reagent was added. The contents were then vortex 
mixed and the absorbance at 595nm was measured after 5 - 1 5  minutes. A blank of 
0.15M NaCl (lOOpl) plus 1ml protein reagent was prepared. A typical standard curve 
is shown in Figure 2.2.
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Figure 2.2 Bradford Assay standard curve
Samples of adipose tissue were prepared at the end of an explant assay by removing the 
medium 199 with a plastic pasteur pipette. The explants (15-20mg adipose 
tissue/sample) were then homogenised in 0.5 -  1ml 0.1% Nonidet P40 detergent to 
remove the fat &om the sample. Each sample (lOOpl) was then added to 1ml protein 
reagent, the dilution factor being taken into account when calculating the final protein 
concentration. The resulting protein concentrations, however, were higher than the top 
of the standard curve and it was suspected that there was some interference occuring 
from the detergent or the turbidity of the sample. A dilution curve of the sample did 
not show parallelism with the standard curve so interference by the sample mixture was 
suspected. Addition of detergent alone was also found to increase absorbance and the 
protein concentration could not be measured due to the high absorbance attributed to 
the detergent.
To overcome this problem, a mixture of Tween 80/acetone (0.5g/l) was used instead of 
Nonidet P-40 as a fat-digester and the samples were spun at 6990 x g for 13 minutes 
after homogenisation in eppendorf tubes to pellet down the protein. The pellet was 
then resuspended in 100-500pl 0.15M NaCl. The sample (lOOpl) was then added to 
1ml protein reagent. Further experiments studying the interference due to Tween
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80/acetone showed that increasing amounts of this detergent also increased the 
absorbance at 595nm (Figure 2.3). However, this problem should have been largely 
overcome in the assay because the protein was pelleted down after the homogenisation 
step in Tween 80/acetone and most of the detergent removed before the absorbance 
was measured. The changes in actual protein concentration were detectable above 
these interferences and this protocol was therefore used to measure the protein content 
of explants.
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Amount of Tween 80/acetone (pi) per ml Bradford Reagent
Values shown are the means of duplicates.
Figure 2.3 Results of testing the turbidity due increasing amounts of Tween
80/acetone
However, when both protein content and wet weight of explants were measured on the 
same samples, no correlation was found between the number or weight of explants and 
protein concentration (r = 0.35, R ^ 0.36 and r = 0.58, F' = 0.10 respectively). As 
expected, there was a significant correlation found between wet weight and number of 
explants (r = 0.89, P = 0.001).
Only 1 -  2pg/ml protein was measured in each sample, even though 15 - 40pg/ml 
would be a predicted value (Christophe & Wodon, 1963). Therefore, improving the
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solubility of the samples was attempted by adding DMF to the NaCl when dissolving 
the pelleted protein. This however made no improvement on sample recovery.
It was therefore concluded that the assay was not suitable under these conditions to 
measure protein in rat adipose tissue explants and it was decided to continue 
expressing explant LPL activities against wet weight of tissue.
2.2.4 Plasma Insulin
Plasma insulin concentrations were measured using a radioimmunoassay technique 
based on a method described by Albano et al. (1972) and modified by Flatt & Bailey 
(1981). The assay uses an '^^lodine labelled insulin tracer, antiserum to insulin raised 
in guinea pigs and a polyethylene glycol (PEG)-accelerated double antibody separation 
step.
The assay was performed at 4°C and samples were assayed in duplicate. Plasma 
samples were defi’osted at the time of the assay and centrifiiged at 463 x g for 10 
minutes at 4°C to remove fibrin which would otherwise prevent accurate pipetting. 
Assay diluent consisting of 0.04M phosphate buffer (pH 6.5), HSA (0.5% w/v) and 
aprotinin (50,000 KlU/lOOml) was placed in LP3 tubes (lOOpl to the standard tubes; 
200pl to the zero standard and the sample tubes; 300pl to the tubes used to determine 
non-specific binding (NSB) during the assay). Standard (lOOpl) ranging fi’om 
1500pmol to 23pmol were added to the standard curve tubes. Standards were 
prepared by serial dilution jftom previously made standards containing synthetic human 
insulin. Plasma samples (lOOpl) were added to the sample tubes and one NSB tube 
was set up for each sample. Charcoal-stripped serum (lOOpl) was then added to the 
standard curve tubes. Anti-insulin antiserum (lOOpl) was then diluted 1:100 in assay 
diluent and added to all tubes except those needed for the NSB determination. The 
tubes were then vortex mixed and left at 4°C overnight.
The ‘^ ^I-insulin label was bought ready purified and was diluted 1:80 immediately prior 
to addition to the assay tubes. Label (lOOpl) was added to all tubes and they were kept
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at 4°C for 48 hours. On day 4 of the assay, normal guinea pig serum was diluted 1:200 
with assay buffer and donkey-anti-guinea pig was diluted 1:20 with assay buffer. lOOpl 
of each and 4% PEG 2000 (700pl) was added to all tubes except the totals tubes. The 
tubes were vortex mixed and held at 4°C for 2 hours before being centrifuged at 1286 
X g for 30 minutes in the Beckmann J-6B. The liquid was aspirated off the tubes under 
vacuum and the pellet containing the bound insulin was counted on a gamma counter.
/I
The intraassay CV was 9.03% at 35pmol^and the interassay CV was 10.7% at the same 
concentration.
Measurement of insulin in rat samples
When insulin levels were measured in rat plasma a rat insulin standard was used. There 
is one amino acid difference in the A-chain and two amino acid differences in the B- 
chain of rat insulin when compared to human insulin. Therefore a specific rat insulin 
standard was reconstituted to 1 mg/ml in 0.4M phosphate buffer (pH 7.4). This was 
then diluted down at the time of the assay using assay diluent to give the same range of 
concentrations as described above. The remainder of the assay was performed the 
same way as the human samples.
2.2.5 Plasma Glucagon-Like Peptide- 1 (GLP-1 )
Plasma GLP-1 was first measured using this method by Elliott et a l 1993 and the 
method described below was adapted fi-om this. This technique is a four day 
radioimmunoassay using ^^^lodine-labelled GLP-1 (7-36) amide and antiserum that is 
specific for C-terminal amidated forms of glucagon-like peptide. Final separation of 
the antibody bound and fi-ee antigen is achieved by the addition of Sac-Cel, a donkey 
anti-rabbit solid phase second antibody coated cellulose suspension.
The assay was performed at 4°C and all reagents prepared immediately prior to the 
assay. Assay diluent was added to all sample and standard tubes (1 OOpl to all samples; 
lOOpl to all standard tubes; 200pl to NSB tubes). A range of standards were prepared 
fi*om lyophilised synthetic human GLP-1 (7-36) amide. The standards were diluted
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from a frozen stock (3200pM) using assay diluent to 5- 160pM. Standard (200pl) was 
added to the standard curve tubes and plasma (200pl) to the sample tubes. One sample 
was run in each assay as a quality control (QC). QC plasma (200pl) was added to the 
appropriate tubes. Charcoal stripped serum (CSS) was prepared by another 
investigator and aliquots were used from the freezer when necessary. CSS (200pl) was 
added to the standard curve tubes. Finally, antiserum (lOOpl) was added to all tubes 
apart from the NSB tubes. This antiserum was raised in rabbits against synthetic 
human GLP-1 (7-36) amide. The antiserum was stored at -20°C at a stock 
concentration of 1:60 in 0.04M phosphate buffer (pH6.5) and diluted 1:100 with assay 
diluent at the time of the assay. The tubes were then vortex mixed and left at 4°C 
overnight.
'^^Iodine-labelled GLP-1 was produced according to the protocol described in Section 
2.2.7 at an earlier date. The label was purified the third day (see Section 2.2.8) and 
lOOpl added to each of the tubes. The tubes were then vortex mixed and left at 4°C 
for 48 hours. On the last day the bound and free antigen were separated. lOOpl Sac- 
Cel was added to all tubes, they were incubated at 4°C for an hour and were stirred 
every 15 minutes during that hour before they were centrifuged at 1852 x g for 10 
minutes. The tubes were then aspirated to remove the free antigen and the remaining 
bound antigen in the pellet was counted on a Multigamma 1260 gamma counter.
The antisera crossreactivity with a range of gastrointestinal hormones, 
glucagon and the synthetic parent molecules, GLP-1 (7-37) and GLP-1 (1-36) amide 
had been previously performed. The antiserum currently used cross reacted 100% with 
GLP-1 (7-36) amide and 87% with GLP-1 (7-37) but showed less than 1% 
crossreactivity with the other hormones. These results suggest that the antiserim binds 
towards the N-terminal of the GLP-1 (7-36) molecule and is therefore unable to 
distinguish between the original and truncated forms of the molecule. The interassay 
CV was 6.2% at 30pmol/l and the intraassay CV was 3.1% at 24pmol/l.
58
________________________________________________________________Chapter 2
2.2.6 Plasma GIP
This procedure is very similar to the plasma GLP-1 (7-36) amide assay and is a 
radioimmunoassay. The assay was first described by Morgan e /«/. (1978). Separation 
of antibody bound and fi*ee antigen is achieved by a second antibody plus PEG. The 
assay employs an antiserum raised in rabbit against purified natural porcine GIP, so on 
day 3, normal rabbit serum and donkey anti-rabbit jwere added instead of Sac-Cel. All 
procedures were performed at 4°C.
The crossreactivity of the antiserum was tested by a previous investigator who showed 
35% crossreactivity with natural porcine GIP but not with any other synthetic 
fi-agments of porcine GIP corresponding to amino acids 1-11, 19-25 or 19-30. The 
interassay CV was 8% at 360pmol/l and the intraassay CV was 3.4% at 297pmoPl.
2.2.7 lODINATION OF GIP OR GLP-1 (7-361 AMIDE
The hormones are iodinated with '^^I-sodium iodide. On the day before iodination 3g 
of Sephadex G-15 were swelled in 15ml of O.IM sodium acetate (pH 5). A disposable 
column was clamped in position and 24cm 1mm diameter PVC tubing was attached to 
the bottom tip of the column. The column was then filled with the swollen Sephadex, 
avoiding any banding or air bubbles. Protein elution buffer was prepared by adding 
0.5% HSA and 5000KIU/ml aprotinin to O.IM sodium acetate pH 5.0. Protein elution 
buffer (15ml) was then passed through the column. The sodium metabisulphite and 
chloramine-T solutions were both made up in 0.4M phosphate buffer, pH 7.4 and 
immediately prior to the iodination. Sodium metabisulphite (lOmg) was dissolved in 
5ml buffer in one bottle and 7.5mg chloramine-T in another bottle of 5ml phosphate 
buffer. GIP or GLP-1 (7-36)amide (5pg) was weighed out on the microbalance, 
transferred to an autoanalyser cup and dissolved in lOpl of 0.4M phosphate buffer 
immediately before the iodination.
The rest of the iodination was carried out in the designated radiochemical laboratory 
behind lead shielding and with the fume cupboard window down as far as possible. 
The autoanalyser cup containing the hormone was clamped behind the lead shield. 
Sodium iodide (lOpl) was added into the bottom of the autoanalyser cup.
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Chloramine-T (lOpl) was added to start the reaction and the reagents were mixed up 
and down with the pipette for 15-20 seconds. At the end of this time, 20pl sodium 
metabisulphite was added to stop the reaction. This process requires two people 
because the timing is so short and crucial to the success of the reaction. Protein buffer 
(200pl) was then added to the cup and the whole cup contents were transferred to the 
column using a disposable pipette. The column was clamped over a fraction collector 
set to 10 drops/fraction and 20 fractions were collected in LP4 tubes. Sufficient 
protein elution buffer was added to the column to keep it saturated throughout this 
process and the column was not allowed to run dry. A sample of each fraction (lOpl) 
was transferred to an LP3 tube and capped. These tubes were then counted for 10 
seconds on the gamma counter. Two peaks were eluted from the column. The first is 
the iodinated hormone which is required, so the peak fraction and the next fraction just 
behind the peak were collected for use. The chosen fraction was then aliquoted into 
LP3 tubes which had previously been coated with lOOpl BSA and frozen at -20°C. At 
the time of the assay, the tracer is affinity purified and the diluted with diluent to give 
5000cpm/100pl.
2.2.8 Affinity purification of radiolabelled GIP and GLP-117-36) amide
LABEL
A disposable plastic column containing small pore glass covalently bound to the 
appropriate low-avidity antibody for each hormone was used for the purification of 
each label. The column was stored in O.IM bicarbonate buffer (pH 9.8) so the first 
step was to remove the caps and allow this to drain through. The column was then 
washed with 10ml 0.95MHC1 which was passed through under pressure from a syringe. 
The column was then washed with four successive aliquots of assay diluent (5ml) 
which were allowed to drain through and the column was stoppered before it went dry. 
The tracer sample was reconstituted with 3ml assay diluent and layered onto the 
column with a disposable plastic pipette. The column was then capped and inserted 
into a boiling tube and roller mixed for 30 minutes. At the same time, a 5ml glass vial 
was filled with assay diluent and rolled for the same length of time. This vial was for 
collecting the eluted purified label and this process reduces the loss of label due to its 
sticking to the walls of the vial. After 30 minutes, the column was reclamped and
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allowed to resettle before the column was washed again with four aliquots of distilled 
water (5ml). The assay diluent was poured out of the vial and the purified label was 
eluted with 5 x 1ml 0.95M HCl. These fractions were collected into the 5ml vial which 
was then capped and inverted to mix. The purified label (lOOpl) was counted and 
diluted to give a count of 5000cpm/100pl for the addition to the assay tubes. The used 
column was washed with 10ml water and 10ml bicarbonate buffer before being stored 
in bicarbonate buffer at 4°C.
Measurement of GIP and GLP-1 in the rodent gastrointestinal tract
The assay for the measurement of GIP or GLP-1 in acid-ethanol extracts (see Section
2.2.9) was modified from the plasma GIP and GLP-1 assay procedures. The assays
were essentially maintained the same but no CSS was added to the standard curve and
lOOpl assay buffer was added to replace the CSS. It was not necessary to use CSS
because the samples were not plasma samples. Samples were run at 1:100 dilution
with assay buffer as this produced GIP levels in the middle of the standard curve.
Serial dilutions of tissue extracts showed parallelism with the standard curve (Figure
2.4).
2.2.9 Acid-ethanol extraction of intestinal GIP or GLP-117-36) amide 
This procedure was first described by Kenny (1955). Acidified ethanol solution (750ml
absolute ethanol; 250ml R.O. water; 15ml 1IM HCl) was added to the frozen tissue
at a concentration of 5ml/g wet weight in a universal glass tube. Tissues were then
scissor cut before sonicating for 15 seconds with an . ultrasonic generator (Dawe
Instruments Ltd.). The resulting homogenate was kept at 4°C for 24 hours prior to
centrifuging at 1852 x g for 10 minutes. The supernatant was decanted, aliquoted into
LP3 tubes and frozen at -20°C until being assayed for GIP or GLP-1 (7-36) amide.
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Figure 2.4 Standard GIF curve with three serial dilutions of acid-ethanol 
extracts of rat gastrointestinal GIF showing parallelism to the curve.
2.2.10 Measurement of plasma triacylglycerol
Plasma TAG levels were measured by an automated, enzymatic, spectrophotometric 
technique on the Cobas Mira Plus analyser (Roche Products Ltd., Herts., U.K.). The 
kit used was supplied by Roche Diagnostic Products Ltd.. The principle of this assay is 
described in the three equations below;
Triacylglycerol lipase ^glycerol + fatty acids
Glycerol + ATP < kinase  ^g^y^erol -  3 -  phosphate + ADP
Glycerol - 3 - phosphate + O2 < > dihydroxyacetonephosphate + H2O2
* GPO = Glycerol-3-phosphate oxidase 
In the presence of peroxidase, the hydrogen peroxide formed effects the oxidative 
coupling of 4-chlorophenol and 4-aminoantipyrme to form a red coloured quinoneimine 
derivative. The colour intensity measured at 500nm is directly related to the 
triacylglycerol concentration in the sample.
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The interassay CV was 2.6% at 2.38mmoHand the intraassay CV was 2.4% at 
2.38mmol;/l.
2.2.11 Plasma NET A
Plasma NEFA were also measured on the Cobas Mira, but using a kit made by WAKO 
Chemical GmbH, Germany and supplied by Alpha Laboratories Ltd. (London). The 
final product is purple coloured and can be measured at 550nm.
NEFA + ATP + CoA acylCoA +AMP +PPi
acyl CoA + O, —acyl CoAoxidase 2 ^ 3  _  trans -  enoyl -  CoA + H jO ,
H 2 O 2 + 3 -  methyl -  N -  ethyl -  (B -  hydroxyethyl) -  aniline + 4  -  amino -  antipyrene
— ■> Purple coloured adduct
The interassay CV was 8.9% at 0.5m m ol^d the intraassay CV was 4.3% at 0.5mmol/l.
2.2.12 Plasma glucose
This was analysed by an enzymatic colorimetric assay on the Cobas Mira analyser. The 
kit was supplied by Roche Diagnostic Products Ltd.. This is an enzymatic photometric 
assay which is read in the UV spectrum. The amount of NADH produced according to 
the equations below is directly related to the amount of glucose in the sample and its 
production is monitored by measuring at 340nm.
D - glucose + ATP _hcxokmase _^  ^  - glucose - 6  - P + ADP 
D - glucose - 6  - P + NAD* > D -  gluconate -  6  -  P + NADH + H
The interassay coefficient of variation was 1.05% at 4.03mmol/1 glucose and the 
intraassay CV was 0.5% at the same level.
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2.2.13 Plasma total cholesterol and HDL/LDL cholesterol
Total and HDL-cholesterol were assayed using kits supplied by Roche Diagnostic
Products Ltd. on the Cobas Mira analyser. The total cholesterol assay is an enzymatic
colorimetric test based on the following reactions;
Cholesterol ester + H2O —  ^esterase  ^Qj^olesterol + fatty acid^
Cholesterol + O2 — oxidase  ^^ 4  _ cholesterol -  3 -  one +
H 2 O 2  + 4-chlorophenol + 4 - aminophenazone— Peroxidase ^q^inoneininederivative
In the presence of peroxidase, the hydrogen peroxide formed affects the oxidative 
coupling of phenol and 4-aminoantipyrine to form a red-coloured quinoneimine 
derivative. The colour intensity measured at 500nm is directly related to the 
cholesterol concentration.
HDL samples
These were prepared by precipitating out the apolipoprotein B-containing lipoproteins 
prior to the measurement using a reagent supplied by Roche Diagnostics Ltd.. HDL 
reagent containing phosphotungstic acid and magnesium chloride (500pl) was added to 
200pl plasma sample and allowed to stand at room temperature for 10 minutes. The 
sample was centrifuged at 12000rpm for 2 minutes in a microcentrifuge. The HDL- 
cholesterol, remaining in the clear supernatant, was then measured using the same kit 
as total cholesterol. LDL-cholesterol was calculated from total and HDL-cholesterol 
according to Friedewald’s formula (cited by Jenkins et al. 1989; Mackness & 
Durrington, 1992);
LDL -  C(mmol /1) = Total serum cholesterol -  |^HDL -  C + 2
The intraassay CV for total cholesterol was 1.15% and the interassay CV was 1.23%, 
both using a standard (‘Seronorm’) of a known concentration of 7.8mmoFl. The 
intraassay and interassay CVs for HDL-cholesterol at 2.24mmoFl were 1.9% and 2.0% 
respectively.
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2.2.14 Plasma paracetamol
This is an enzymatic spectrophotometric method where acetaminophen is hydrolysed to
4-aminophenol by a bacterial aryl acylamidase (aryl-acyl-amide amidohydrolase). The
4-aminophenol released is then coupled to o-cresol in the presence of ammoniacal
cupric sulphate to yield a blue indophenol dye, the production of which was measured
on the Cobas Mira analyser. The production of the blue colour measured at 615nm
was directly related to the concentration of paracetamol in the plasma sample. The
intraassay and interassay CVs were 1.4% and 0.9% at 2.0mmol/l respectively. 
(Hallworth, 1983),
2.2.15 Tissue protein determination
The method used to measure protein concentration in the rat livers was that first 
described by Lowry et a l (1951). The assay was conducted at room temperature. 
Standard, sample or quality control (400pl) was placed in a glass test tube, 2ml Biuret 
reagent added and the tubes immediately vortex mixed before being stood for 10 
minutes. At the end of this time, Folin Ciocalteu reagent (200pl) was added and the 
tubes were immediately vortexed. The tubes were left for 30 minutes and the 
absorbance at 750nm was read on the UV-VIS Spectrophotometer UV1201 
(Shimadzu).
Samples
Liver samples were extracted and stored as described in Chapter 5. The rat livers were 
washed, scissor minced and homogenised in 1.15% (w/v) KCl. The homogenates were 
diluted to 25% (w/v) with 1.15% (w/v) KCl such that Igram liver = 4ml diluted 
homogenate. The homogenate was transferred into sterile centrifuge tubes and 
centrifuged at 9000 x g  and 4°C for 20 minutes in a Beckman J2-21 centrifiige. The 
resulting supernatant (S9 fraction) was decanted and aliquoted into LP3 tubes and 
stored at -20°C. The cytosolic fraction used in the Lowry assay was prepared by 
spinning the S9 fraction at 105000 x g  and 4°C for 1 hour in a Beckman L7 
ultracentrifuge. At the time of the assay, samples were diluted 1:100 so that the results 
fell in the middle of the standard curve.
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A range of standards between 0 -  200 |ig/ml(w/v) were made using BSA (Fraction V)
in distilled water.
Quality Controls
Two quality controls were used in each assay which corresponded to 15 and 30pg 
protein.
A typical standard curve is shown in Figure 2.5.
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Figure 2.5 Standard Curve of protein eoncentration as measured by the Lowry
Assay
Values shown are means of duplicates.
2.2.16 CYTOSOLIC SUPEROXIDE DISMUTASE ACTIVITY
The dismutation of superoxide radicals is catalysed by superoxide dismutase (SOD) 
according to the equation below;
0 ^ - - +  0 ^ - - +  2 H "  ” °  > H , 0 ,
6 6
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Based upon the methods of McCord and Fridovich (1969) and Salin and McCord 
(1974), superoxide dismutase activity was determined by the degree of inhibition o f the 
reduction of cytochrome C, when compared to commercial preparations of superoxide 
dismutase. Superoxide anions were generated by the progressive oxidation of 
hypoxanthine and xanthine to yield uric acid.
Reagents
Potassium phosphate buffer (50mM, pH 7.8) containing EDTA (0.1 mM)
Hypoxanthine ( 1.5mM)
Xanthine oxidase (56mU/ml)
Cytochrome C (0.3mM)
Superoxide dismutase (0 -lOU)
Protocol
Samples of the 25% (w/v) cytosolic fraction described in Section 2.2.15 were diluted 
1:100 in phosphate buffer at the time of the assay. Phosphate buffer (2.6ml), 
hypoxanthine (lOOpl), xanthine oxidase (lOOpl), cytochrome C (lOOpl) and sample 
were added to a cuvette and mixed thoroughly. The linear, initial rate of reaction was 
followed at 550nm using the Kontron Instruments Uvikon 860 spectrophotometer. 
The superoxide dismutase activity of the samples was calculated by comparison with a 
standard curve in the range of 0 -  lOU superoxide dismutase.
2.2.17 Cytosolic catalase activity
The enzyme catalase is present in the peroxisomes where it catalyses the conversion of 
hydrogen peroxide into water and oxygen and it can catalyse the oxidation by hydrogen 
peroxide of various compounds. Catalase is therefore a unique oxidoreductase enzyme 
where hydrogen peroxide serves as both a donor and acceptor and its main fiinction is 
to detoxify hydrogen peroxide. This assay measured the remaining hydrogen peroxide 
in the reaction mixture by reaction with titanium ions under acid conditions to yield a 
yellow coloured titanium-peroxide complex. The method used was based on that 
described by Baudhuin (1974).
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Reagents
20mM imidazole buffer (pH 7) containing BSA (Ig/L)
2% Triton X-100(v/v)
20mM imidazole buffer (pH 7) containing BSA (Ig/L) and 3.5mM hydrogen peroxide 
Titanyl sulphate (2.25g/L) in 2Msulphuric acid
Protocol
At the time of the assay all the above solutions were cooled on ice and the samples of 
25% (w/v) cytosolic fraction (see Section 2.2.15) were diluted 1:200 with imidazole 
buffer. Aliquots of the diluted cytosol fraction (100pi) were added to precooled glass 
test tubes. Triton X-100 (100pi) was added and the reaction started by the addition of 
imidazole buffer containing hydrogen peroxide (2ml). The reaction was held on ice for 
4 minutes and terminated by the addition of titanyl sulphate (3ml). The final 
absorbance was read at 405nm using a Kontron Instruments Uvikon 860 
spectrophotometer. The activity of the sample was ascertained by reference to a 
standard curve, using hydrogen peroxide in the range of 0 -  6pmoles per tube.
2.2.18 Cytosolic glutathione reductase activity
Glutathione reductase is the enzyme mediating the reduction of oxidised glutathione 
(GSSG). The activity in the samples was measured by a method first described by 
Carlberg & Mannervick (1975).
Reagents
O.IM Potassium phosphate buffer (pH 7.5) containing 0.1% (w/v) EDTA
17.5mM Oxidised glutathione
0.3mM Flavin adenine dinucleotide (FAD)
2mM NADPH in 1% (w/v) NaHCOs
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Protocol
Samples of the 25% (w/v) cytosolic fraction (see Section 2.2.15) were diluted 1:50 
with potassium phosphate buffer at the time of the assay. To a quartz 
spectrophotometer cuvette was added diluted sample (3ml), oxidised glutathione 
(200pl) and FAD (lOOpl). The reaction was initiated by the addition of NADPH 
(200pl) and followed at 334nm using a Kontron Instruments Uvikon 860 
spectrophotometer with a thermal heated cell (37°C). The glutathione reductase 
activity was calculated using the extinction coefficient E = 4.3mM‘'cm'*.
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3. SHORT-TERM HORMONAL 
rONTROT. OF HEPARTN- 
REÏ EASARÏ F T.IPOPROTF.fN 
T.TPASF, TN EXPLANTS OF RAT 
ADIPOSE TISSUE
3.1 INTRODUCnON
Many factors control the activity of lipoprotein lipase (LPL) including nutritional and 
hormonal factors (see Chapter 1). This chapter describes the use of an in vitro system 
to study the hormonal factors affecting LPL activity in rat adipose tissue. Experiments 
were carried out to look at the effects of insulin, GIP and the glucagon family of 
peptides on LPL activity. As described in Chapter 1, one of the main sites of LPL 
synthesis is adipose tissue (Bensadoun, 1991). Following intracellular processing, the 
mature enzyme is secreted to the endothelial surface where it is anchored by 
glycosaminoglycans on the plasma membrane (Eckel, 1989). At the luminal surface, 
LPL is responsible for hydrolysing TAG from chylomicrons and VLDL. The fatty 
acids produced then pass into the adipocytes and are re-esterified to TAG for storage. 
Loss of LPL activity, and hence reduced clearance of dietary fat from the bloodstream 
postprandially, has been linked to risk of coronary heart disease, hypertension and 
diabetes (Howard, 1987; Bjomtorp, 1990).
The aim of the study was to investigate the control of heparin-releasable LPL activity 
in explants of rat epididymal adipose tissue. Heparin is known to stabilise LPL and 
displace it from binding sites on the endothelial lining of capillaries and plasma 
membranes so releasing it into the surrounding culture medium. Heparin-releasable 
LPL is therefore a measure of intracellular biologically active LPL (Pykalisto et al. 
1975; Bensadoun, 1991).
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Insulin is one of the main hormones regulating LPL activity in adipose tissue. LPL 
activity in the tissue is directly related to plasma insulin levels during fasting and 
feeding, and is increased by intravenous injection of insulin (Spooner et a l 1979). 
Other workers have reported increases in the incorporation of radio labelled leucine into 
LPL following a 2 hour incubation with insulin-containing medium (Speake et a l 
1985). The fall in LPL activity over 2 days incubation of bovine adipose tissue explants 
was reduced when insulin (2mU/ml) was added to the medium (Faulconnier et a l
1994). It is therefore a reasonable expectation that changes in the exposure of adipose 
tissue to insulin as a result of changes in diet or other hormones will have profound 
effects on adipose tissue metabolism.
Certain gastrointestinal hormones may also have the ability to affect adipose tissue LPL 
activity directly. Specific receptors for GIP and GLP-1 have been reported in adipose 
tissue which thus makes the direct action of these hormones on adipose tissue LPL 
feasible (see Section 3.4). The effects of GIP and GLP-1 were discussed in detail in 
Chapter 1. The 24 hour pattern of circulating GIP closely mimics that of TAG 
concentrations throughout the day. Also, parallel increases in postprandial plasma 
GIP, TAG and postheparin LPL activities have been seen following a series of meals 
whose fat content was increased from 20g to 80g (Murphy et a l 1995). Therefore the 
study of the effects of GIP at near physiological concentrations on LPL activity have 
important implications with regards to disease risks associated with poor postprandial 
fat clearance and may also be relevant in the control of regional fat distribution.
The specific hormones of the family of glucagon-related peptides studied here included 
GLP-1 (7-37), GLP-1 (1-37), GLP-1 (7-36) amide , GLP-1 (1-36) amide, GLP-2 and 
glucagon itself. All these hormones are processed from the same hormone precursor -  
preproglucagon. There are relatively few differences in amino acid sequence between 
these hormones. The positioning of the amino acids within the hormones strongly 
affects the biological activity of the hormones and it is for these reasons that many of 
the glucagon-like peptides were studied in the present work. GLP-1 (7-36) amide, the 
most abundant circulating form of GLP-1, has not previously been shown to have 
direct effects on adipose tissue LPL activity. It has however been shown to have
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antidiabetogenic effects by increasing insulin secretion, decreasing glucagon release and 
improving insulin sensitivity (Egan et al. 1994). GLP-1 (7-36) amide has been shown 
to stimulate glycerol and cAMP production in rat adipocytes (Ruiz-Grande et al
1992), to stimulate fatty acid synthesis in explants of adipose tissue (Oben et a l 1991) 
and to stimulate lipolysis in rat adipose tissue (Beety, 1994). This evidence, together 
with the discovery of an abundance of GLP-1 (7-36) amide receptors in solubilised 
adipose tissue membranes (Valverde et a l 1993), suggests a role for GLP-1 in the 
regulation of lipid metabolism in health and disease.
Specific receptors for glucagon have been isolated in solubilised membranes of human 
adipose tissue (Merida et a l 1993). The lipolytic effect of glucagon in several species 
both in vivo and in vitro has been widely documented (Lefebvre, 1983; Kawai et a l
1995), but there are conflicting results from human work. In contrast to GIP and 
GLP-1 (7-36) amide, glucagon and GLP-2 do not stimulate fatty acid synthesis in 
explants of rat adipose tissue (Oben et a l 1991). GLP-2 has recently been shown to be 
secreted in parallel with GLP-1 in response to the ingestion of a mixed meal (Hartmann 
et a l  1996). The effects of glucagon in adipose tissue are not well defined and the 
direct effects of the less well researched peptides of the glucagon-like family on LPL 
activity have not been documented to date.
During the time that these explant experiments were taking place, a large number of 
studies into the effects of melatonin on postprandial lipid metabolism during simulated 
shift work were being run at the University of Surrey. Previous work had reported 
melatonin to have an effect on insulin sensitivity and cholesterol metabolism (Lima et 
a l 1994; Müller-Wieland et a l 1994). Therefore as part of ongoing collaboration 
between studies it was decided to study the effects of melatonin on LPL activity in 
vitro using the explant method.
Melatonin is a hormone produced from serotonin and secreted by the pineal gland. It is 
known to be one of the most important circadian time-signalling factors, circulating 
levels being high at night and lower during the day (Arendt, 1985). Adipocytes 
preincubated in the presence of increasing melatonin concentrations have shown
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enhanced cell responsiveness to insulin (Lima et at. 1994). Further work by the same 
group showed reduced adipocyte responses to insulin in pinealectomised rats compared 
with control animals (Lima et al. 1996). Work within the Surrey group has recently 
shown subjects to exhibit tendencies toward lipid intolerance at night (Hampton et al. 
1996). Earlier in this thesis, the modulation of cholesterol metabolism by diet, 
lipoproteins, hormones and drugs has been discussed. Recent studies suggest that 
melatonin also modulates cholesterol metabolism (Müller-Wieland et al. 1994; Sandyk 
& Awerbach, 1994). Since elevated LDL-cholesterol levels have been implicated in 
the risk of atherosclerosis and are closely linked to postprandial TAG metabolism, the 
importance of the pineal gland in cholesterol metabolism and postprandial lipaemia 
must not be overlooked.
It was therefore decided to perform preliminary experiments to examine the effects of 
melatonin on rat epididymal adipose tissue LPL activity. This could, in turn, help to 
improve our understanding of changes which occur in lipid metabolism between day 
and night.
3.2 METHODS
The procedure for an explant experiment is described in Section 2.2.3 of Chapter 2. In 
this chapter each result expressed represents a mean of three days work. On each day 
two rats were sacrificed and enough explants were cut to enable four wells of a 
multiwell plate for each control or test hormone. Therefore results are expressed as a 
mean of 12 wells (6 rats). Only results fi*om experiments when 2nM insulin produced a 
statistically significant rise in LPL activity were considered valid and therefore included 
in the final pooled results. Stocks of hormones were prepared to a high concentration 
in Medium 199 containing 0.1% bacitracin and fi*ozen at -20°C. Each test hormone 
was added at two concentrations ranging between 2nM -  40nM. The levels at which 
the hormones were added represented one low concentration and one which was many 
times in excess of physiological levels to ascertain whether the hormone had any 
pharmacological effects on LPL activity. The low concentration (4nM) was used on
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the basis that GIP produced a significant effect on LPL activity at this level and would 
therefore be a basis for comparison against other hormones. On the day of the 
experiment, hormones were prepared immediately before addition to the medium and 
were diluted to the required concentration in medium 199 containing 0.1% bacitracin 
(pre-warmed to 37°C). The Wistar Albino rats were 250g -  300g in weight and were 
supplied by the Experimental Biology Unit of the University of Surrey or by B & K 
Universal Ltd. (North Humberside, U.K.). All rats were fed on the same standard rat 
chow prior to sacrifice and were killed at 08:30 hours on the day of the experiment.
During early work in this area aprotinin was added to the stock hormones as a protease 
inhibitor. During these experiments we had not formulated the criteria that a 
significant insulin stimulation would signify a valid experiment. Consequently only the 
basal and 8nM GIP data are shown below.
120 1
100 -
80 -
60 -5.s
I
I  40
20 4
□  Basal 
0  8nM GIP
Figure 3.1 The effects of 8nM GIP (containing 2000kiu aprotinin/0.5ml medium 
199) on heparin-releasable LPL activity in explants of rat epididymal tissue. 
Values are mean (SEM) for 18 wells (6 rats).
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GIP did not significantly increase LPL activity in the explants in these early 
experiments. It was at this time that evidence was published showing that aprotinin 
was not an effective protease inhibitor and that degradation of the biologically active 
N-terminal of GLP-1 still occurred in the presence of 0.1% aprotinin (Deacon et al. 
1995a). It was therefore decided to add 0.1% bacitracin to the hormone solutions and 
the culture medium. The effective improvement on GIP stimulation of LPL activity 
and other hormones is shown in the results section.
3.3 RESULTS
3.3.1 Expression OF RESULTS
LPL activity is usually expressed in absolute units of pmol oleate released per minute 
per mg wet weight tissue. Absolute values ranged from 0 - 2 9  pmol oleate 
released/min/mg wet weight in the basal wells and 3 - 6 5  pmol oleate released/min/mg 
wet weight in the insulin (2nM) stimulated wells. In the following results section 
changes in LPL activity have been presented as % change in activity from basal. As 
mentioned earlier, each experiment represents three separate days of work. There was 
a large variation in actual LPL activity levels on different days. However, even though 
basal and hormone-stimulated values were lower on some days than others, the 
percentage changes in hormone stimulation seen were similar.
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3.3.2 E f f e c t s  OF GIP
The effects of 4nM and 8nM GIP on rat epididymal adipose tissue LPL activity are 
shown in Figure 3.2. Insulin (2nM) and GIP (4nM and 8nM) significantly increased 
the LPL activity above basal levels (P < 0.001) by 274 ± 32%, 329 ± 23% and 232 ± 
24% respectively.
500 -1
■> 350
0  Basal 
M 2nM Insulin
□  4nM GIP
□  8nMGIP
Figure 3.2 The effects of 4nM and 8nM GIP on heparin-releasable LPL activity 
in explants of rat epididymal adipose tissue. Values are mean (SEM) for 12 wells 
(6 rats). Columns with the same symbol are significantly different from one 
another {P < 0.001).
Basal LPL activities were 6.31 ± 0.81 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3.3.3 E f f e c t s  OF GLP-H7-36) AMIDE
The effects of 4nM and 40nM GLP-1 (7-36) amide on rat epididymal adipose tissue 
LPL activity are shown in Figure 3.3. Insulin (2nM) and 4nM GLP-1 (7-36) amide 
significantly increased the LPL activity by 93 ± 26% and 125 ± 29% above basal (P < 
0.05 and f  < 0.01 respectively). GLP-1 (7-36) amide (40nM) only produced a small 
effect on LPL activity which did not reach statistical significance.
350 1
300 -
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□  4nM GLP-1 (7-36) 
amide
□  40nM GLP-1 (7-36) 
amide100 -
50 -
Figure 3.3 The effeets of 4nM and 40nM GLP-1 (7-36) amide on heparin- 
releasable LPL activity in explants of rat epididymal adipose tissue. Values are 
mean (SEM) for 12 wells (6 rats). Columns with the same symbols are 
significantly different from one another P <  0.05; ** p <  0.01).
Basal LPL activities were 8.96 ± 1.79 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3.3.4 E f f e c t s  OF GLP-1(7-37)
The effects of 4nM and 40nM GLP-1 (7-37) on rat epididymal adipose tissue LPL 
activity are shown in Figure 3.4. Insulin (2nM) significantly increased the LPL activity 
by 190 ± 56% (P < 0.001). GLP-1 (7-37) (40nM) showed a trend towards increasing 
the LPL activity but this did not reach statistical significance.
350 -1
300 -
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□  4nM GLP-1 (7-37)
□  40nM GLP-1 (7-37)
Figure 3.4 The effects of 4nM and 40nM GLP-l(7-37) on heparin-releasable 
LPL activity in explants of rat epididymal adipose tissue. Values are mean 
(SEM) for 12 wells (6 rats). Columns with the same symbols are significantly 
different from one another {* P<  0.001).
Basal LPL activities were 10.32 ± 0.97 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3.3.5 E f f e c t s  OF GLP-H 1-36) AMIDE
The effects of 4nM and 40nM GLP-1 (1-36) amide on rat epididymal adipose tissue 
LPL activity are shown in Figure 3.5. Insulin (2nM) significantly increased the LPL 
activity by 95 ± 18% above basal (P < 0.01). GLP-1 (1-36) amide (40nM) also 
significantly increased the LPL activity, by 130 ± 26.15% (P < 0.001). GLP-1 (1-36) 
amide (4nM) showed a trend towards increasing the LPL activity but this did not reach 
statistical significance.
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Figure 3.5 The effects of 4nM and 40nM GLP-1 (1-36) amide on heparin- 
releasable LPL activity in explants of rat epididymal adipose tissue. Values are 
mean (SEM) for 12 wells (6 rats). Columns with the same symbols are 
significantly different from one another {* P<  0.01; ** p <  0.001).
Basal LPL activities were 5.86 ± 0.36 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3.3.6 E f f e c t s  OF GLP-1 (1-37)
The eflfects of 4nM and 40nM GLP-1 (1-37) on rat epididymal adipose tissue LPL 
activity are shown in Figure 3.6. Insulin (2nM) significantly increased the LPL activity 
by 106 ± 28% above basal {P < 0.05). GLP-1 (1-37) (4nM or 40nM) showed a trend 
towards increasing the LPL activity but this did not reach statistical significance.
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Figure 3.6 The effects of 4nM and 40nM GLP-1 (1-37) on heparin-releasable 
LPL activity in explants of rat epididymal adipose tissue. Values are mean 
(SEM) for 12 wells (6 rats). Columns with the same symbols are significantly 
different from one another (* P < 0.05).
Basal LPL activities were 5.18 ± 0.79 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3.3.7 E f f e c t s  o f  GLP-2
The effects of 4nM and 40nM GLP-2 on rat epididymal adipose tissue LPL activity are 
shown in Figure 3.7. Insulin (2nM) significantly increased the LPL activity by 122 ± 
41.16% above basal (P < 0.05). GLP-2 (4nM and 40nM) suggested a trend towards 
stimulating LPL activity but this did not reach statistical significance.
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Figure 3,7 The effects of 4nM and 40nM GLP-2 on heparin-releasable LPL 
activity in expiants of rat epididymal adipose tissue. Values are mean (SEM) for 
12 wells (6 rats). Columns with the same symbols are significantly different from 
one another {* P<  0.05).
Basal LPL activities were 7.40 ± 1.63 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3.3.8 E f f e c t s  OF GLUCAGON
The effects of 4nM and 30nM glucagon on rat epididymal adipose tissue LPL activity 
are shown in Figure 3.8. Insulin (2nM) significantly increased the LPL activity by 133 
± 24% above basal (P <0.01) and 4nM glucagon also significantly increased the LPL 
activity, by 163 ± 41% above basal (P < 0.001). Glucagon (30iiM) showed a trend 
towards lowering the LPL activity by 61 ± 20.1% below basal but this did not reach 
statistical significance.
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Figure 3.8 The effects of 4nM and 30nM glucagon on heparin-releasable LPL 
activity in explants of rat epididymal adipose tissue. Values are mean (SEM) for 
12 well (6 rats). Columns with the same symbols are significantly different from 
one another (* P<  0.01; ** p <  0.001).
Basal LPL activities were 3.33 ± 0.47 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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3 .3 .9  E f f e c t s  o f  m e l a t o n in
The effects of 4nM and 8nM melatonin on rat epididymal adipose tissue LPL activity 
are shown in Figure 3.9. Insulin (2nM) significantly increased the LPL activity by 162 
± 48.7% above basal (P < 0.05). Melatonin at a concentration of 8nM significantly 
increased LPL activity by 222 ± 48.23% above basal (P < 0.01). However, although at 
a lower concentration of 4nM, melatonin showed a trend towards increasing LPL 
activity, this was not statistically significant.
400 -I
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Figure 3.9 The effects of 4nM and 8nM melatonin on heparin-releasable LPL 
activity in explants of rat epididymal adipose tissue. Values are mean (SEM) for 
12 wells (6 rats). Columns with the same symbols are significantly different from 
one another {* P<  0.05; ** p <  0.01).
Basal LPL activities were 3.02 ± 0.37 pmol oleate released/min/mg tissue at 37°C 
(mean ± SEM).
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Table 3.1 Summary of the effects of hormones on heparin-releasable LPL 
activity in explants of rat epididymal adipose tissue.
Hormone Concentration (nM) Effect on LPL activity
Insulin 2 t
GIF 4 t
8 t
GLP-1 (7-36) amide 4 Î
40 —
GLP-1 (7-37) 4 —
40 (T)
GLP-1 (1-36) amide 4 (t)
40 t
GLP-1 (1-37) 4 (T)
40 ( t)
GLP-2 4 ( t)
40 ( t)
Glucagon 4 t
30 ( i )
Melatonin 4 ( t )
8 t
Where each symbol means;
—  = no effect on LPL activity
( t)  = non-significant rise in LPL activity
f  = statistically significant rise in LPL activity above basal
(-1) = non-significant fall below basal activity levels
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3.4 DISCUSSION
3.4.1 Advantages and disadvantages of methodologies employed 
3.4.L I  Explant techniques
Two preparations have been widely used for studying hormonal effects on adipose 
tissue status in vitro: adipocyte preparations and explants of adipose tissue. The main 
advantage of the explant technique is that the endothelial architecture of the adipose 
tissue is preserved and therefore the in vivo environment is closely preserved within the 
system. Also, cell viability is maintained for long periods when explants are incubated 
in culture. This is necessary for the study of hormones, whose actions may take hours 
to produce an effect. One possible disadvantage of using explants is their lack of long­
term viability in culture. However, it has previously been shown in our laboratory that 
the explants remain responsive to hormones for up to 8 hours in culture Medium 199 
(Beety, 1994) which gives confidence in their use for these experiments. Also, early 
validation work for these experiments showed LPL activity to increase linearly beyond 
2 hours incubation indicating certainty that at 2 hours the explants are functioning 
normally. Much of the published work in this area describes work in isolated 
adipocytes, where the processes of isolating adipocytes from the surrounding 
connective tissues prior to their use could lead to cell damage in the endothelium of the 
adipocytes. This could in turn lead to structural damage such as loss of receptor 
integrity which could question the viability of previous work using adipocytes.
3.4.1.2 LPL measurement
Heparin-releasable activity measures a processed form of the enzyme thought to 
represent the intravesicular, active form of LPL. This fraction is thought to be the 
most representative of LPL involved in the clearance of circulating TAG. However, it 
has been reported that heparin has the effect of activating and preserving the activity of 
LPL (Bensadoun, 1991). It is possible that the act of stripping LPL from the cell 
surface may contribute to alterations m the apparent activity or release of activity of 
this enzyme.
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3.4.2 Factors affecting the variability of LPL measurement in adipose
TISSUE EXPLANTS
The LPL activity measurements reported in this chapter show large standard deviations 
about the mean. The following sections have attemped to explain some of the reasons 
for this variability.
3.4.2.1 Tearin2 o f  tissue
One reason for the variability of LPL activity exhibited could have been tissue damage 
due to tearing whilst extracting the fat pads from the animal or during cutting the 
explants. Obviously this was minimalised during all the experiments and explants were 
discarded if noticeable tearing had taken place; however it is possible that some 
undetected damage could have occurred.
3.4.2.2 Quantification bv wet weisht
The problem of this assay with regards to expression of the data was discussed in detail 
in Chapter 2. Quantifying the data against the wet weight of tissue may have led to 
variability in the results. Different quantities of moisture may have remained on the 
tissue when they were weighed and may therefore have affected the accuracy and 
precision of results. This was avoided as much as possible by draining the tissue 
against the side of the wells. Although actually blotting the tissue was tried, this led to 
loss of tissue due to adherence to the blotting paper surface. We were unable to 
express the results against the protein content of the explants due to methodological 
problems. More time and work is necessary in this area to evaluate the possibility of 
expressing results against DNA content of the explants.
3.4.2.3 Nutritional status o f  the animal
Sensitivity of adipose tissue to hormonal stimulation may well be affected by the 
nutritional status of the animal. Adipose tissue LPL activity is known to be higher in 
the fed state than following a period of fasting. Thus the state of the animal at sacrifice 
may have affected the responses of LPL to hormonal stimulation. In order to
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overcome these possible effects the adipose tissue explants were rested for 90 minutes 
and washed prior to addition of the hormone. Previous validation work in our 
laboratory has also shown no difference between fed and fasted rats on LPL 
stimulation within explants (Knapper, unpublished data) -  this is therefore unlikely to 
have played a part in the large standard deviations seen.
3.4.2.4 Variation in measurement o f  LPL activity
Although it is possible that some variation may have arisen from the assay of LPL in 
the culture medium, this was not so in these experiments. The intra-assay coefficient of 
variation for the LPL assay was only 4.9% and the inter-assay coefficient of variation 
was only 8.7%. Therefore variation at this stage of the explant assay was not 
occurring to an appreciable degree.
3.4.2.5 Size o f  exvlants
Since the cut surface of the explants is more susceptible to LPL release by heparin, the 
total surface area of the explants could affect total LPL release. Small explants would 
therefore release proportionately more LPL than large explants because of their higher 
surface area : volume ratio. However, there was no correlation between weight of 
tissue per well and LPL activity/g wet weight tissue (r = 0.23, P ~ 0.33), therefore this 
was not significantly affecting the assay variability.
3.4.3 Degradation of the peptides by protease activity
The reason for some of the variability in the reported results may have been the 
occurrence of hormonal degradation in our system. Post-translational processing of 
gastrointestinal hormones has been studied in detail, but only recently has the metabolic 
fate of the biologically active products received attention. GLP-1 (7-36) amide has 
been shown to be broken down very quickly by the removal of two N-terminal amino 
acids in vivo by the enzyme dipeptidyl peptidase IV (Deacon et al. 1995b). The
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product, GLP-1 (9-36) amide, is inactive but has been shown to act as an antagonist at 
the pancreatic B cell GLP-1 receptor in vitro (Grandt et al. 1994).
It is thought that the C-terminal sequence of gut hormones is needed for receptor 
binding but an intact N-terminal appears necessary for the generation of second 
messengers. It is also through this concept that N-terminally fragmented GLP-1 was 
proposed to antagonise intact GLP-1 at the receptor level by its ability to bind to the 
receptor but not be able to transduce a signal (Adelhorst et al. 1994). Dipeptidyl 
peptidase IV (DPP IV) is a specialised aminopeptidase which removes dipeptides from 
bioactive peptides that contain proline or alanine as their penultimate N-terminal amino 
acid (Mentlein et al. 1993). It was Deacon and her colleagues who confirmed this as 
being the major enzyme responsible for hormone degradation in vivo (Deacon et al. 
1995a). They incubated plasma containing intact GLP-1 in the presence of either 
diprotin A (a specific DPP IV inhibitor) or bacitracin (a non-specific inhibitor) and saw 
no degradation to GLP-1 over a 30 minute incubation at 37°C. However in the 
presence of previously used protease inhibitors such as aprotinin or EDTA 56% GLP-1 
was converted to the metabolite in plasma. GIP begins its N-terminal sequence with 
Tyr-Ala and both GLP-1 (7-36) amide and GLP-2 start with His-Ala, leaving them all 
open to degradation by DPP IV.
The competition from a degradation product with the active hormone could also 
explain why no significant effect was seen at high concentrations of GLP-1 (7-36) 
amide, yet at low concentrations, where less hormone is open to degradation, there 
was less competition for receptors and a significant stimulation of LPL activity was 
observed. GIP is also degraded by the loss of two N-terminal amino acids, the 
resulting peptide being GIP (3-42).
Deacon and colleagues have shown that DPP IV is active at physiological picomolar 
concentrations in vivo (Deacon et al. 1995a) and it has been identified in capillary 
endothelial and surrounding cells which could be within adipose tissue. The total 
absence of metabolite in plasma incubated with diprotin A suggests that, at least in 
plasma, DPP IV is the only enzyme responsible for degradation at the N-terminus of
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GLP-1. However, plasma DPP IV has a half life of 20 minutes. As GLP-1 has a half 
life of 3 minutes in vivo, there must be other factors degrading GLP-1 in adipose tissue 
culture but these factors are unidentified at present. The fact that the half life of GLP-1 
(7-36) amide is less than 5 minutes in vivo and 20 minutes in vitro (Buckley & 
Lundquist, 1992), together with the presence of peptidases, means that inclusion of 
peptidase inhibitors is imperative in such experiments as are described in this chapter, 
where incubation is for 2 hours.
Bacitracin was used as an inhibitor in these experiments after the initial discovery that 
the addition of 0.1% bacitracin to the culture medium produced a significant 
stimulatory effect of GIP upon LPL activity which we had not been able to show with 
aprotinin as the protease inhibitor. Bacitracin is a non-specific inhibitor of proteases 
and was chosen so that it would not only eliminate degradation from DPP IV, but also 
inhibit degradation from the other unidentified factors mentioned above.
3.4.4 The effect of peptide hormones on adipose tissue LPL activity
3.4.4.1 Insulin
In this study, we confirmed the observations of other workers that insulin stimulates 
heparin-releasable LPL activity. Eckel and colleagues reported stimulation of heparin- 
releasable LPL from isolated rat adipocytes by insulin (400ng/ml) but did not show an 
effect of insulin on LPL extractable from cells by detergents following previous heparin 
release (Eckel et al. 1984). This gives good evidence that heparin does release LPL 
from the cells into the medium. Insulin (2nM) acted consistently on LPL activity 
throughout the experiments and consequently was used as an indication of a reliable 
experiment. There are close relationships between insulin and the gastrointestinal 
hormones described in this chapter. For example GIP, a known potentiator of glucose- 
stimulated insulin release via the entero-insular axis, may also modulate the effects of 
insulin by directly altering target tissue insulin sensitivity (Starich et al. 1985).
3.4.4.2 GIP
The demonstration of a statistically significant positive effect of both 4nM and 8nM 
GIP replicates previous experiments (Knapper et al. 1995b). It strengthens the
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hypothesis that GIP is an important hormonal signal linking meal size to postprandial 
LPL activity in the physiological control of lipaemia and postprandial fat deposition. 
The use of bacitracin provides an explanation as to why we demonstrated an effect of 
GIP when other investigators had failed to show an effect in rat adipose tissue explants 
(Beety, 1994).
3.4.4.3 The ^lucason family o f peptides
Structure-activity relationships of the glucagon-like peptides with regard to their ability 
to stimulate insulin have been well documented. The importance of an intact N- 
terminal of the glucagon family of hormones to enable biological activity has been 
shown by several investigators (Suzuki et al. 1989; Mentlein et al. 1993; Deacon et al. 
1995b). Therefore we expected GLP-1 (7-36) amide and GLP-1 (7-37) to be active 
but not GLP-1 (1-36) amide or GLP-1 (1-37) because in the latter two hormones the 
critical amino acids in positions 7 and 8 are masked by the N-terminal hexapeptide. 
There is evidence that metabolites of the peptides studied may be biologically active, 
acting as agonists or antagonists of the parent hormone at its receptor (Deacon et al. 
1995b). Some of the glucagon family of peptides are also metabolised to inactive 
relatives by the removal of N-terminal amino acids. For these reasons a number of 
hormones were studied -  the biologically active hormones and also those which are 
biologically inactive in terms of their ability to stimulate insulin.
The results of the GLP-1 group of hormones are varied and difficult to interpret since 
many of the results do not conform to previous theories about their activities. Briefly 
the following results were observed;
• GLP-1 (7-36) amide produced a significant rise in LPL activity at 4nM but had no 
effect at 40nM.
• GLP-1 (7-37) had no effect at 4nM but showed a trend towards increasing the 
activity at 40nM.
• GLP-1 (1-36) amide significantly increased LPL activity at 40nM but only showed 
a trend towards increasing the activity at 4nM.
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• GLP-1 (1-37) and GLP-2 showed a trend to increasing the LPL activity at 4 and 
40nM but did not reach statistical significance.
• Glucagon significantly increased LPL activity at 4nM but only showed a trend 
towards decreasing the activity at 40nM.
Previous work studying the effects of GLP-1 (7-36) amide on LPL activity in explants 
of rat adipose tissue showed a small, non-significant rise in LPL activity in response to 
8nM GLP-1 (7-36) amide (Knapper et al. 1995b). However, the addition of bacitracin 
to our explant system has shown that GLP-1 (7-36) amide at 4nM increased LPL 
activity. GLP-1 (7-36) amide has also been shown to stimulate lipolysis in adipose 
tissue (Beety, 1994). Therefore the finding that 4nM GLP-1 (7-36) amide at near 
physiological concentrations stimulated LPL in adipose tissue may be important in 
terms of adipose tissue metabolism. Although some workers have reportedly identified 
specific GLP-1 receptors in adipose tissue membranes (Valverde et al. 1993), others 
have not been able to find these receptors (Fehmann, personal communication). GLP-1 
may be acting by binding to other receptors on the adipose tissue membranes. Riuz- 
Grande demonstrated that GLP-1 (7-36) amide and glucagon had different lipolytic 
effects on isolated rat adipocytes and concluded that the two hormones must act 
through different receptors and mechanisms (Ruiz-Grande et al. 1992). These findings 
were echoed by Valverde the following year who found specific receptors for both 
glucagon and GLP-1 (7-36) amide on adipose tissue membranes (Valverde et al.
1993). Binding of GLP-1 (7-36) amide was 3 times higher than the glucagon binding 
capacity, suggesting that there are more specific receptors for GLP-1 (7-36) amide. 
This was not, however, reflected in the effects of glucagon and GLP-1 (7-36) amide on 
LPL activity in the adipose tissue explants because both hormones stimulated the 
activity to a similar extent at 4nM concentration. Interestingly, Valverde found no 
effect on specific binding when GLP-1 (7-36) amide was coincubated with GLP-1 (1- 
36) amide, GLP-2 or glucagon (Valverde et al. 1993). This is another reason to 
believe that GLP-1 (7-36) amide has its own specific receptors.
There is evidence that GLP-1 antagonists also bind to other receptors, particularly 
glucagon receptors (Montrose-Rafizadeh et al. 1996). The lack of effect found at
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40nM GLP-1 (7-36) amide could be due to the action o f proteases breaking down the 
large amounts of peptide into inactive fragments which have been shown to act as 
receptor antagonists. Although 0.1% bacitracin appears to protect GIP from protease 
degradation, GLP-1 may require a higher concentration of bacitracin since it appears 
prone to breakdown more quickly. Although 0.1% was a satisfactory concentration of 
bacitracin to protect GLP-1 in plasma it may not have been enough in tissue. 
Validation work did not however show differences in hormone activities on LPL 
activity when bacitracin concentration was increased to 0.2%.
The effects of glucagon on LPL activity in explants of rat epididymal adipose tissue 
have not been reported previously. Insulin and glucagon are known to act in 
opposition to one another. The ratio between the two hormones is important in such 
circumstances as the feed-starve cycle where the insulinrglucagon ratio alters to affect 
glycogenolysis or gluconeogenesis in starvation or the fed state respectively. However, 
glucagon significantly stimulated LPL activity at 4nM concentration. The response to 
a higher concentration (30nM) was more as predicted, with glucagon producing a non­
significant suppression of LPL activity. The accumulation of free fatty acids is knovm 
to result in inhibition of LPL activity in vitro (Bengtsson & Olivecrona, 1980). In this 
instance high glucagon may be stimulating lipolysis, which is under the control of 
hormone-sensitive lipase. This, in turn, would lead to increased free fatty acids in the 
medium and a decrease in LPL activity. This is consistent with previous work by Eckel 
who has shown that substances which stimulate lipolysis in adipocytes, such as 
glucagon and adrenaline, decrease the activity of LPL (Eckel, 1987).
3.4.4.4 Melatonin
The investigation into the effects of melatonin on adipose tissue LPL activity has never 
before been investigated. Since subjects have recently been shown to tend towards a 
lipid intolerance to an oral fat load at night (Hampton et al. 1996), and circulating 
melatonin levels are higher at night, it would have been reasonable to expect no 
stimulatory effects of melatonin on LPL activity. However, although no significant 
effect was seen at near physiological concentrations, supraphysiological levels
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significantly stimulated LPL activity in the adipose tissue explants. In previous 
postprandial studies in our laboratory postheparin plasma LPL activities have 
correlated with postprandial TAG concentrations (Murphy et al. 1996). It could 
therefore be possible that melatonin in vivo does not affect LPL activity in the human 
situation but the rise in TAG levels at night directly trigger a rise in LPL activities. 
These findings are difficult to reconcile with the hypothesis that melatonin is partially 
responsible for the observed deterioration of lipid tolerance at night via its effects on 
LPL. However, the clearance of an intravenous fat load is faster later in the day (Frape 
et al. 1996) consistent with the present findings. Other factors such as a diurnal 
variation in gastric emptying may be more important in determining the diurnal 
variation in postprandial lipaemia when fat is consumed orally.
3.4.5 Future WORK
The findings described, especially in terms of possible degradation, suggest further 
study is required to ascertain more fully the underlying mechanisms of the hormonal 
control of adipose tissue LPL activity in vivo. The recent development of specific 
receptor antagonists for GIP and GLP-1 will enable much more specific determination 
of these hormonal effects. For example, in some of the cases where GLP-1 may be 
acting via non-specific receptors, the addition of a GIP antagonist into the culture 
medium would help to elucidate whether it was the GIP receptor that GLP-1 was 
using. Tseng and colleagues have recently published the discovery of a new GIP 
receptor antagonist, GIP (7-30)-NH2, which, although reducing the stimulatory effect 
of GIP on insulin release by 72% in rats, did not effect GLP-1 activity postprandially 
(Tseng et al. 1996). They also reported that GLP-1 binding to its receptor was 
unaffected by administration of the agonist GIP (7-30)-NH2.
GLP-1 antagonists which have been formulated in the last two years include exendin 
(9-39) amide. This antagonist has been shown to inhibit insulin release when infiised 
alongside GLP-1 alone, but did not effect glucagon stimulation of insulin, therefore 
providing further evidence for a specific GLP-1 receptor (Montrose-Rafizadeh et al.
1996). A newer antagonist still is a- aminoisobutyric^-GLP-1 (7-36) amide (Aib^- 
GLP-1 (7-36)amide), published this year as an effective replicate of GLP-1 itself. On
93
Chapter 3
incubation with DPP IV the analog was inert to degradation for two hours even though 
GLP-1 itself was almost totally reduced to its metabolites within the same time 
(Knudsen et al. 1996). The availability of such stable, structurally similar analogs will 
enable long incubations such as those required in these experiments without the 
problem of degradation. The discovery of new analogs and antagonists of these 
hormones will therefore aid the elucidation of the mechanisms behind many of these 
hormonal actions.
Other future work would include an extension of the range of concentrations of 
hormones. Those hormones which have produced a significant rise at 4nM could be 
added at lower concentrations to investigate the lowest limit of stimulatory activity. In 
order to detect the lower concentration threshold of effects of the hormones which 
have produced a significant rise in LPL activity at higher concentrations it would be 
necessary to add a range of concentrations between 4nM and 40nM.
At the end of this work a few experiments were performed in which combinations of 
hormones were added together to represent more physiologically relevant scenarios. 
When more than one hormone was added competition could have occurred between 
insulin and the other hormones for the receptors. If  hormones act synergistically it 
suggests that they act via different mechanisms. Thus the addition of combinations of 
hormones into the system would provide an insight into the mechanisms of actions of 
these hormones. This work should be furthered by the addition of different 
combinations of hormones into the assay system, thereby mimicking physiological 
events.
In order to perform any other work in this area it would be necessary to reduce further 
the inter-assay variability. Due to insufficient time, investigation of the reasons for 
such high variability could not be conducted thoroughly. Although expression of LPL 
activity against the protein content of the tissue was not a viable solution, reduction of 
the variability may be achieved by expression of the results against DNA content of the 
adipose tissue.
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4. THE EFFECTS OF MEAL 
FREQUENCY ON POSTPRANDIAL 
LIPOPROTEIN METABOLISM
4.1 INTRODUCTION
The traditional pattern of eating two or three meals/day could be called a ‘gorging’ 
pattern. Rats, who ‘browse’ eat all night typically represent a ‘nibbling’ diet of eating 
little and often. It has been suggested that the metabolic consequences of a given diet 
may depend partially on the fi*equency with which meals are eaten (Fabry & 
Tepperman, 1 970). Recently, Government advice has suggested a cut in our total fat 
and sugar intake and an increase in the intake of dietary fibre (Department of Health, 
1 9 9 4 ). However, the results of such advice could be affected by the regularity with 
which we eat. The effects of meal frequency on nutrient metabolism, and especially 
lipid levels, had been overlooked until a recent surge of interest in this area of research. 
This chapter will describe the background research in this area and from this point out 
the gaps which have been filled by the specific study described.
4 .1 .1  A n im a l  STUDIES
Initially, work on meal frequency was investigated in rats, who normally eat little and 
often throughout the night (ie. nibbling) but eat virtually nothing during the day. Early 
studies using rats indicated that feeding once a day, compared to nibbling, induced 
differences in many areas of metabolism (Fabry et al. 1 9 6 4 ). Feeding one meal a day 
increased postprandial serum insulin, increased the sensitivity of adipose tissue to 
insulin and led to increased cholesterol synthesis. Many rat studies have looked at 
whether rats trained to consume their food in a short period of time (meal-fed) are 
more efficient in converting food energy to body energy than animals allowed ab 
libitum food (nibbler) (de Bont et al. 1 975 ; Hill et al. 1 9 88 ; Bazotte et al. 1 9 8 9 ; 
Wheeler et al. 1990). If rats are fed for only two hours a day, they consume 2 0 %  less 
food than nibbling rats but still gain weight at the same rate (Leveille, 19 7 2 ). Muiruri
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and Leveille (1970), when changing rats from one feeding pattern to another, showed 
that the previous feeding pattern influenced adipose tissue lipogenesis and body weight 
changes. Rats converted from meal-eating to nibbling gained weight faster and 
accumulated body fat faster than did rats permanently on a nibbling diet. They also 
showed that lipogenic enzyme activities such as acetyl CoA carboxylase and fatty acid 
synthetase in adipose tissue homogenates from converted rats decreased only slowly to 
the levels observed in the control nibblers, suggesting an advantage in maintaining a 
constant nibbling diet. In 1989, Bazotte et al. also showed differences in blood glucose 
maintenance and free fatty acid mobilisation in rats fed different meal frequencies. 
Stomach emptying was faster in the rats allowed free access to food compared to those 
on restricted meal times. The possible implications for human pathology of these 
findings in animals has stimulated many researchers to study the effects of meal 
frequency in man.
4.1.2 HUMAN STUDIES
Early human work, carried out in the 1960s, produced results which conflicted with 
other contemporary and recent studies. However, a comparison of results is difficult as 
study designs have varied widely. The interest in this area of work was fueled by 
epidemiological studies which suggested that ‘gorging’ was associated with a tendency 
towards obesity and hypercholesterolaemia (Fabry et al. 1964) and an increased risk of 
cardiovascular disease (Fabry et al. 1968). Previous human studies fall into three clear 
categories with regards to study design.
1. Studies which took measurements from subjects whilst they were actually 
consuming either a nibbling or gorging diet.
2. Studies which took fasting measurements during or at the end of a period on either 
a gorging or nibbling diet.
3. Studies which took mean plasma levels of various parameters whilst subjects were 
on the diets and then did a glucose tolerance test (GTT) at the end of each study 
period to look at the effects of previous meal frequency on GTT (Peters, 1979; 
Jenkins et al. 1989).
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The first reported human work in the area used 5 hospitalised patients and compared 
the effects of consuming 1, 3 or 10 meals a day. The work showed that an increase in 
meal frequency resulted in lower serum TAG, total cholesterol and phospholipid levels 
over a twelve hour period (Gwinup et al. 1963) and although the changes were small 
they were consistent between subjects. Changes produced by nibbling were rapidly 
reversed by gorging and vice versa. In 1968 Fabry et al. suggested that meal pattern 
could affect the individual's risk of coronary heart disease, and later showed a 
relationship between obesity, hypercholesterolaemia and meal frequency (Fabry & 
Tepperman, 1970). However, other work around this time produced conflicting data. 
A study of 51 male students found no significant differences in fasting lipid levels after 
eight days on a nibbling- or meal-eating diet (Jagannathan et al. 1963). Swindells et al. 
(1968) also showed no significant differences in lipid levels of six female subjects 
following the consumption of either 2 or 9 meals a day. However, this study did not 
use free-living subjects and Jagannathan et al. (1963) fed his subjects a liquid formula 
during the study, not everyday foods. In 1967, other investigators reported higher 
mean plasma TAG and cholesterol levels in 15 women after both a nibbling and 
gorging routine when compared to their normal diets (Irwin & Freely, 1967).
More recently, work has indicated that eating many small meals a day (nibbling) 
compared to an isocalorific diet taken as a few large meals a day (gorging), results in 
reduced fasting serum cholesterol (McGrath & Gibney, 1994), insulin and 
apolipoprotein B concentrations (Jenkins et al. 1989; Verboeket-van de Venne & 
Westerterp, 1991; Wo lever, 1990). However, during the study by McGrath and 
Gibney (1994) on male office workers (age 22-51 years), alongside changes in meal 
frequency the subjects altered their percentage energy intake from fat and protein and 
significantly decreased their alcohol intake. These changes alone accounted for the 
changes in cholesterol, insulin and apo lipoprotein B concentrations that were reported. 
Jenkins et al. (1989) studied the effects of increasing the frequency of meals on fasting 
serum lipid concentrations and carbohydrate tolerance in seven healthy middle-aged 
men. This study showed significantly higher 12 hour responses in plasma blood 
glucose, serum insulin, C-peptide and triacylglycerol (TAG) concentrations when 
subjects consumed 3 meals compared with 17 snacks daily for a two week period. The
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serum insulin level was lower at the end of the nibbling than at the end of the 3 meal 
period. Serum total cholesterol levels were 8.5% (± 2.5%) lower, LDL-C was 13.5% 
(± 3.4%) lower and apolipoprotein B was 15.1% (± 5.7%) lower, in those subjects 
consuming the nibbling diet when compared to the same subjects consuming an 
equicaloric diet in three meals a day. However, this study was scrutinized by 
Southgate in 1990 because the diet which subjects followed was a “prudent” diet with 
a third o f the energy coming from fats and over half from carbohydrates. The dietary 
fibre content was also 37g a day, so the drop in cholesterol concentration was 
predictable since subjects were on a high fibre/low fat diet during the study.
These effects of altered meal frequency on plasma cholesterol concentrations have been 
echoed in more recent research by Jones et al. (1993). He gave 12 normolipidaemic 
male subjects a liquid formula as either 3 or 6 meals a day for 3 days and took blood 
samples every 4 hours on days 2 and 3. The subjects consuming 6 meals had 
significantly lower plasma insulin {P < 0.05) and GIP levels (P < 0.001) throughout the 
day. Plasma total cholesterol concentrations fell in both groups but cholesterol 
synthesis (measured using deuterium incorporation into plasma free cholesterol by 
calculation) was significantly lower (P < 0.01) following the consumption of 6 
meals/day.
One study suggested a mechanism for how increased meal frequency may lead to 
slower absorption of food which in turn could explain the better blood glucose control 
and lipid-lowering effects of soluble fibre (Wolever, 1990). Seven healthy males 
consumed an equicaloric liquid diet either in 3 or 72 equal portions (‘sipping’) over a 
twelve hour study period. Mean 12 hour blood glucose levels did not change between 
the two regimes but the total integrated insulin area was reduced by 32% on sipping (P 
< 0.01). Mean serum free fatty acids and total cholesterol levels were reduced by 20% 
and 2.6% respectively (P < 0.01). The study therefore concluded that it is the slower 
absorption which occurs after continual sipping that leads to better maintenance of 
blood glucose levels and this could be relevant to the treatment of diabetic patients.
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Although most of the studies described above have measured glucose and insulin 
changes, some have looked at the effects of altered meal frequency on TAG fluctuation 
whilst on the diet (Terpstra et a l 1978) and a few have looked at postprandial TAG 
profiles. Van Gent et a l (1979) put six male students on 6 day diets of either 3 meals a 
day or 8 meals a day. At the end of each intervention period diurnal profiles of blood 
TAG were measured; no significant differences were seen between the diets. Wolever 
(1990) showed decreased plasma TAG levels in young male subjects consuming many 
small intakes of liquid formula when compared to 3 bolus doses of formula a day. 
Arnold et a l (1994) performed a postprandial study in hypercholesterolaemic subjects. 
16 male and female subjects consumed their normal diet as 3 or 9 meals a day for 3 
weeks. After this time the TAG response to a standard high fat meal was measured Vi 
hourly for VA hours postprandially. It was not significantly altered following either 
dietary period. NEFA have also been found to be raised significantly when following a 
gorging diet compared to a nibbling diet (Van Gent et a l 1979; Wolever, 1990; 
Bertelsen ûf/. 1993).
4 .1 .3  A im s
Most previous studies have looked at changes in fasting parameters during periods of 
altered meal frequency and it is not clear whether these changes affect postprandial 
responses to a standard test meal. As the majority of people spend most of their time 
in the postprandial state, this study looked at the effects of the previous two weeks 
eating pattern on the metabolic handling of a high fat test meal. The aim of this study 
was to examine the effects of altering meal frequency on postprandial lipaemia and 
other associated parameters. The subjects were required to maintain a nibbling or 
gorging type diet for two weeks, immediately followed by a study day. Fasting levels 
of TAG, insulin and NEFA were also studied to enable the comparison with previous 
studies. Whether a habitual nibbling or gorging diet results in any adaptational 
responses of hormones or enzymes has not been fully elucidated. LPL activity, mRNA 
levels, insulin and NEFA levels were measured to determine an overall response in 
adipose tissue. Hormones and metabolites were measured to assess the extent and 
duration of postprandial lipaemia following the test meal.
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The work described used free-living, female subjects who consumed their normal diet 
throughout the study, only altering meal frequency. Our subjects consumed the same 
foods on each regime, so that any changes seen would have been due to meal 
frequency. The study described has overcome many previous criticisms such as feeding 
subjects liquid formulae or subjects changing the nutrient content of their diet as well 
as altering meal frequency. Also, this study compared realistic numbers of meals such 
as 2 and 12 meals per day, which it would be possible to consume in an everyday 
lifestyle.
4.2 METHODS
Before the study began, ethical consent was obtained from the South West Surrey 
Health Authority Local Research Ethics Committee and from the University of Surrey 
Research Ethics Committee. All the subjects signed an informed consent form prior to 
the first study day.
4.2.1 Subject RECRUITMENT
Eleven free-living female subjects were recruited on to the study. The subjects were all 
from the School of Biological Sciences at the University of Surrey and therefore had 
above average nutritional knowledge. They all satisfied the following criteria;
0 Age 2 1 -2 4  years 
0 BMI >19 kg/m^ < 29 kg/m^
0 Alcohol intake <14 units/week
0 Not taking any fish oil, evening primrose oil or other dietary supplements 
0 Non-smokers
0 No significant current or previous medical history 
0 No regular medication (excluding oral contraceptives)
4.2.2 Dietary intervention
The subjects received one of two diets for a two week period, then had a three week 
wash out period before receiving the other diet for a further two weeks. The dietary
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periods involved eating either 2 meals a day (gorging) or 12 meals a day (nibbling), the 
same foods being eaten on each dietary period and apportioned appropriately. The aim 
of this study was to look at the effects of meal frequency so it was important to keep 
the food intakes the same on the two diets. In order to help subjects, they were 
provided with a set of scales and were given two weeksx)f varied diet sheets as a guide 
which were formulated to give approximately 9MJ (2000Kcal) energy per day, with an 
average 40% calories as fat, 20% calories as protein and 40% calories as carbohydrate. 
Three 24 hour dietary recalls were recorded for each subject to assess food intake 
before the study and on each of the diets. A suggested meal plan for the daily intake 
on the two diets is shown below;
Table 4.1 Suggested meal plan for the nibbling and gorging periods 
Gorging Diet Nibbling Diet
Middav meal 112 noonl 8 am Yoghurt
Ham and tomato sandwiches 9 am Ham sandwich (16 slice bread), orange juice
(3 slices of bread) 10 am Ham sandwich (16 slice bread), orange juice
Crisps 11 am /6 bag crisps, satsuma
Apple, Satsuma 12 noon 16 bag crisps, apple
Chocolate bar 1 pm Ham sandwich (1 slice bread)
2 pm Chocolate bar, 16 banana
Evening meal (6pm) 3 pm Ham sandwich (1 slice bread)
Chilli and rice 4 pm Chocolate bar, 16 banana
Yoghurt 5 pm 16 portion chilli and rice
Orange juice 6 pm 16 portion chilli and rice
2 chocloate bars 7 pm Chocolate bar, satsuma.
Banana, Satsuma
The total energy intake of the above diet was 7MJ ; 37% energy came from fat.
4.2.3 P o s t p r a n d ia l  STUDY
Each subject attended a postprandial study day on the day immediately before the study 
began and on the day after each intervention period. They came into the unit after a 
twelve hour fast having been asked not to undertake any strenuous exercise or
101
Chapter 4
consume any alcohol on the previous day. The subjects then had an intravenous
cannula inserted into an antecubbital vein and two fasting blood samples (18ml) were
taken. The cannula was kept patent using sodium citrate between blood sampling. The
subjects were then fed a standard test meal (see Table 4.2) together with ISOOmg
(Holt e /a /. 1979)
paracetamol, as a marker of gastric emptying^ and 150mg retinyl palmitate, as a marker 
of chylomicron transport. Blood samples (18ml) were taken at 30 minutes and 1 hour 
after commencement of the meal and thereafter hourly for eight hours. During the 
study days, subjects rested quietly in the investigation unit and were allowed fi*ee 
access to water and decaffeinated ‘diet’ beverages without milk or sugar, but no other 
food was consumed until the end of the study period. An adipose tissue needle biopsy 
was taken under local anaesthetic from the paraumbilical region of the abdominal wall. 
This was for analysis of LPL gene expression and occurred on the study days following 
each dietary intervention period but not on the initial study day. (The gene expression 
results are shown in Chapter 6). Eight hours after the meal a single bolus dose of 
intravenous heparin (7500 units) was given at a distant site and further blood samples 
(5ml) were taken at 5 and 15 minutes postheparin for the measurement of LPL activity. 
All blood was collected in heparinised tubes and centrifuged at 7500 x g  within 15 
minutes of collection. Plasma was separated and stored at -20°C until analysis.
Table 4.2 Composition of the Test Meal used during the meal frequency study.
Food Ouantitv 
(g or ml)
Enerev
(MJ)
Fat
(g)
Protein
(g)
Carbohvdrate
(g)
Sliced White Bread 70 0.63 0.90 5.4 35
Cheddar Cheese 30 0.51 10.4 7.7
-
Flora Margarine 10 0.30 8.2
— -
Whole Milk 130 0.35 5.1 4.2 6
Orange Juice 200 0.30
—
1.0 18
Double Cream 120 2.22 5 2 . 0 2.0 4
Nesquik Chocolate 
Milkshake Powder
15 0.24 0.24 0.20 14.7
Total 4.55 76.84 20.5 77.7
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4 .2 .4  A n a l y t ic a l  METHODS
Plasma TAG, NEFA, glucose, paracetamol, total and HDL cholesterol were measured 
spectrophotometrically using automated enzymatic assays on the COBAS Mira Plus 
analyser as described in Chapter 2. LDL cholesterol concentration was calculated 
using Friedwald’s formula (Friedwald et al. 1972) shown below;
LDL - C (mmol /1) = Total serum cholesterol - [ HDL - C + TAG
V 2.2
LPL activity was measured using the radioactive triolein emulsion technique as 
described in Chapter 2. The results are expressed as milliunits of activity (mU) where 
one unit is equivalent to 1 mmol oleate released per minute at 37°C expressed per ml 
plasma.
Plasma insulin, GIP and GLP-1 were measured by radioimmunoassays as described in 
Chapter 2.
The subjects' food intake from the 24 hour dietary recalls were quantified using 
household measures from which weights of portion sizes were calculated (Crawley, 
1988). Diet composition was calculated by another investigator using COMPEAT 4 
dietary analysis programme based on McCance and Widdowson food tables (Holland 
et al. 1991). The degree of compliance to the dietary intervention was evaluated by 
interviewing the subjects on each study day and asking them to state subjectively how 
they felt their comphance rated on a linear analogue scale where 0 was very bad and 10 
was very good (see Appendix I).
4.2.5 S t a t is t ic a l  ANALYSES
Mean values (± SD and SEM) for each measurement and each test meal were 
calculated. Differences in time response curves and in the calculated areas under the 
curve (AUC) were analysed by analysis of variance, with specific differences located 
using the Duncans post-hoc test. Correlation coefficients were calculated using
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Pearson’s Test for Correlation on Instat for Mackintosh Version 2.01 Graph Pad 
Software. Values o f f  < 0.05 were taken as the lowest level of significance.
4.3 RESULTS
4.3.1 Analysis of dietary intakes by questionnaires and 24 hour dietary
RECALLS
The mean dietary intakes of energy, protein, fat, carbohydrate and the percentage 
energy as fat, carbohydrate and protein each day for the two week intervention periods 
are given in Table 4.4. There were few differences between the intakes of any nutrient 
during the intervention periods of the study. Fat intake was significantly higher during 
the gorging diet than on the normal diet (P < 0.05) although fat intake was similar on 
the nibbling and gorging diets. There was a significant correlation between the dietary 
intakes of individuals on the two diets for percentage energy as fat (r = 0.75, P = 
0.008), carbohydrate (r = 0.60, P = 0.005) and protein (r = 0.68, P = 0.002). 
Compliance of the subjects, analysed by a linear analogue scale were 90% (range 80 -  
100%) for the gorging period and 78% (range 68 -  88%) during nibbling. There was a 
significant difference between the compliance during each dietary period, with the 
compliance during nibbling being significantly lower than during gorging (P = 0.01). 
Analysis of the questionnaires revealed that 5 of the 11 subjects ate one snack on one 
day during the gorging diet and 6 subjects failed to eat 12 meals every day on the 
nibbling diet. Of these subjects, 1 person missed meals on one day and 5 people missed 
meals on 3 days. The minimum number of meals eaten during the nibbling period was 
five. Therefore the average number of meals was 11.90 on the nibbling diet and 2.03 
on the gorging diet. The average compliance to the intervention period was higher 
during the first compared with the second dietary period (88% ± 11 versus 80% ± 12) 
regardless of the meal frequency during that period.
Table 4.3 shows the weights and body mass indexes for the eleven subjects at each 
stage of the study and Table 4.4 shows the dietary intakes throughout the study. There 
was a statistically significant difference in fat intake between the normal and gorging
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diets (P < 0.05). There were no other significant changes in dietary intake and the 
BMIs did not change significantly during the study.
Table 4.3 Weight and BMI of each subject at the end of each diet period
Normal Diet Nibbling Diet Gorging Diet
Subject Weight BMI Weight BMI Weight BMI
kg kg/m^ kg kg/m^ kg kg/m^
1 68.2 26.1 65.0 24.9 68.7 26.3
2 59.8 20.6 60.1 20.7 59.7 20.5
3 59.8 22.8 59.0 22.5 60.0 22.9
4 65.9 24.2 66.4 24.4 65.7 24.1
5 64.4 20.8 62.6 20.2 64.4 20.8
6 65.3 27.2 64.1 26.7 65.7 27.3
7 65.7 21.0 66.4 21.2 67.1 21.4
8 65.5 25.1 66.7 25.7 65.1 24.9
9 69 28.4 66.0 27.1 68.4 28.1
10 65.5 21.4 67.4 22.0 65.7 21.5
11 56 21.5 58.1 22.4 58.3 22.4
Mean 64.1 23.6 63.8 23.4 64.4 23.7
SD 3.9 2.8 3.3 2.4 3.5 2.7
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Table 4.4 Comparison of the intakes of macronutrients and their contribution to 
the energy intake on the normal diet and during the two dietaiy intervention 
periods expressed as mean (SD) for the 11 subjects.
Normal Diet Nibbling Diet Gorging Diet
Energy (MJ) 7.94(1.01) 8.64(1.67) 8.89(1.03)
% Energy as fat 31.8 (6.4) 34.4 (5.1) 36.1 (5.3)
% Energy as protein 13.7 (2.8) 15.0 (3.8) 13.9 (2.9)
% Energy as CHO 54.0 (7.3) 50.7 (5.5) 49.8 (4.3)
Protein (g) 66.9 (21.8) 76.2 (22.6) 73.6 (18.7)
Fat (g) 66.0(16.1) 79.3 (21.7) 81.0* (20.0)
Carbohydrate (g) 265 (44) 276 (53) 279 (23)
Significantly higher when compared to the normal diet (P < 0.05)
4.3.2 Plasma TAG
The triacylglycerol responses to a standard test meal following two weeks on a normal, 
gorging or nibbling diet are shown in Figure 4.1 and Table 4.5. There were no 
statistically significant differences in the fasting TAG levels when the three groups were 
compared. Following the consumption of a standard test meal, plasma TAG levels 
rose fi'om similar fasting values to peak values at 196 ± 38 minutes in the gorging 
group, 201 ± 55 in the normal group and 212 ± 62 minutes after two weeks nibbling. 
The plasma TAG levels returned to just below preprandial levels after 480 minutes in 
all the study groups. There were no statistically significant differences in the times to 
peak, total or incremental AUC when the three response curves were compared.
106
Chapter 4
Table 4.5 Fasting TAG and AUC data following two weeks on a normal, gorging 
or nibbling diet. AUC data is given as mmol/I.min. Values are mean (SD) for
11 subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Fasting
TAG(mmoFl)
1.07 0.34 1.08 0.25 1.10 0.37
Total AUC 752 266 756 226 787 284
30-240 AUC 379 156 436 160 421 194
240-480 AUC 341 132 287 104 330 130
Incremental AUC 238 173 234 227 259 220
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Figure 4.1 Postprandial plasma triacylglycerol responses to a standard test meal 
following altered meal frequency. Values are mean (SEM) for 11 subjects.
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4.3.3 Fasting plasma total cholesterol. HDL-chqlesterol and LDL-
CHOLESTEROL CONCENTRATIONS
The fasting values for these parameters are shown in Table 4.6. Only two fasting blood 
samples were taken for these analyses, since little change in plasma choleseterol would 
be expected from one acute meal intake. There were no significant changes in fasting 
total or LDL-cholesterol levels following the dietary intervention, but there was a 
significant increase in HDL-cholesterol following the gorging routine compared to the 
nibbling diet (P < 0.05).
Table 4.6 Fasting lipids following periods on a normal, gorging or nibbling diet. 
Values are mean (SD) for the number of subjects shown.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
TAG (mmoFl) n=l 1 1.07 0.37 1.09 0.25 1.10 0.37
Total cholesterol 
(mmol/1) n= ll
4.63 0.79 4.75 0.77 4.50 0.72
HDL cholesterol 
(mmoFl) n= ll
1.62 0.40 1.73* 0.48 1.60 0.36
LDL cholesterol 
(mmol/1) n=l 1
2.53 0.86 2.52 0.80 2.40 0.73
Values are significantly different from the corresponding normal levels (P<0.05)
4.3.4 Plasma NEFA
The NEFA reponses to altered meal frequency are shown in Figure 4.2 and Table 4.7. 
Plasma NEFA concentrations fell sharply for 60 minutes after the consumption of the 
test meal and reached preprandial levels by 5 -  6 hours after completion o f the meal 
(Figure 4.2). Following two weeks on the normal diet the subjects’ NEFA levels rose
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to baseline levels after 360 minutes. After two weeks on a gorging diet the NEFA 
levels were higher than baseline at 300 minutes postprandially but returned to normal 
levels by the end of 8 hours. Those following two weeks nibbling had higher levels 
than baseline at 240 minutes and did not return to baseline within the 8 hours study 
time. Fasting NEFA levels were significantly reduced on the study days following both 
dietary intervention periods compared to the normal diet (P = 0.02) (Table 4.7). There 
were no differences in the total AUC for plasma NEFA levels, however there were 
changes in the incremental AUC data. The incremental AUC was significantly higher 
following two weeks on the nibbling diet when compared to the normal diet (P = 0.03). 
The AUC 30 -  240 was significantly lower following the gorging and nibbling diets 
when compared to the normal diet and the gorging values remained lower in the 240 -  
480 AUC (P = 0.01) (see Table 4.7). The statistics applied to plasma NEFA were 
confirmed using repeated measures ANOVA using time as the within subject variable 
on Datadesk for Mackintosh.
Table 4.7 Fasting plasma NEFA levels and AUC for NEFA responses to a 
standard test meal after two weeks on a normal, gorging or nibbling diet. AUC 
data is given as mmoI/l.mm| Values are mean (SD) for 11 subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Fasting NEFA 
(mmoFl)
0.763 0.275 0.524* 0.218 0.475* 0.193
Total AUC 308 66 258 68 270 42
3 0 -2 4 0  AUC 99 28 84* 29 78* 22
2 4 0 -4 8 0  AUC 191 44 160* 44 179 35
Incremental AUC -58 135 42* 116 6 115
* Values are significantly different to the corresponding values in subjects consuming 
the normal diet (P < 0.05).
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Figure 4.2 Postprandial plasma NEFA responses to a standard test meal 
following altered meal frequency. Values are mean (SEM) for 11 subjects.
4.3.5 Plasma GLUCOSE
The postprandial glucose responses are shown in Figure 4.3 and the detailed
differences in the area under the curve (AUC) data are shown in Table 4.8. All the
groups showed similar postprandial responses to the standard test meal with two clear
peaks. The hrst peak was about 30 minutes postprandially in all the groups. The
mean
nibbling group showeû a^second peak at 155 minutes postprandially which was later 
than the groups on either a normal diet or a gorging diet who had a second peak at 144 
and 90 minutes after the meal respectively. The individuals in the normal and gorging 
groups returned to preprandial levels by the end of the study period. Those who had 
been following a nibbling diet had still not returned to normal levels 480 minutes 
postprandially. Although the gorging group had a higher mean fasting glucose level 
the difference was not statistically significantly different from the other two groups 
(Table 4.8). There were no statistically significant differences seen following either
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dietary intervention period in the fasting levels, time to peak or in the total or 
incremental AUC data when compared to levels after two weeks following a normal 
diet.
Table 4.8 Fasting plasma glucose values and AUC data following altered meal 
frequency. AUC data is given as mmol/l.min. Values are mean (SD) for 11
subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Fasting Glucose 
(mmoFl)
5.16 0.77 5.46 1.03 5.10 0.75
Total AUC 2572 319 2632 390 2598 150
3 0 -2 4 0  AUC 1142 178 1179 203 1150 186
240 -  480 AUC 1269 133 1282 175 1284 164
Incremental AUC 94.06 159.08 7.92 444.24 150.07 122.99
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Figure 4.3 Postprandial plasma glucose response to a standard test meal 
following altered meal frequency. Values are mean (SEM) for 11 subjects.
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4.3.6 P la s m a  INSULIN
Plasma insulin responses are shown in Figure 4.4 and Table 4.9. Plasma insulin levels 
rose rapidly postprandially and gradually returned to preprandial levels over the eight 
hour study period. The nibbling group reached peak levels at 93 ± 70 minutes 
postprandially, the gorgers at 109 ± 52 minutes and following two weeks on a normal 
diet the highest level was at 68 ± 36 minutes postprandially. There were no statistically 
significant differences in the times to peak or AUC when the three response curves 
were compared and this can be seen in the graph where values are clearly very similar 
in all the groups.
Table 4.9 Fasting plasma insulin values and AUC data following altered meal 
frequency. AUC data is given asj pmol/I.min , Values are mean (SD) for 11
subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Fasting insulin 
(pmoFl)
50.91 16.84 51.39 7.75 57.09 21.50
Total AUC 92096 31157 93869 29588 92835 25387
3 0 -2 4 0  AUC 66851 28640 65808 24724 61635 22520
240-480  AUC 22053 5146 27383 14785 26164 14039
Incremental AUC 67657 29837 69203 29347 65429 22638
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Figure 4.4 Postprandial plasma insulin responses to a standard test meal 
following altered meal frequency. Values are mean (± SEM) for 11 subjects.
4.3.7 P o s t h e pa r in  pla s m a  l ip o pr o t e in  l ipa se  a c t iv it y
The postheparin LPL activities after two weeks on each dietary period are shown in 
Table 4.10 and Figure 4.5. The 15 minute postheparin samples were significantly 
higher than the 5 minute samples in all the groups. Mean LPL activities were higher 
after the gorging and nibbling diets when compared to the normal group. However, 
only the 5 minute postheparin activity following nibbling was statistically significantly 
higher than normal {P < 0.05).
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Table 4.10 Postheparin plasma LPL activity in 11 subjects following altered meal 
frequency. Values are mean (SD) for 11 subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
5 minute postheparin 
LPL activity (mU)
54.2 20.4 79.2 44.5 102* 55.8
15 minute postheparin 
LPL activity (mU)
104t 38 116.3t 36.5 137.lt 70.6
Mean value was significantly different from normal diet (*) or the corresponding 5 
minute sample (t) {P < 0.05).
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Figure 4.5 Changes in postheparin LPL activity levels following altered meal 
frequency. Values are mean (SEM) for 11 subjects in the gorging and nibbling 
group and 9 subjects in the normal group. Columns with the same symbol are 
significantly different from one another {P< 0.05).
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4.3.8 P la s m a  p a r a c e t a m o l
Figure 4.6 and Table 4.11 show the changes in plasma paracetamol levels after the 
standard test meal in the three groups. The paracetamol levels rose sharply 
immediately after intake and the shapes of the postprandial curves were very similar 
following all the dietary intervention periods, peaking at 144 ± 51, 135 ± 62 and 180 ± 
28 minutes after completion of the meal in the normal, gorging and nibbling groups 
respectively. Circulating levels of paracetamol were still detectable at the end of the 
study period. There were no significant changes in the times to peak, total or 
incremental AUC data when the groups were compared.
Table 4.11 Paracetamol AUC data following altered meal frequency. Values are
mean (SD) for 11 subjects.
AUC data is given as mmol/l.min.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Total AUC 39.29 6.32 40.41 6.77 39.59 6.43
3 0 -2 4 0  AUC 22.99 3.56 23.07 4.18 23.25 4.09
240-480  AUC 15.03 4.09 16.01 3.43 15.0 3.58
Incremental AUC 32.81 6.44 34.17 6.25 33.34 6.88
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Figure 4.6 Postprandial plasma paracetamol responses to a standard test meal 
following altered meal frequency. Values are mean (SEM) for 11 subjects.
4.3.9 P lasma GIF
Plasma GIP responses are shown in Figure 4.7 and numerically in Table 4.12. Plasma 
GIP levels rose sharply after the consumption of a standard test meal from similar 
fasting levels in the three groups. The response curves reached a mean maximum at 
133 ± 91, 185 ± 57 and 202 ± 82 minutes postprandially in the normal, gorging and 
nibbling groups respectively and at the end of the study period the levels in all groups 
were slightly above preprandial values. There were no significant differences in the 
fasting levels, times to peak or postprandial AUC for the GIP response curves 
following any of the two week diets.
1 1 6
Chapter 4
Table 4.12 Fasting plasma GIP levels and AUC data following altered meal 
frequency. AUC data is given as pmol/I.min .Values are mean (SD) for 11
subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Fasting GIP(pmoFl) 75.41 90.62 66.69 93.93 81.36 115.56
Total AUC 78708 42070 84143 61854 83230 55153
30 -  240 AUC 44634 22364 46178 31024 44640 27325
240 -  480 AUC 33040 19458 36705 31579 36740 27969
Incremental AUC 42507 19228 52132 20337 44175 13191
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Figure 4.7 Postprandial GIP responses to a standard test meal following altered 
meal frequency. Values are mean ± SEM (n=ll).
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4.3.10 P la s m a  GLP-1 (7-36) AMIDE
The postprandial GLP-1 response curves are shown in Figure 4.8. The fasting values 
and AUC data following each dietary intervention period are shown in Table 4.13. 
There were no statistically significant differences in fasting GLP-1 levels when the 
three groups were compared. Plasma GLP-1 levels rose sharply after completion of 
the test meal and peaked at 86 ± 72 minutes in those who had followed a nibbling diet 
for two weeks prior to the test meal. The group of subjects who had maintained a 
normal dietary intake showed peak GLP-1 levels at 141 ± 7 4  minutes postprandially, 
however those following two weeks of gorging had GLP-1 levels peaking later at 163 
± 67 minutes postprandially. Plasma GLP-1 levels returned to preprandial levels 480 
minutes after consumption of the standard test meal.
Table 4.13 Fasting plasma GLP-1 levels and AUC data following altered meal 
frequency. AUC data is given as I  pmol/I.min^. Values are means (SD) for 11
subjects.
NORMAL DIET GORGING DIET NIBBLING DIET
Mean SD Mean SD Mean SD
Fasting GLP-1 
(pmoFl)
15.87 6.82 11.14 2.04 12.71 5.55
Total AUC 13002 3041 13871 4422 14058 2883
3 0 -2 4 0  AUC 7819 2142 8329 2918 8295 1772
240 -  480 AUC 4321 1365 4925 1828 4773 1409
Incremental AUC 5383 2534 8522 4022 7956 3516
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Figure 4.8 Postprandial plasma GLP-1 responses to a standard test meal 
following altered meal frequency. Values are mean (SEM) for 11 subjects.
4.4 DISCUSSION
well fed
The majority o^people spend most of their time in the postprandial state so this study 
looked at the effects of the previous two weeks eating pattern on the metabolic 
handling of a high fat test meal. The aim of this study was to examine the effects of 
altering meal frequency on postprandial lipaemia and other associated parameters. 
Many of the current results do not reflect those previously reported and the reasons for 
this are discussed later on. The main results are shown below;
• Subject compliance to the two dietary regimes was very good (above 75%).
• There were no significant differences between macronutrient intakes on the two 
intervention diets.
• There were no significant differences in fasting TAG, total or LDL-cholesterol 
levels following any dietary period.
• Fasting HDL-cholesterol was significantly higher following the gorging diet than 
levels on the normal diet (T < 0.05).
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• Fasting NEFA levels were significantly reduced following both dietary intervention 
periods compared to the normal diet {P -  0.02).
• The incremental AUC for NEFA was significantly higher following the nibbling diet 
when compared to the normal diet {P = 0.03).
• The AUC (NEFA) 30 -  240 was significantly lower following both the gorging and 
nibbling diets and the AUC 240 -  480 was significantly lower in the gorging group 
when compared to those in the normal diet group (P < 0.01).
• There were no significant differences in postprandial plasma concentrations of TAG, 
glucose, insulin, GIP or GLP-1 levels in response to a standard test meal following 
the nibbling or gorging regimes.
• The 5 minute postheparin plasma LPL activity following the nibbling diet was 
significantly higher when compared with the normal diet (P < 0.05).
Analysis of the dietary intakes during the study indicated that, as requested, subjects 
ate very similar foods on both diets. However, they found it difiScult to split up the 2 
gorging meals into 12 equicaloric snacks. This led to uneven nutrient intake on the 
nibbling days and may have been a cause for some of the unexpected results seen. This 
problem arose despite the fact that the subjects were recruited from the School of 
Biological Sciences and had above average nutritional knowledge and is a point worth 
noting for further work in this area. The importance of giving diets of identical 
composition in studies designed to evaluate metabolic responses to nibbling or gorging 
was proven by McGrath and Gibney in 1994. They demonstrated changes in the 
contribution to energy intake from protein, fat, saturated fatty acids and alcohol when 
the subjects were asked to change from a snacking diet to a meal-eating routine. The 
changes in nutrient intake were solely responsible for the cholesterol changes seen, not 
the alteration in meal frequency. The importance of close guidance with regards to 
food choice must therefore be stressed.
Despite the problems in compiling diets to suit each subject, compliance throughout the 
study was excellent (90% compliance reported whilst gorging and 78% whilst 
nibbling). This high degree of compliance was achieved by the subjects being well 
motivated, known to the investigators and having close contact with the investigators.
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It is interesting to note that the compliance to the first diet was higher than the second, 
independent of whether subjects were nibbling or gorging (8 8 % versus 80%). 
Although the subjects were randomly allocated to each diet, 7 out of 11 subjects were 
assigned the gorging regimen for the first two weeks. This may explain the difference 
in overall compliance. The practical difficulties of the dietary regimens were revealed 
by interview with the subjects. Different problems arose with the two diets. Subjects 
reported hunger in the morning on the gorging diet and lack of time for 1 2  meals a day 
due to work pressures whilst nibbling. These difficulties could only be overcome by 
keeping subjects in a metabolic unit for the duration of study. This would ease time 
pressures, but may lead to other stresses and places subjects in a less realistic lifestyle 
which could cause other problems.
The standard test meal was designed to have a mixed nutrient composition which 
would produce clear responses in all the parameters that were to be measured. In 
practical terms, the meal was designed to be energy dense and have a high satiety value 
but to be small in volume to suit all the subjects. It represented ‘normal’ food intake in 
terms of the actual foods consumed even though the amount of fat ingested in one meal 
was high. Many previous studies have used liquid formulae which may have altered 
gastric emptying rates (Wolever, 1990; Jones et al. 1993). This would in turn alter 
gastrointestinal hormone levels which we have shown to have important effects on the 
metabolism of dietary fat (see Chapter 3). It was also important that the meal was 
energy dense but not bulky. This was especially pertinent for the subjects who had 
been following a nibbling diet of many small meals each day. The nibblers would have 
found a bulky meal hard to consume within % hour because of the sheer volume.
The administration of paracetamol with the standard test meal allowed the assessment 
of gastric emptying rates during the eight hours following the meal. It has been 
suggested that the intake of different nutrients can affect the rate of gastric emptying 
(Brown et al. 1994). Also, following the two weeks on a nibbling diet, there was 
concern that the subjects might find the standard test meal difficult to consume with 
consequent effects on gastric emptying. However, no statistically significant 
differences in paracetamol levels were found after any dietary period, suggesting that
121
Chapter 4
gastric emptying and rates of fat absorption were unaffected by dietary routine on the 
study day.
Many previous studies have found that a nibbling diet leads to lower plasma TAG 
levels over a diurnal period (Gwinup et al. 1963), lower fasting total cholesterol and 
lower LDL cholesterol levels(Jenkins et al. 1989; Arnold et al. 1993; McGrath & 
Gibney, 1994). This study did not find significant differences in plasma TAG or 
cholesterol levels, although total cholesterol levels were lowest following the nibbling 
diet (4.50 ± 0.72) and highest after the gorging period (4.75 ± 0.77). All previous 
work on meal fi-equency has been in male subjects. Lipid metabolism in women is 
influenced by sex hormones, specifically oestrogens, which may mask small changes in 
postprandial lipaemia in female subjects. Premenopausal young women reportedly 
have low cholesterol levels (Barrett-Connor, 1994) and this may also have masked any 
reduction following increased meal frequency. Ideally the study would be performed in 
women at the same stage in their menstrual cycle to minimise the effects of oestrogen 
(Taylor & Ward, 1993), but this was not practicable in the present study. The lack of 
significant changes in cholesterol levels may also be due to the lack of change in 
postprandial insulin levels after each dietary intervention period. Small changes in 
plasma insulin levels have been reported in relation to small fiuctuations in LDL- 
cholesterol specifically following altered meal frequency (Jenkins et al. 1989).
Many investigators have looked at the effects of meal frequency on the fasted state or
have followed the metabolic consequences of altering meal frequency over a 24 hour
{well fed
period (Jagannathan et al. 1964; Jenkins et al. 1989). As/yindividuals spend the 
majority of their time in the postprandial state , this study was designed to investigate 
the effects of previous meal frequency on the postprandial metabolic handling of a 
standard test meal. Studies measuring 24 hour profiles have shown lower total TAG 
levels when the subjects ate smaller, more frequent meals (Jagannathan et al. 1964; 
Terpstra et al. 1978; Van Gent et al. 1979; Jenkins et al. 1989). The present study did 
not detect any significant changes in fasting or postprandial TAG levels. Our subjects 
reported a low percentage energy from fat (30%) compared to the national average
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(40%), and this did not change during the dietary interventions. This may be a reason 
for the lack of changes seen in plasma TAG during the study.
Any alteration in lipoprotein lipase activity has implications for an individual's disease 
status because it is the central enzyme in clearance of dietary TAG from the blood 
stream. LPL activity was higher after the nibbling diet compared to the normal diet 
which was unexpected, but may have been due to the constant activation of LPL 
through regular food intakes. Higher LPL activity would be beneficial as high LPL 
levels have been correlated with decreased risk of CAD, both when associated with 
exercise (Weintraub et a l 1989) and n-3 PUFA intake (Herzberg, 1991).
Differences in LPL activity may explain the interesting alterations in NEFA response 
following the changes in meal frequency. The raised NEFA in the later part of the 
postprandial curve in the nibblers could be due to higher LPL levels. The nibblers were 
used to small frequent meals until the study day. This large bolus of fat in the test meal 
could have overloaded the systems of NEFA clearance after LPL-mediated hydrolysis. 
High NEFA levels cause a surge in release of LPL from its storage pools in the 
capillary endothelium (Karpe et a l 1993). This would mean less LPL available for the 
hydrolysis of TAG from the chylomicrons released in the late postprandial phase. In 
turn, this would cause an increase in the number of TAG-rich chylomicrons remaining 
uncleared for a longer time which have been implicated in the development of CHD 
(Zilversmit, 1979). Fasting NEFA levels were significantly lower following both 
dietary intervention periods. This was an unexpected result and may have been due to 
the subjects fasting for longer than 1 2  hours prior to the first study day and therefore 
increasing NEFA levels from adipose tissue for use in liver TAG synthesis (Frayn et a l  
1993). In addition, the stress of cannulation in nervous subjects, unaccustomed to such 
studies, might have increased NEFA levels on the first study day.
In conclusion, this study showed few significant effects of meal frequency on 
postprandial lipaemia in young female subjects. The study results did not confirm the 
previous studies which suggested that nibbling is beneficial in reducing the 
concentrations of lipids and certain hormones. However, this study demonstrated the
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importance of close contact with the subjects to attain good compliance. It also 
highlighted the difficulties of studying women, and the problems of intervention which 
causes changes in lifestyle such as eating 12 times a day. The rigorous control of diet 
content and composition in the present study has meant that few changes were seen as 
a consequence of altering meal frequency. This suggests that reported effects of meal 
frequency may be due to unintentional alteration in nutrient and energy intake in 
previous studies. Further work with older, postmenopausal women or middle-aged 
men and longer intervention periods, alongside maintaining such scrupulous dietary 
intervention may lead to further enlightenment on this subject.
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5. EFFECTS OF MATERNAL AND 
EARLY DIET ON LIPID 
METABOLISM IN ADULT LIFE
5.1 INTRODUCTION
Over the last decade, there has been a surge of evidence consistent with the hypothesis 
that alterations in maternal nutrition during pregnancy may irreversibly affect aspects of 
physiological and biochemical functions in the foetus. Thus poor maternal diet has 
potential adverse consequences for the later health of the offspring. The wealth of 
research in this area has particularly covered the effects of a maternal low protein diet 
on foetal growth, organ development and metabolic and morphological changes in the 
foetus (Langley & Jackson, 1994; Langley et al. 1994). Epidemiological studies in 
humans have demonstrated an association between ischaemic heart disease, 
hypertension and impaired glucose tolerance in adults, with low birthweight and altered 
placental growth (Barker ûf/. 1989; Barker e/a/. 1990; Hales e/a/. 1991). However, 
the paucity of controlled prospective studies testing early hypotheses has meant slow 
progress with regards to mechanistic explanations. A major question on infant diet and 
health which remains to be answered is by what mechanisms do maternal diets 
influence long-term morbidity in the progeny.
5.1.1 Animal STUDIES
Very early work on the effects of malnutrition on organ cell size and number suggested 
that cellular effects of malnutrition depended on the phase of growth at the time of 
malnutrition (Winick & Noble, 1966). Although this work did not study the 
programming effects from maternal nutrition to the offspring, the results did show that 
the earlier the insult occurred, the less efficient the recovery, if recovery was possible at 
all. The following year, a study was published which stated that ‘the stunting effect is 
induced in the progeny during gestation’ (Blackwell et al. 1967). It is these effects of
125
________________________________________________________________Chapter 5
gestational insults on progeny which have been thoroughly investigated and confirmed 
more recently.
Ovemutrition in the early postnatal period has long been discussed as an important 
factor in the development of obesity, diabetes and hyperlipoproteinaemia. Many 
studies have compared litter sizes in rodents and looked at the effect on development 
of the offspring as a model for over- (small litter sizes) and undernutrition (large litter 
sizes). Compared with animals in large litters, animals growing up in small litters 
show:
• increased efficiency of energy utilisation
• larger cell size and increased number of adipocytes
• higher plasma insulin levels
• decreased rate of thyroxine secretion
• decreased hormone-stimulated lipolysis in adipose tissue in vitro
• higher plasma GIF levels.
As early as 1968, Knittle and Hirsch showed that early nutritional experiences could 
effect permanent changes in cell number and size. They specifically studied the 
epididymal fat pad and found that these were heavier in rats raised in litters of 4 
compared with those firom rats raised in litters of 22. These workers stated that at 20 
weeks old this difference was due to both cell size and cell number of adipocytes. 
Another study also looked at animals which were 20 days old and showed plasma 
insulin and cholesterol levels to be higher in rats fi*om litters of 4 compared with 14. 
These changes were still evident at 50 and 60 days old (Hahn, 1984).
In 1972, Reiser and Sidelman demonstrated that exposure of neonatal male rats to high 
levels of milk cholesterol protected them as adults fi'om dietary-induced 
hypercholesterolaemia. These results suggest that an early exposure to a high 
cholesterol diet may have initiated mechanisms that maintained serum cholesterol at 
lower concentrations in later life. On the contrary though, another study reported that 
early exposure to overfeeding or early exposure to a high fat diet led to 
hypereholesterolaemic responses in adulthood in rodents following an abnormal
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challenge of 3 day exposure to a high fat diet (Coates et a l 1983). Higher LPL 
activities were also found in animals from small litter sizes, independent of age, 
suggesting an early and long-term determination of this enzyme activity (El Habet et al 
1979). It is this apparent early setting or programming of enzymes, specifically 
enzymes involved in lipid metabolism, which the current study set out to investigate 
further. Although there have been many studies looking at the effects of pre-weaning 
diet on later outcome (Coates et a l 1983; Hahn, 1984; Aubert et a l 1988), there have 
not been many studies on the effects of maternal nutrition during gestation on outcome 
in the progeny. Recent evidence has suggested that the long lasting effects can occur 
earlier than the pre-weaning period, i.e. during gestation. The critical morphological 
development of the embryonic tissues occurs during the first 1 0  days of gestation in the 
rat. Maternal dietary changes (no glucose in the diet) increased the number of 
resorptions and dead foetuses found at 1 2  days compared to a normal mixed dietary 
intake (Kubow & Ko ski, 1995). It is therefore reasonable to assume that nutritional 
stresses in early gestation could affect the outcome of pregnancy.
Other studies have also examined the timing of maternal dietary change on pregnancy
outcome. A recent study compared the effects of maternal feeding restriction for the
first 17 days of gestation with restriction right through gestation to day 7 of lactation.
No differences were observed in the length of gestation or litter size as a consequence
of the dietary restrictions. However, feeding restriction during lactation seriously
disturbed the nursing performance of the dam and reduced the growth rate in the
offspring. The dams who had dietary restrietion during lactation tended toward
cannibalization, some offspring died and weight gain in the offspring was poor.
Dietary restriction for the first 17 days of gestation had little effect on the outcome of
-up
pregnancy, suggesting that a catch^phase of growth occurred in the remainder of the
gestational period (Kawaguehi et a l 1994). Maternal diet did not affeet litter size, pup
birthweight or length of gestation in another recent trial (Fiorotto et a l 1995). These
Ï1995)
results eontradict those of Kobow and Koski^reported earlier and stress the necessity 
for more work in this area.
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Figure 5.1 Summary of the proposed maternal and in utero nutritional 
influences on the foetus and the subsequent effects of programming relevant to 
nutrition (Adapted from Goldberg & Prentice, 1994).
5.1.2 HUMAN STUDIES
When Wordsworth said “The child is father of man”, he summarised neatly the 
argument proposed by Barker and co-workers that factors affecting the human foetus 
and young have long lasting effects and are important causes of later diseases, such as 
ischaemic heart disease (IHD), stroke and chronic bronchitis. The work in humans 
elucidating this hypothesis is vast and there have been many papers pubHshed in the last 
ten years describing retrospective epidemiological studies on men in Preston and 
Hertfordshire (Fall et al. 1992, Barker et al. 1993b; Hales et al. 1991). This section 
will briefly summarise the relevant findings which are also depicted in Figure 5.1.
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Barker proposed that influences which impair growth and development in early life may 
be risk factors for IHD. To test this hypothesis, 5654 men born in Hertfordshire 
during 1911-1930 were traced. At birth and at 1 year, these men had had their weights 
recorded and the records were traced for this work. By 1987, 1186 men had died. 
The standardised mortality ratios for IHD fell significantly with increasing weight at 1 
year (P < 0.002) and a similar trend was seen when birthweight and deaths from IHD 
were related to one another although this was not significant (Barker et al. 1989). The 
death rates from IHD in men who weighed 8.2kg or less at one year of age were three 
times higher than those who weighed more than 1 1 .8 kg.
As mentioned in the animal section, there has been speculation that the high cholesterol 
and saturated fat content of milk received in early life may influence Hpid metabohsm 
throughout life (Reiser & Sidelman, 1972; Coates et al. 1983). In 1992 Fall and 
colleagues examined whether the method of infant feeding could be associated with 
adult serum lipid concentrations and mortality from IHD (Fall et al. 1992). The study 
compared 485 men, aged 59 -  70 years, living in Hertfordshire. The type of infant 
feeding, birthweight and weight at one year had been recorded. The men were divided 
into three groups;
• those who had been breast fed alone and had not been weaned at 1 year
• those who were breast fed alone and weaned before 1 year
• those who had been both breast and bottle fed.
The results showed that -  compared with men weaned before one year -  men not 
weaned had higher mean serum total cholesterol concentration, LDL-cholesterol 
concentration and apo B levels. Men who had been bottle fed also had a high 
standardised mortality ratio for IHD and high mean serum total cholesterol 
concentration, LDL-cholesterol and apo B concentrations. In all the groups serum apo 
B was lower in men with higher birth weight at one year (Fall et al. 1992). This study 
therefore confirmed that age at weaning and type of food during infancy (and 
consequently growth in infancy), influence adult serum lipid concentrations.
In a diflferent group of subjects another study related growth in utero to adult serum 
cholesterol concentrations. This was a follow-up study of 219 men and women born in
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Jessop Hospital (Sheffield) whose size at birth had been recorded. Men and women 
who had a small abdominal circumference at birth showed raised serum total- and 
LDL-cholesterol and apo B levels. Small head and chest circumferences at birth were 
similarly associated with the aforementioned parameters. These associations were 
independent of gestational age, indicating a reflection of reduced rates of foetal growth 
rather than with premature birth. The fact that LDL concentrations are affected by 
altered gestational growth could indicate permanent changes in cholesterol metabolism 
and may suggest permanent changes in growth of the foetal liver (Barker et al. 1993a). 
This work has particular relevance to the current study since lipid metabolism is an 
integral part of the work.
Another large area of study by the same group of workers has related foetal growth to 
insulin secretion in adult life. There is evidence that Type II (non-insulin dependent) 
diabetes mellitus is programmed in foetal life and infancy. A study of 370 
Hertfordshire men, aged 59 -  70 years, showed plasma glucose levels 30 minutes and 2 
hours after a 75g oral glucose load to be inversely related to birthweight and weight at 
one year (Hales et al. 1991). In a follow-up trial, 42 younger men aged 18 - 25  years 
were given a standard 75g oral glucose load and a blood sample was taken after 30 
minutes. An inverse association was found between birthweight and plasma glucose 
such that an increase of 1kg in birthweight corresponded to a decrease of 1.5mmol/l in 
30-minute glucose level (Robinson et al. 1992). Syndrome X encompasses insulin 
resistance, hypertension and hyperlipidaemia. In 1993, Barker studied two cohorts 
from the same pool of people to determine whether syndrome X was related to 
reduced foetal growth. The prevalence of syndrome X fell progressively in both men 
and women, from those who had the lowest to those who had the highest birthweights. 
In addition to low birthweight, subjects with syndrome X also had smaller head 
circumference and below average dental eruption at one year. In conclusion, NIDDM 
and hypertension have a common origin in sub-optimal in utero development (Barker et 
al. 1993b).
When a standard oral glucose tolerance test was performed on 140 men and 126 
women born in Preston during a follow-up study, those subjects found to have
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impaired glucose tolerance or NIDDM had lower birthweight, a smaller head 
circumference and were thinner at birth (Phipps et a l 1993). These results therefore 
confirmed other results found in Hertfordshire and suggest that poor glucose tolerance 
may be a consequence of maternal undernutrition. The following year another study on 
the Preston cohort demonstrated thinness at birth to be related to insulin resistance in 
adult life (Phillips et a l 1994).
5.1.3 Fish OILS
Fish oils are rich in n-3 PUFAs. They have become a well established dietary 
recommendation for improving several disease states including atherosclerosis, 
hypertension and arthritis (Clarke et a l 1988). The n-3 PUFAs are characterised by a 
double bond positioned three carbon atoms away from the terminal methyl group. The 
major n-3 fatty acids found in fish oil are eicosapentaenoic acid (EPA; 020:5) and 
docosahexaenoic acid (DHA; 022:6).
Fish oils have been shown to reduce hepatic Hpogenesis and VLDL secretion and 
increase postheparin plasma LPL activity (Daggy et a l 1987; Zampelas, 1994). Fish 
oils also lead to increases in the rate of chylomicron clearance (Levy et a l 1991). All 
these factors lead to an overall reduction in plasma TAG levels seen in studies when 
consuming a high fish oil intake. Some of the more recent and relevant work in this 
area is reported in Table 5.1.
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Table 5.1 Reported effects of dietary fish oil intake.
Authors Subiects/animals Results
Yamazaki et al. 1987 Male rats on one of three diets for 14 
days;
1. 15% fish oil
2. 15% safïlower oil
3. Control (no added fat)
• Fish oil diet significantly lowered 
plasma TAG levels compared to other 
two diets.
Haug & H0stmark, 
1987
Adult male rats put on three diets for 4 
weeks (16 rats/group);
1. 22% coconut oil
2. 11% coconut +11% fish oil
3. 22% fish oil
• Plasma TAG, cholesterol and 
phospholipids lower in fish oil fed rats 
compared with coconut oil fed group.
• VLDL lower in coconut/fish group and 
fish group compared to pure coconut 
oil fed group.
Herzberg & 
Rogerson, 1989
Adult male rats put on six diets (four 
rats/group);
1. 60% fiiictose + 10% tallow
2. 60% fiiictose + 10% com oil
3. 60% fi-uctose + 10% fish oil
4,5,6 As above but with glucose replacing 
the fi-uctose.
• Adipose tissue LPL activity unaffected 
by dietary fat or carbohydrate.
• LPL activity in heart & skeletal muscle 
higher in fish oil fed groups.
L’Abbé e/a/. 1991 Four groups of 8 rats fed 20% fat diet for 
16 weeks as;
1. 60% lard + 40% com oil
2. 72% lard + 28% linseed oil
3. lard + 14% linseed + 10% com + 25 
% fish oil
4. 30% lard + 20% com + 50% fish oil
• Diet 4 produced the largest cholesterol 
lowering effect.
• TAG levels only significantly reduced 
in female rats.
D’Aquino e/a/. 1991 Two groups of 6 male rats fed one of two 
diets for 6 weeks;
1. 15% fish oil
2. 15% coconut oil
• Serum TAG and total cholesterol were 
lower in fish oil fed group.
Benhizia e/a/. 1994 Four groups of 7 male rats fed one of four 
diets for 16 days;
1. 4% fat (control diet)
2. 25% lard
3. 25% lard + fish oil
4. 25% lard + com oil
• Compared to the control diet, lard and 
lard/corn diets induced a significant 
rise in plasma TAG.
• Lard/fish oil diet reduced plasma TAG 
compared to the control diet or lard 
diets.
• Chylomicron TAG increased in lard 
and lard/corn diets compared to 
controls. No difference between 
lard/fish oil diet and controls.
• Lard/fish diet led to reduced VLDL 
and LDL levels compared to controls.
• Decrease in epididymal adipose tissue 
LPL after lard or lard/corn diets 
compared to controls. Lard/fish diet 
led to increase in adipose tissue LPL 
activity.
Eritsland e/a/. 1995 511 men, age 59 ± 8.8 years. Supplement 
of 3.4g EPA/DHA for 9 month follow-up 
study.
• Serum TAG decreased by 19.1%.
• No significant differences in total, 
LDL or HDL cholesterol, apo A1 or 
apo 3100.
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In summary, the consensus of opinion is that the consumption of fish oils leads to 
hypotriacylglycerolaemia. However, the substitution of membrane fatty acids with 
potentially unstable n-3 PUFA could increase susceptibility of cellular membranes to 
lipid peroxidation. Fish oil feeding has been shown to challenge the antioxidant 
defence system and therefore increase the susceptibility of tissues to free radical 
oxidative damage (Saito et a l 1994; D’Aquino et a l 1991; L’Abbé et a l 1991). 
Enzymatic defense against reactive oxygen species involves a cooperative action of 
superoxide dismutase (SOD), catalase and glutathione peroxidase.
5.2 AIMS AND OBJECTIVES
The wealth of evidence described here supporting Barker’s hypothesis stimulated this 
research to reproduce the phenomenon in an animal model in order to delineate the 
underlying mechanisms. The specific aim was to look more closely at the mechanisms 
involved behind ‘programming’ -  when an early stimulus or insult is exerted at a 
critical or sensitive period, resulting in long term change in the structure or function of 
the organism (Lucas, 1990). Animals bom to dams who had consumed either a high 
fish oil diet or a mixed oil diet for the last two weeks of gestation were weaned onto 
one of the special diets. The animals were either sacrificed at five weeks of age to 
represent early life or at ten weeks of age to represent adulthood. The central 
hypothesis was that the type of fat received in early life could determine the level of 
LPL gene expression which is maintained into later life and that a diet high in n-3 
PUFA would be associated with higher levels of LPL expression. Thus we aimed to 
study the apparent setting of enzyme levels early in life which could then be overloaded 
in later life during periods of dietary stress. Three liver enzymes were measured in 
order to assess the influence of the high fish oil on oxidative status throughout the 
study -  SOD, catalase and glutathione reductase. Plasma and gastrointestinal levels of 
GIP and GLP-1 were measured since these affect LPL levels either directly or through 
their influence on the enteroinsular axis. Ethical considerations and time constrained 
the use of human subjects, so rodents were used because of their relatively short life­
cycle and the ease with which their diets can be manipulated.
133
________________________________________________________________Chapter 5
5.3 METHODS
5.3.1 A n im a l s
The pregnant animals used in this study were Wistar Albino rats, obtained from the 
Rodent Breeding Unit at the University of Surrey. Transfer of the pregnant animals 
from the breeding unit to the Experimental Biology Unit was performed at least 24 
hours prior to the start of the breeding study. The pregnant females were individually 
caged on a sawdust bedding for the last two weeks of gestation. A standard twelve 
hour photoperiod (0700 -  1900hr) was maintained, temperature kept at 22±2°C and 
humidity kept close to 50%. On the day after each litter was born, litter sizes were 
standardised to six offspring per dam by spreading the young between the dams in each
dietary group. The pups were weaned at 21 days old and the dams sacrificed. The 
offspring were either sacrificed 
(‘adult’), as shown in Figure 5.2.
seven
at two weeks post-weaning (‘young’) or six weeks
5.3.2 D iet
In the current study a comparison was made between 5% (w/w) fat intake purely as 
fish oil and fat intake comprising 5% (w/w) mixed oil. The mixed oil diet -  made up of 
coconut, olive, com and palm oils -  was designed as a control diet to represent a 
typical U.K. daily fatty acid intake. The diets were supplied in aluminium dishes 
equipped with a lid and screen to prevent spillage and were pair-fed to the pregnant 
rats. Tap water was provided ad libitum. The composition of the diets (w/w) was: 
60% maize starch, 20% casein, 5% fat, 4% cellulose, 5% sucrose, 5% vitamin/mineral 
mix and 0.2% methionine. Details are given in Table 5.2 and Table 5.3. The oils were 
obtained from different sources -  coconut oil was obtained from a specialist indian 
supermarket, com and olive oils from a local supermarket, palm oil from Akisan 
Enterprises, London and MaxEPA was kindly donated by Seven Seas Ltd. (Kingston- 
upon-Hull, U.K.). The same batch of each diet was used for the entire study and was 
stored at -20°C throughout the trial to avoid oxidative degradation. Food intake was 
recorded daily prior to parturition. Upon weaning, the progeny were fed the same test 
diet as the dams, ad libitum, until sacrifice after two or seven weeks. Food intake per
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cage was recorded and divided between the number of offspring per cage to ascertain 
mean food intake per rat per day. Food was removed during the day (09:00 -  
17:00hrs) prior to sacrifice and all the animals fed a standard test diet overnight before 
sacrifice. The test diet was based on the standard RMl rodent diet (Special Diet 
Services, Essex) -  the exact composition of the test diet is shown in Table 5.4.
5.3.3 Handling of blood and tissue samples
The rats were killed in the fed state by exsanguination under ether anaesthetic and the 
blood was collected into 5ml heparinised tubes. Within one hour the blood was 
centrifuged at 3000rpm for 1 0  minutes at room temperature in a benchtop centrifuge. 
The plasma was removed and aliquoted into LP3 tubes before being fi*ozen at -20°C 
until fiirther analysis. Blood samples, liver and gastrointestinal tract were obtained 
fi'om all the rats killed on one day regardless of sex. The liver, small and large intestine 
were removed and weighed fresh. The intestine was split into two -  the small intestine 
being taken as the section from the base of the fundus to the ileo-caecal junction -  and 
was flushed with water and blotted prior to weighing. These organs were then snap 
frozen in liquid nitrogen and stored at -20°C for later analysis. Omental adipose tissue 
was removed from only two animals on each day of sacrifice and placed in Medium 
199 prewarmed to 37°C for the assessment of LPL activity in explants of omental 
tissue. The rats chosen for LPL activity measurements were picked at random. 
Epididymal adipose tissue was removed from the male rats and immediately placed into 
a mixture of guanidium isothiocyanate, chloroform, isoamylalcohol and P- 
mercaptoethanol as the first step of RNA extraction (see Section 2.2.2).
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FISH OIL GROUP 
5% fish oil diet 
(Maxepa)
MIXED OIL GROUP 
5% mixed oil diet 
(coconut, olive, corn & palm oils)
i
6 PREGNANT W/A RATS 4 PREGNANT W/A RATS
OFFSPRING STANDARDISED TO 6 RATS/LITTER
OFFSPRING WEANED AT 21 DAYS 
ONTO 5% FISH OIL DIET
OFFSPRING WEANED AT 21 DAYS 
ONTO 5% MIXED OIL DIET
HALF SACRIFICED AT 5 WEEKS (‘YOUNG’), 
following a standard mixed oil test meal (25% fat) 
Killed by cervical dislocation under anaesthetic.
4
REMAINDER FED NORMAL RAT CHOW
4
HALF SACRIFICED ATIOWEEKS ( ADULTS’), 
following a standard mixed oil test meal (25% fat) 
Killed by cardiac puncture/cervical dislocation
Figure 5.2 Simplified diagrammatic representation of the rat study protocol.
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Table 5.2 Composition of the mixed oil diet.
ComDonent Amount (g / lOOg)
Starch 60.0
Sucrose 5.0
Casein 2 0 . 0
Cellulose 4.0
Coconut oil 1 . 1
Olive oil 1 . 1
Corn oil 0 . 6
Palm oil 2 . 2
Methionine 0 . 2
Vitamin/mineral mix * 5.0
* See Table 5.5
Table 5.3 Composition of the high fish oil diet.
Component Amount (g / lOOg')
Starch 60.0
Sucrose 5.0
Casein 2 0 . 0
Cellulose 4.0
Fish oil 5.0
Methionine 0 . 2
Vitamin/mineral mix * 5.0
* See Table 5.5
Table 5.4 Composition of the high mixed oil test diet fed overnight prior to
sacrifice.
Comnonent Amount (g / lOOg)
RMl Diet (Special Diet Services) 75.0
Coconut oil 5.5
Olive oil 5.5
Corn oil 3.0
Pahn oil 1 1 . 0
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Table 5.5 Composition of the vitamin and mineral mix added to the rat diets.
VITAMIN/MINERAL AMOUNT PER KILOGRAM OF 
DIET
Vitamin A S.Omiu
Vitamin D3 l.Omiu
Vitamin E 25g
Vitamin B2 5.0g
Vitamin K lO.Og
Nicotinic acid lO.Og
Calcium Pantothenate lO.Og
Folic acid 0.5g
Vitamin Bi 5.0g
Vitamin B^ 5.0g
Biotin 2 0 .0 mg
Vitamin B 12 5.0mg
Vitamin C 20.0g
Inositol lOO.Og
Choline lOO.Og
p-aminobenzoic acid 50.0g
Potassium S.Omg
Iron 50.0g
Cobalt 0.5g
Manganese 50.0g
Copper lO.Og
Zinc 20.0g
Iodine 0.5g
Magnesium l.Omg
Sodium chloride S.Omg
Phosphorus S.Omg
Calcium 7.0mg
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5.4 STATISTICAL ANALYSES
Mean values (± SD and SEM) for each measurement were calculated, Bartlett’s test 
was applied to test for homogeneity of variances in the data. Changes which occurred 
during the study were tested for statistical differences using One-way Analysis of 
Variance (ANOVA) on Instat for Mac :intosh Version 2.01 Graph Pad Software. A 
Tukey-Kramer Multiple Comparisons Test was then applied to locate the differences. 
Values of P < 0.05 were taken as the lowest level of significance. Pearson's 
Correlations were performed to detect correlations between plasma TAG and GIP 
levels.
5.5 RESULTS
5.5.1 Changes in animal and organ weights during the study
Changes in the total body weight during the study and numbers of animals used are 
shown in Figure 5.3. Birthweights are not shown because it was not possible to handle 
the offspring at that stage of development. Handling newborn rats could lead to 
rejection by the dam. All the animals looked to be a similar size at biiTh and weights 
were significantly higher in adulthood compared to the offspring as we expected. 
There were no significant differences in weight between the two dietary groups at any 
stage during development.
250 -,
^ 2 0 0&£)
^  150
>.100
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”  50
E3 FO Weaning n=32 
O MO Weaning n=18
□  FO Young n=17
□  MO Young n=10 
■  FO Adult n=18
□  MO Adult n=8
Figure 5.3 Change in animal body weight over the duration of the study. Values 
are mean (SEM). FO = Fish oil fed; MO = Mixed oil fed.
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Certain organ fresh wet weights were measured at the time of sacrifice before the 
organs were frozen in liquid nitrogen. The results are shown in Table 5.6. There were 
no significant differences in the weights of the small or large intestine between the two 
dietary groups in the young or adult rats. The weights of the livers were similar 
between the two dietary groups in the young rats. The adult rats which had consumed 
the high mixed oil diet had significantly heavier livers compared to the fish oil fed 
adults {P < 0.05). However, when the ratio of liver weightibody weight was calculated 
no significant differences were seen between the groups.
Table 5.6 Weight changes in the small and large intestine and liver over the 
duration of the study. Liver:body weight ratios are also shown.
Wet weight (g). Mean ± SEM.
FO Young 
n =  17
MO Young 
n =  10
FO Adult 
n =  18
MO Adult 
n = 8
Whole body 47.9 ± 4.07 47.45 ± 6.57 193.00 ±8.41 214.79 ±10.48
Small intestine 2.65 ±0.17 2.54 ±0.13 6.56 ± 0.27 6.00 ± 0.35
Large intestine 0.84 ± 0.27 0.90 ±0.12 2.34 ±0.33 2.65 ± 0.33
Liver 3.06 ± 0.22 2.89 ±0.14 9.64 ± 0.40 * 11.16 ±0.43 *
Liver : body 
weight (%)
6.48 ± 0.28 6.13 ±0.27 5.01 ±0.07 5.22 ± 0.09
* Liver weights were significantly higher in the adult rats fed the mixed oil diet when 
compared to the high fish oil fed rats {P < 0.05).
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5.5.2 Plasma TAG
Plasma TAG concentrations in the four groups are shown in Figure 5.4. Plasma TAG 
levels were significantly higher in the fish oil fed young compared to the mixed oil fed 
group (P <0.01) and compared to the adults on the same diet (P < 0.001). The plasma 
TAG levels were lower in the young group compared to the adults in the mixed oil fed 
animals but this did not reach significance. The mean plasma TAG concentrations 
were similar in both dietary groups in the adult rats, even though the spread of data 
was different.
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□  FO Adult n = 17
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Figure 5.4 Plasma TAG levels (mmoFl) in rats fed a fish oil or mixed oil diet at 
five weeks old (young) or nine weeks old (adult). Values are mean (SEM). FO = 
Fish oil fed; MO = Mixed oil fed. Columns with the same symbols are 
significantly different from one another (* P <  0.01; ** p <  0.001).
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5.5.3 P l a s m a NEFA
Plasma NEFA concentrations in the four groups are shown in Figure 5.5. There were 
no significant differences between the young and adult rats nor between rats fed the 
two different diets.
o
0.8
0.7 - 
0.6 -  
0.5
1“
1 “
cc
0.2
0.1
0
1
1
1 □ FO Young n =  13
□  MO Young n = 8
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Figure 5.5 Plasma NEFA concentrations (mmol/1) in rats fed a fish oil or mixed 
oil diet at five weeks old (young) or nine weeks old (adult). Values are mean 
(SEM). FO = Fish oil fed; MO = Mixed oil fed.
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5.5.4 P la s m a  t o t a l  c h o l e s t e r o l
Plasma total cholesterol concentrations in the four groups are shown in Figure 5.6. 
Plasma total cholesterol levels were significantly lower in adulthood when compared to 
the young, regardless of the diet fed (P < 0.001). There were no significant differences 
in the total plasma cholesterol between the dietary groups in the young or adult 
animals.
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□  MO Adult n = 8
Figure 5.6 Plasma total cholesterol (mmol/1) in rats fed a fish oil or mixed oil diet 
at five weeks old (young) or nine weeks old (adult). Values are mean (SEM). FO 
= Fish oil fed; MO = Mixed oil fed. Columns with the same symbols are 
significantly different from one another {P< 0.001).
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5.5.5 P l a s m a  GIP
Plasma GIP concentrations in the four groups are shown in Figure 5.7. In the fish oil 
fed and mixed oil fed groups, plasma GIP levels were significantly higher in the young 
animals compared to the adults (P < 0.001 and P < 0.01 respectively). No significant 
differences were seen between the dietary groups either in the young or adult animals.
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Figure 5.7 Plasma GIF levels (pmol/1) in rats fed a fish oil or mixed oil diet at five 
weeks old (young) or nine weeks old (adult). Values are mean (SEM). FO = Fish 
oil fed; MO = Mixed oil fed. Columns with the same symbol are significantly 
different from one another {* P <  0.01; ** p <  0.001).
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5.5.6 GIP IN GASTROINTESTINAL EXTRACTS
GIP in small intestinal extracts in the four groups are shown in Figure 5.8. GIF in acid 
ethanol extracts of large intestine were neghgible compared to the small intestinal levels 
and made no significant contribution to the total intestinal GIP concentrations -  hence 
they are not shown. GIP in extracts of the small intestine were significantly higher in 
adult animals irrespective of dietary group ( f  < 0.001). In the adult animals GIP levels 
were significantly higher in the mixed oil fed group compared to the fish oil fed group 
( f  <0.001).
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Figure 5.8 Total extracted gastrointestinal GIF concentrations in rats fed a fish 
oil or mixed oil diet at five weeks old (young) or nine weeks old (adult). Values 
are mean (SEM). FO = Fish oil fed; MO = Mixed oil fed. Columns with the 
same symbols are significantly different from one another {P< 0.001).
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5 .5 .7  P l a s m a  INSULIN
Plasma insulin concentrations in the four groups are shown in Figure 5.9. Although 
plasma insulin levels were higher in the fish oil fed adults compared to the young in that 
group, there was little difference in the mixed oil fed group. None of these differences 
were statistieally significant. There were no significant differences between the two 
dietary groups.
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Figure 5.9 Plasma insulin levels (pmol/1) in rats fed a fish oil or mixed oil diet at 
five weeks old (young) or nine weeks old (adult). Values are mean (SEM). FO = 
Fish oil fed; MO = Mixed oil fed.
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Table 5.7 Glucose:insulin ratios in rats fed a fish oil or mixed oil diet at five 
weeks old (young) or nine weeks old (adult). FO = Fish oil fed; MO = Mixed oil 
fed.
Glucose: Insulin Ratio
FO Young 
n = 10
MO Young 
n = 6
FO Adult 
n=  17
MO Adult 
n — 8
Mean 0.035 X 10" 0.038 X 10" 0.028 X 10" 0.038 X 10^
SEM 0.005 0.019 0.004 0.012
5.5.8 P l a s m a  GLUCOSE
Plasma glucose concentrations in the four groups are shown in Figure 5.10. Plasma 
glueose levels were lower in the young groups eompared to the adults. This reached 
statistieal significanee in the fish oil fed group only {P < 0.05). There were no 
significant differences in the glucoseiinsulin ratios between the fish oil fed or mixed oil 
fed groups at any age (see Table 5.7).
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Figure 5.10 Plasma glucose levels (mmol/1) in rats fed a fish oil or mixed oil diet 
at five weeks old (young) or nine weeks old (adult). Values are mean (SEM). FO 
= Fish oil fed; MO = Mixed oil fed. Columns with the same symbols are 
significantly different from one another {P< 0.05).
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5.5.9 LPL GENE EXPRESSION
LPL mRNA levels in the four groups are shown in Figure 5.11. There were no 
significant differences in the young rats between the two dietary groups. Gene 
expression levels were relatively high in the mixed oil fed adults and were significantly 
higher than the fish oü fed adults (P < 0.001) and the mixed oil fed young {P < 0.001).
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Figure 5.11 LPL gene expression (LPL/actin) in rats fed a fish oil or mixed oil 
diet at five weeks old (young) or nine weeks old (adult). Values are mean (SEM). 
FO = Fish oil fed; MO = Mixed oil fed. Columns with the same symbol are 
significantly different from one another (P< 0.001).
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5.5.10 HEPARIN-RELEASABLE o m e n t a l  a d ip o s e  t is s u e  LPL ACTIVITY
Omental adipose tissue LPL activities in the four groups are shown in Figure 5.12. 
Basal, heparin-releasable adipose tissue LPL activities were highest in the young rats in 
both dietary groups when compared to the adults and this reached significance in the 
fish oil fed group {P < 0.05). Although the mean activities varied between the groups 
this did not reach statistical significance because of the small numbers of animals and 
the large standard deviation in the fish oil fed young.
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Figure 5.12 Omental adipose tissue LPL activity in rats fed a fish oil or mixed oil 
diet at five weeks old (young) or nine weeks old (adult). Values are mean (SEM). 
FO = Fish oil fed; MO = Mixed oil fed. Columns with the same symbol are 
significantly different from one another {P < 0.05).
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5.5.11 L i v e r  s u p e r o x id e  d i s m u ta s e  (SOD) a c t i v i t y
Liver SOD activities in the four groups are shown in Figure 5.13. Liver SOD activities 
were lower in the adult rats regardless of which diet was fed. The fish oil fed young 
had significantly higher SOD levels compared to the fish oil fed adults or the mixed oil 
fed young (F < 0.01 and P < 0.05 respectively).
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Figure 5.13 Superoxide dismutase (SOD) coneentrations in rats fed a fish oil or 
mixed oil diet at five weeks old (young) or nine weeks old (adult). Values are 
mean (SEM). FO = Fish oil fed; MO = Mixed oil fed. Columns with the same 
symbol are signifieantly different from one another (* P <  0.05; ** p < 0.01).
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5.5.12 L iver catalase activity
Liver catalase activities in the four groups are shown in Figure 5.14. Liver catalase 
activities were lower in the young groups compared to the adults and this difference 
reached statistical significance in the fish oil fed animals (P < 0.001). The fish oil fed 
young had significantly higher liver SOD activities than the mixed oil fed young (P <
0.05). Fish oil fed adults also had significantly higher liver SOD activities than the 
mixed oil fed adults (P < 0.001). There was no significant difference between the 
mixed oil fed young and adult groups.
□  FO Young n = 13 
H MO Young n = 10
□  FO Adult n = 13
□  MO Adult n = 8
Figure 5.14 Catalase activities in rats fed a fish oil or mixed oil diet at five weeks 
old (young) or nine weeks old (adult). Values are mean (SEM). FO = Fish oil 
fed; MO = Mixed oil fed. Columns with the same symbols are significantly 
different from one another {* P <  0.05; ** P <  0.001; *** P <  0.001).
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5.5.13 G l u t a t h io n e  r e d u c t a s e  a c t iv it y
Liver glutathione levels in the four groups are shown in Figure 5.15. There was little 
change in the liver glutathione activities during the study. The enzyme activity was 
higher in both dietary groups in the young animals compared to the adults but this only 
reached significance in the fish oil fed group {P < 0.05). There were no significant 
differences seen when the two dietary groups were compared at either stage of 
development.
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Figure 5.15 Glutathione reduetase activities in rats fed a fish oil or mixed oil diet 
at five weeks old (young) or nine weeks old (adult). Values are mean (SEM). FO 
= Fish oil fed; MO = Mixed oil fed. Columns with the same symbols are 
significantly different from one another (P < 0.05).
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5.5.14 GLP-1 (7-36) a m id e  in  e x t r a c t s  o f  t h e  l a r g e  in t estin e
GLP-1 (7-36) amide in acid ethanol extracts of the large intestine in the four groups are 
shown in Figure 5.16. GLP-1 (7-36) amide levels were higher in the adults compared 
to the young animals irrespective of the diet fed. This only reached statistical 
significance in the fish oil fed group (7* < 0.001).
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Figure 5.16 GLP-1 (7-36) amide extracted from the large intestine of rats fed a 
fish oil or mixed oil diet at five weeks old (young) or nine weeks old (adult). 
Values are mean (SEM). FO = Fish oil fed; MO = Mixed oil fed. Columns with 
the same symbol are significantly different from one another {P < 0.001).
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5.5.15 GLP-1 (7-361 a m id e  in  e x t r a c t s  o f  th e  sm a l l  in t e stin e
GLP-1 (7-36) amide eoncentration in acid ethanol extracts of the small intestine in the 
four groups are shown in Figure 5.17. Small intestinal GLP-1 (7-36) amide levels were 
signifieantly higher in the adult animals compared to the young in both the fish oil fed 
and the mixed oil fed groups {P < 0.05 and P < 0.001 respectively). GLP-1 (7-36) 
amide levels were significantly higher in the mixed oil fed adults compared to the fish 
oil fed adults {P < 0.001). Compared to GLP-1 (7-36) amide levels extracted Ifom the 
large intestine (see Section 5.5.14), levels were much higher in the small intestine.
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Figure 5.17 GLP-1 (7-36) amide extracted from the small intestine of rats fed a 
fish oil or mixed oil diet at five weeks old (young) or nine weeks old (adult). 
Values are mean (SEM). FO = Fish oil fed; MO = Mixed oil fed. Columns with 
the same symbols are significantly different from one another (*P < 0.05; **P < 
0.001; 0.001).
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5.6 DISCUSSION
Rats are unreliable breeders; with litter sizes typically varying between five and twelve. 
Standardising litter sizes is therefore the only option. Unfortunately in this study the 
dams fed the high fish oil diet were better breeders than those fed the mixed oil diet. In 
the original group of mixed oil fed dams two dams cannabilised the offspring, one dam 
only produced one young and one dam appeared not to be pregnant. The mixed oil fed 
arm of the study therefore had to be restarted. This resulted in a lower number of 
dams in this dietary group because there were the only four dams at the correct stage 
of gestation at that time. It is unlikely that this behaviour was due to the diet 
consumed because the second group of dams behaved normally and produced plenty of 
ofifspriug.
There have been many papers published describing the changes in plasma enzymes and 
lipid profiles during postnatal development in the rat (Planche et al. 1980; 
Semenkovich et al. 1989; Mao & Hamosh, 1992). As the first stage of this study was 
performed on rats only two weeks post-weaning, a time of rapid developmental 
change, this may have had profound effects on the results. However, five weeks of age 
is almost the latest opportunity to study a ‘young’ rat, before it becomes pubertal. The 
results of this study are discussed in the light of previous findings on both the effects of 
development and the known effects of dietary n-3 PUFA intake.
5.6.1 TAG
High circulating TAG levels occur immediately postpartum which relate to the low 
clearing ability of extrahepatic tissues and the sudden high fat intake as suckling 
commences. This then places the animal into a state where overloading of the TAG 
clearance ability occurs (Hamosh et al. 1978). The suckling diet is a high fat diet 
which provides more than 50% calories from TAG. Thus the fact that plasma TAG 
levels were found to be higher in the young animals was as expected. However, the 
raised plasma TAG levels seen in the young group on a high fish oil diet was an 
unusual result since n-3 PUFA is known to have a hypotriacylglycerolaemic effect in
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adult rats. This TAG raising effect of fish oil intake has been reported in some 
previous rat studies (L’Abbé et al. 1991) and in humans, especially in association with 
a low fat diet (Roche & Gibney, 1996) but a mechanism explaining the effect is not yet 
clear. By adulthood this effect had been eliminated and the level of plasma TAG was 
similar in both groups. Thus any effect on TAG that the altered fatty acid composition 
produced in the young animals was not maintained into adulthood whilst fed on normal 
chow.
5.6.2 LPL ACTIVITY AND GENE EXPRESSION
To date, there are no data on the long term effects of early dietary fatty acid 
composition on LPL expression and activity. Changes in enzyme activities of the 
lipolytic system, such as LPL, can refer to changes in storage of TAG in adipose tissue. 
For example, one study found higher LPL activity in animals from small litter sizes 
independent of age (El Habet et al. 1979). This could refer to an early and long-term 
determination of the enzyme activity. A higher level of LPL gene expression and 
activity would be beneficial in terms of greater capacity for the postprandial clearance 
of plasma TAG when challenged with a fatty meal, with consequent benefit in terms of 
cardiovascular disease risk. If, through changes in dietary availability or formulation, 
potentially beneficial alterations in gene expression can be shown in rodents, there 
would be grounds on which to explore the effects of modifying diet in pregnant human 
mothers and possibly formula milk composition in infants.
It has been shown previously that a high fish oil diet increases LPL mRNA levels in 
adult rats (Murphy et al. 1993) and postheparin LPL activity in humans (Zampelas et 
al. 1994). In 1978, Cryer and Jones published results of LPL activity changes in 
different adipose tissue sites during development. LPL activity in epididymal tissue 
increased up to the middle of the suckling period and then fell progressively to very 
low values during the remainder of the time spent with the mother. On weaning LPL 
levels increased sharply and this period of elevation in activity persisted up to 11 -  13 
weeks. The large variation in LPL activity seen in this study may have been due to the 
rapid changes in development occurring when the ‘young’ samples were obtained.
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Although the heparin-releasable LPL activities in omental adipose tissue reported in 
Section 5.5.10 did not show any significant differences between the two dietary groups 
there were clear trends depicted. This could be due to the large standard errors 
incurred with the methodology used (refer to Chapter 4 for a fiill explanation). Haug 
and Hostmark (1987) reported an unusual decrease in epididymal adipose tissue LPL 
and hepatic lipase activities in rodents consuming a high proportion of fish oil in the 
diet. This could have been an adaptive response to the low concentration of substrate 
(TAG) for these enzymes because, as explained earlier, high fish oil intakes led to 
decreases in plasma TAG (Haug & Hostmark, 1987). Most of the previous work has 
shown that fish oils do increase epididymal adipose tissue LPL activity although the 
methods used have been different (Benhizia et al. 1994). Previous reports have 
measured LPL activity in acetone-ether powders of adipose tissue. This method 
measures both active and inactive LPL whereas the explant methodology employed in 
this study only measures active LPL and is therefore the superior of the two methods. 
The other advantage of the explant method employed in this work is that the integrity 
of the adipose tissue is maintained and therefore the in vivo environment is closely 
preserved within the system. Also, the cell viability is maintained during the long 
periods when the explants are incubated in culture. The LPL activity results tend 
toward mimicking most other previous work by showing increases in the fish oil fed 
group and this effect continued through to adulthood, however the changes did not 
reach statistical significance.
The LPL mRNA levels shown in Section 5.5.9 show a large rise in LPL gene 
expression during adulthood in the mixed oil fed rats. In the young animals there 
appeared to be no effect of diet but in adulthood the LPL mRNA levels were 
significantly higher in the mixed oil fed group. LPL mRNA and adipose tissue activity 
did not follow similar patterns during this study but they were measured in different 
tissues. Adipose tissue LPL activity and mRNA have previously been shown to vary 
between sites within one animal (Cryer et al. 1978) and in humans (Ranganathan et al. 
1995). Although changes in LPL with age could be interfering with the dietary effects, 
LPL mRNA levels in epididymal fat pads in one study, measured at 24 days old, were 
high and remained at the same level into adulthood (Semenkovich et al. 1989). This
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finding was also seen in 1977 by Heitanen and Greenwood when they did not find 
changes in LPL activity in epididymal fat after day 21 (Heitanen & Greenwood, 1977). 
The pronounced increase in rate of cell growth (cell size and number) in epididymal 
tissue occurs after 21 days (Cryer & Jones, 1978). Therefore it is likely that the 
changes seen in LPL mRNA were true effects of diet and were not masked by tissue 
changes with age. The very high expression in the mixed oil fed adults was 
extraordinary. This may be indicative of an overstimulation which may almost suggest 
an insensitivity occurring in that tissue. This might increase on further ageing and 
should be investigated ftirther.
5.6.3 In s u l in  SENSITIVITY
There were no significant changes in plasma insulin or NEFA levels in response to 
changes in background diet. The only marked change in plasma glucose levels was a 
significant increase jfiom young to adult rats in the fish oil fed group. The 
glucose:insulin ratio is a measure of insulin sensitivity. When glucose and insulin levels 
were grouped together in the glucose:insulin ratio, there were no significant changes. 
This therefore suggests no major changes in insulin sensitivity were occurring between 
the dietary groups or at différent ages. Previous studies have shown lower plasma 
insulin levels following the consumption of a high fish oil diet in rats (Baltzell et al. 
1991). However, as that study did not pair feed the animals, the differences seen could 
have been due to changes in actual quantities of food intake. Although the current 
study unexpectedly failed to show any significant changes in insulin levels, there was a 
strong trend towards fish oil increasing the insulin in adulthood and therefore having 
some carry-over effect from intervention in early fife. The changes shown in this study 
do not therefore reflect the changes expected in the fight of earlier human work 
showing early changes in weight, possibly due to diet, being finked to the risk of insulin 
sensitivity in adulthood (Phipps et al. 1993; Phillips et a/. 1994).
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5.6.4 P l a s m a  t o t a l  c h o l e s t e r o l
Cholesterol levels were high in the young rats -  suggesting that the levels had not 
dropped during the two weeks after the high fat load experienced during suckling. 
Reiser & Sidelman demonstrated that exposure of neonatal male rats to high levels of 
milk cholesterol protected them as adults fi-om dietary-induced hypercholesterolaemia. 
They suggested that early exposure to a high cholesterol diet initiated mechanisms that 
maintained serum cholesterol at lower concentrations later in life -  again pointing 
towards the idea of biological imprinting or programming (Reiser & Sidelman, 1972). 
Although in this study no significant differences were found between the groups fed 
fish oil or a mixed oil diet, in both the young and adult rats total plasma cholesterol 
levels were lower in the fish oil fed group which supports previous findings (L’Abbé et 
al 1991; D’Aquino e/a/. 1991).
5.6.5 G a st r o in t e s t in a l  h o r m o n e s
The insulinotropic gut hormones GIP and GLP-1 may be of importance with respect to 
effects of dietary fatty acid composition on LPL via their effects on the enteroinsular 
axis. Although it has been shown that GIP and GLP-1 secretions are affected by diet 
(Kwasowski et al. 1985; Elliott et al. 1993), no significant differences were seen 
between the two dietary groups in this study. Plasma GIP levels were very high in the 
young animals compared to those in adulthood and at both ages were much higher than 
human levels of the hormones. The adult values we found reflected those reported by 
Chen et al. 1995. They found basal plasma GIPs of 100 -  160pmoPl and our adult 
(fed) values were 150 -  250 pmoPl. Plasma GIP and TAG levels correlated 
significantly (r = 0.66; P < 0.001) in the present study, therefore suggesting a possible 
link between GIP levels and postprandial TAG metabolism. The purpose of measuring 
intestinal postprandial levels of GIP and GLP-1 (7-3 6) amide in young and adult rats 
was to assess their possible physiological role in fat deposition in the postprandial 
period and during development. Intestinal extracts of GIP and GLP-1 (7-36) amide 
followed the same pattern throughout this study, with levels being significantly lower in 
the young rats compared to the adults irrespective of the diet fed {P < 0.001).
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The adult rats in this study had been consuming normal rat chow prior to receiving the 
standard test diet the night before sacrifice. The standard chow had a lower fat content 
and higher carbohydrate content than the test diet which the young animals were 
consuming. These findings are in line with recent findings by Knapper and colleagues 
who found young pigs to secrete more GIP and GLP-1 (7-36) amide in response to 
carbohydrate rather than fat (Knapper et a l in press). Although this is contrary to the 
human situation (Penman et a l 1981), it may be a species difference in stimulus- 
secretion coupling (Knapper, 1992). The higher GLP-1 (7-36) amide levels in adults 
are consistent with a role for this hormone when glucose is the precursor for fat 
deposition. It was a curious finding that GLP-1 (7-36) amide levels were higher in 
extracts of the small intestine compared to extracts of the large intestine since GLP-1 
(7-36) amide producing cells are thought to increase in number from the duodenum to 
the distal jejunum and ileum and again, from the proximal to the distal colon, reaching 
maximum cell density in the rectum (Eissele er ûf/. 1992).
5.6.6 L iv e r  ENZYMES
Catalase activities have previously been reported to increase in response to fish oil 
feeding (Yamazaki et a l 1987). Catalase is an enzyme responsible for the 
detoxification of H2O2, a role also performed by glutathione peroxidase. So when 
catalase activity rises, glutathione peroxidase should fall. Since glutathione peroxidase 
and glutathione reductase act antagonistically to one another, it would be expected that 
catalase and glutathione reductase levels would change together. However, in the 
current study, although catalase was significantly increased following fish oil feeding, 
there were no significant changes detected in glutathione reductase activity in response 
to diet. Although fish oils are known to increase peroxisomal p-oxidation activity, no 
effect was seen in the enzymes associated with glutathione metabolism (Yamazaki et 
al 1987). L’Abbé et a l also found no significant differences m glutathione peroxidase 
activity following 16 weeks of 20% fish oil feeding in growing rats (L’Abbé et a l 
1991). Langley and Kelly showed hepatic glutathione reductase to reduce with age 
(Langley & Kelly, 1992). In the light of these results it is not surprising that 
glutathione reductase did not alter as a result of dietary changes but was lower in the
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older animals. Previous results have indicated that enhanced lipid peroxidation occurs 
with oxidative stress of elevated tissue n-3 fatty acids and is accompanied by reduced 
SOD activity (L’Abbé et al. 1991) or no significant change in SOD activity (D’Aquino 
et al. 1991). Only in the young animals did the reduction in enzyme activity following 
the mixed oil diet reach statistical significance and the effect of dietary change did not 
last into adulthood.
5.6.7 C o n c l u s io n  a n d  s u g g e st io n s  f o r  f u t u r e  w o r k
In conclusion, most of the differences shown were between young animals and adults. 
This suggests that changes in the postprandial handling of a standard test meal are 
affected by age and/or recent changes in dietary fatty acid intake only, with age 
appearing to be the major influence. Early diet affects LPL expression but not activity 
later in life; however, future studies are required to elucidate the mechanisms of these 
effects. In this study changes occurring with age masked the effects due to the dietary 
changes.
In order to elucidate whether the unexpected results are reliable, the study needs to be 
repeated with a larger number of animals. The study would be improved by:
(i) including different levels of intervention with fish oil such as 5%, 10% and 20% 
(w/w) of the diet as fish oil in order to identify at which level maximum changes 
would occur and
(ii) including an older age group of animals so that there would be three groups - 
young, adult and old animals.
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6. MEASUREMENT OF LPL GENE 
EXPRESSION
6.1 INTRODUCTION
This chapter describes the measurement of LPL mRNA and its application to human 
and rat studies. The work outlines the development and validation of the Northern blot 
technique to measure human LPL mRNA and the making of a specific cDNA probe for 
LPL. LPL is synthesised in parenchymal cells of the vascular endothelium and are 
processed intracellularly before being transported to the endothelial surface of the 
vessel. Active LPL is in the form of dimers which are stabilised by binding to heparan 
glycosaminoglycans at the endothelial surface. Further details of LPL production and 
action were given in Chapter 1 (Section 1.2.2.). Since it is not yet clear whether LPL 
is secreted in response to changes in circulating TAG levels or whether TAG levels are 
a result of circulating LPL activity, this chapter studies attempts to cover all 
possibilities.
6.1.1 M e t h o d s  o f  m e a s u r in g  LPL
LPL can be measured at many stages in its production and secretion;
• LPL mRNA in tissue samples
• LPL protein mass in tissue samples
• LPL activity in tissue samples
• LPL activity in postheparin plasma
• LPL activity (circulating levels) in plasma.
Each measurement gives individual information and may be affected by various stimuli 
at different time points with respect to food ingestion or hormonal secretion. There are 
advantages and disadvantages of all the methods. Thus by employing more than one 
method of measurement an overall picture of the changes occurring in LPL may be 
obtained, along with a picture of the processes controlling regulation of the enzyme. A
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more detailed summary of the measurement of LPL was given in Chapter 1 -  this 
chapter concentrates on the measurement of LPL mRNA.
The advantage of measuring tissue LPL mRNA levels alongside tissue activity is that 
mRNA represents both the functional and residual LPL, therefore giving an estimate of 
cellular potential for synthesizing active LPL. Tissue mRNA levels give a 
measurement of potential LPL and can provide an idea of the timing of LPL release. 
Tissue LPL measurements also have the advantage of giving detail as to local LPL 
production. The disadvantages of tissue measurements are their invasive nature and 
the difficulty of obtaining enough tissue to perform the techniques described. Fatty 
acid synthase mRNA levels have been shown to be suppressed within hours of feeding 
a high PUFA diet to rats (Clarke et al. 1990) and with removal of this diet, the levels 
returned to normal within three hours. Another advantage of measuring mRNA levels 
for an enzyme is that they provide explanations for the mechanisms behind dietary 
effects on enzymes such as LPL. The kinetics of changes in enzyme levels in response 
to alterations in dietary fatty acid intake can help to detemine if these changes are 
substrate or hormone driven. The specific interest in fish oils on LPL gene expression 
stemmed fi*om work by Clarke and colleagues who showed fish oils to have a direct 
effect on gene expression (Clarke & Abraham, 1992).
6.1.2 Aims
The measurement of LPL mRNA using Northern blot analysis was described in 
Chapter 2. This chapter had four objectives;
1. To produce a specific cDNA probe for LPL mRNA. This was necessary in order to 
detect changes in LPL mRNA levels during the rat and human studies described in 
this thesis.
2. To validate the measurement of rat LPL mRNA using the methods described in 
Chapter 2.
3. To measure human LPL mRNA using this same methodology.
4. To measure LPL mRNA in adipose tissue biposies taken fi*om subjects on the meal 
fi*equency study described in Chapter 5 and to detect any effects of altering meal 
fi-equency on LPL gene expression.
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6.2 METHODS
6.2.1 Human adipose tissue biopsy
Much of the work in this chapter involves the use of human adipose tissue. To obtain 
an adipose tissue sample the volunteers were made comfortable lying supine. 
Lignocaine hydrochloride B.P. (2%; 5ml) was injected subcutaneously into the 
paraumbilical region of the abdomen. Initially a fine needle was used to make a small 
incision. Then a larger (12 gauge) needle attached to a 20ml syringe was inserted 
through the incision. Suction was applied using a forwards and backwards motion to 
draw the adipose tissue into the syringe. On withdrawal of the needle, pressure was 
applied to prevent bruising and a plaster placed over the wound to avoid infection or 
bleeding. On removal, the biopsy sample was placed directly in a denaturing solution 
containing guanidium isothiocyanate, chloroform, isoamylalcohol and 2- 
mercaptoethanol. Total RNA was extracted from the samples immediately (see 
Section 2.2.2 of Chapter 2) and frozen at -20°C until all the samples had been collected 
ready for frirther analysis.
For the purpose of future work it was necessary to make sufficient quantities of the 
1.6kb cDNA probe specific to LPL. The probe was kindly donated originally by Oka, 
Texas (Gotoda et al. 1989). The full cDNA sequence is given for reference in Figure 
6.1. The following sections describe the methodologies used to produce larger 
quantities of the probe.
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1 CCACTTCTAG CTGCCCTGCC A T C C C C T T T A AAGGGCGACT TGCTCAGCGC
5 1 CAAACCGCGG CTCCAGCCCT CTCCAGCCTC CGGCTCAGCC GGCTCATCAG
1 0 1 TCGGTCCGCG CCTTGCAGCT CCTCCAGAGG GACGCGCCCC GAGATGGAGA
1 5 1 GCAAAGCCCT GCTCGTGCTG ACTCTGGCCG TGTGGCTCCA GAGTCTGACC
2 0 1 GCCTCCCGCG GAGGGGTGGC CGCCGCCGAC CAAAGAAGAG A TT T TA T C G A
2 5 1 CATCGAAAGT AAATTTGCCC TAAGGACCCC TGAAGACACA GCTGAGGACA
3 0 1 CTTGCCACCT CATTCCCGGA GTAGCAGAGT CCGTGGCTAC C TG TC A TTTC
3 5 1 AATCACAGCA GCAAAACCTT CATGGTGATC CATGGCTGGA CGGTAACAGG
4 0 1 AATGTATGAG AGTTGGGTGC CAAAACTTGT GGCCGCCCTG TACAAGAGAG
4 5 1 AACCAGACTC CAATG TCATT GTGGTGGACT GGCTGTCACG GGCTCAGGAG
5 0 1 CATTACCCAG TGTCCGCGGG C TA CACCAAA CTGGTGGGAC AGGATGTGGC
5 5 1 CCGGTTTATC AACTGGATGG AGGAGGAGTT TAACTACCCT CTGGACAATG
6 0 1 T C C A TC TC TT GGGATACAGC CTTGGAGCCC ATGCTGCTGG CATTGCAGGA
6 5 1 AGTCTGACCA ATAAGAAAGT CAACAGAATT ACTGGCCTCG ATCCAGCTGG
7 0 1 A C C TA A C T TT GAGTATGCAG AAGCCCCGAG TC G TC TTTC T CCTGATGATG
7 5 1 C AG ATTTTGT A G ACG TCTTA CAC AC ATTCA CCAGAGGGTC CCCTGGTCGA
8 0 1 AGCATTGGAA TCCAGAAACC AGTTGGGCAT GTTGACATTT ACCCGAATGG
8 5 1 AG G TA CTTTT CAGCCAGGAT GTAACATTGG AGAAGCTATC CGCGTGATTG
9 0 1 CAGAGAGAGG ACTTGGAGAT GTGGACCAGC TAGTGAAGTG CTCCCACGAG
9 5 1 CGCTCCATTC A TC T C T T C A T CGACTCTCTG TTGAATGAAG AAAATCCAAG
1 0 0 1 TAAGGCCTAC AGGTGCAGTT CCAAGGAAGC CTTTGAGAAA GGGCTCTGCT
1 0 5 1 TGAGTTGTAG AAAGAACCGC TGCAACAATC TGGGCTATGA G ATCAATAAA
1 1 0 1 GTCAGAGCCA AAAGAAGCAG CAAAATGTAC CTGAAGACTC GTTCTCAGAT
1 1 5 1 GCCCTACAAA GTCTTCCATT ACCAAGTAAA G A TTC A TTTT TCTGGGACTG
1 2 0 1 AGAGTGAAAC CCATACCAAT CAGGCCTTTG A G A TTTC TC T GTATGGCACC
1 2 5 1 GTGGCCGAGA GTGAGAACAT CCC ATTCA CT CTGCCTGAAG T TTC CA CA AA
1 3 0 1 TAAGACCTAC TC C TTC C TA A TTTA CA CA G A GGTAGATATT GGAGAACTAC
1 3 5 1 TCATGTTG AA GCTCAAATGG AAGAGTGATT CATAC TTTA G CTGGTCAGAC
1 4 0 1 TGGTGGAGCA GTCCCGGCTT CGCCATTCAG AAGATCAGAG TAAAAGCAGG
1 4 5 1 AGAGACTCAG AAAAAGGTGA T C T T C T G T T C TAGGGAGAAA GTG TCTCATT
1 5 0 1 TGCAGAAAGG AAAGGCACCT GCGGTATTTG TGAAATGCCA TGACAAGTCT
1 5 5 1 CTGAATAAGA AGTCAGGCTG AAACTGGGCG A ATCTACAG A ACAAAGAACG
1 6 0 1 GCATGTGAAT TO
Figure 6.1 Full cDNA sequence of human lipoprotein lipase
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TE Buffer 
lOmmolTris 
Immol EDTA
pH 7.4
Tris acetate (TAE) buffer 
484g Tris base 
114.2ml glacial acetic acid 
200ml EDTA (0.5M; pH 8)
For 10 litres 
of 10 X buffer
L-agard litre) 
lOg tryptone 
5g yeast extract 
lOgNaCl 
ISgagar
1 litre R.O. water
Stored set, at 
room temperature.
TENS Buffer (per lOmf)
200plNaOH (5M)
250pl sodium dodecyl sulphate (20%) 
9.5ml TE Buffer
Cracking 2 X Buffer (per 50ml) 
2ml 5M NaOH 
2.5ml 10% SDS 
1 Og sucrose
L-Broth ( 1 litre) 
lOg tryptone 
5 g yeast extract 
lOg NaCl 
1 litre R.O. water
Loading Buffer 
0.25% bromophenol blue 
0.25% xylene cyanole FF 
0.25% acridine orange 
50% glycerol
6.2.3 R e s t r ic t io n  e n d o n u c l e a s e  d ig e s t io n  o f  DNA
The first stage of the work involved opening up an appropriate vector into which the 
insert DNA (ie. LPL probe) could be ligated. The following were placed in a 
micro centrifiige tube;
1 pi 10 X digest buffer H (Amersham)
1 pi vector (~ 1 pg)
8 pi DEPC water
1 pi EcoRl (endonuclease supplied by Amersham)
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This was incubated at 37°C for 1 -  2 hours. The reaction was stopped by placing the 
tube in a water bath at 65°C for 10 minutes to inactivate the EcoRl. The tube was 
then left on ice until the next step, ligation.
6.2.4 Ligation
This step leads to the formation of recombinant DNA molecules. The DNA of interest 
was ligated into the mammalian expression factor pUSlOOO (kindly donated by Dr. P. 
Sanders, University of Surrey) (see Figure 6.2). The first step was to dilute the 
digested vector 1:10 by the addition of 90pl DEPC water to lOpl of vector. The 
following were added to a microcentrifuge tube;
1 pi diluted vector 
Ipl insert DNA (probe )
1 pi 10 X ligase buffer (Amersham)
1 pi T4 ligase (Amersham)
6pl DEPC water
The reaction mixture was incubated at 12°C overnight while the vector and insert DNA 
ligated together.
6.2.5 Transformation of the host bacteria
Escherichia coli (E. coli) was cultured by placing 200pl stock culture in 10ml L-Broth 
and incubating overnight in a shaking oven at 37°C. The overnight culture was then 
diluted by placing 500pl of it in 30ml L-Broth. The mixture was incubated at 37°C in a 
shaking oven until anabsorbance at 650nm was attained(approximately 2 hours). This 
was left on ice for 20 minutes to stop the replication of bacteria before being 
centriftiged at 2000 x g for 5 minutes in a Beckman J6 centrifuge. The supernatant 
was discarded and the pellet resuspended in 10ml CaCL (O.IM). Once again the 
suspension was spun at 2000 x g for 5 minutes in the J6 centrifuge. The supernatant 
was discarded, the pellet resuspended in 1ml CaCL (O.IM) and chilled on ice for 30 
minutes. At this stage the cells were competent and remained so for several hours.
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DMSO (3^1), 2 -  5|il recombinant DNA (ligation mixture) and competent cells (200pl) 
were combined in a microcentrifuge tube and left on ice for 30 minutes. The 
suspension was then heat shocked for 2 minutes at 42°C before being returned to the 
ice for a further 30 minutes. L-Broth (200pi) was added and the mixture shaken for 1 
hour at 37°C before being plated out.
B
PA
MCS gpt
hcmv/Ss
H
Amp
on
Where;
B
hcmv = Human cytomegalovirus (promoter/enhancer)
MCS = Multiple cloning site PA = Poly-A addition site
E = EcoRl restriction site gpt = gpt expression cassette
H = Hind III restriction site Amp = Ampicillin resistance marker
B = Bam HI restriction site ori = origin of replication
Ss = Sstl restriction site
Figure 6.2 Diagrammatic representation of the vector pUSlOOO
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The L-agar (set at room temperature) was heat treated in a steamer for 40 minutes 
until it became a homogenous liquid. Ampicillin (lOOpl; 50mg/ml) was added to each 
litre of molten L-agar once it had cooled to hand temperature (to prevent the ampicillin 
being destroyed by heat). This created a selective media in which only E.coli 
containing the vector could grow because the vector contains an ampicillin-resistant 
gene. Once the agar had cooled to approximately 50°C it was poured into plates and 
left to set at room temperature. The plates were inoculated and left to grow up 
overnight in an oven at 37°C.
6.2.6 A s s e s s m e n t  o f  th e  o v e r n ig h t  g r o w t h
The next step was to take the colonies which had been grown up overnight and check 
that the probe had been incorporated into the vector. This was achieved by one of two 
methods.
6.2.6.1 Crackim
This method was used to assess which of the transformed colonies contained the vector 
possessing the probe. Using a sterile pipette tip individual colonies were picked 
directly from the agar plates and each placed near the base of a micro centrifuge tube 
containing EDTA (50pl; lOmM, pH8). Cracking buffer was added (50pl) and the cells 
resuspended by vortex mixing. The samples were incubated at 70°C and allowed to 
cool to room temperature for 20 minutes. KCl (1.5pi; 4M) and Ipl loading buffer 
were added and the tubes vortex mixed before being placed on ice for 5 minutes. The 
samples were then centrifuged for 3 minutes in a microcentrifuge at 4°C. The 
supernatant (25pi) was run on an agarose gel (0.7%) to assess which colonies 
contained the vectors with the insert ligated in. Those plasmid vectors containing the 
insert are longer and therefore migrate at a slower rate through the agarose gel.
6.2.6.2 Miniprep followed by a disest and electrophoresis
Colonies were picked off the plates using a sterile pipette tip and added to 5ml L-broth 
containing 2.5pl ampicillin (50mg/ml). This was then incubated overnight in a shaking 
oven at 37°C. The overnight culture (1.5ml) was spun for 10 seconds in a
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microcentrifuge to pellet the cells. The supernatant was gently decanted, leaving 50 -  
100pi with the cells which were then vortexed at high speed to resuspend the cells 
completely. TENS buffer (300pl) was then added and the mixture vortexed until it 
became glutinous. Sodium acetate (150pl; 3M; pH 5.2) was added and the tubes were 
vortexed to ensure good mixing. The mixture was then spun in a microcentrifiige for 2 
minutes to precipitate the cell debris and chromosomal DNA. The supernatant was 
transferred to a fresh tube and mixed with 0.9ml ethanol (100%) which had been 
precooled to -20°C. Plasmid DNA and RNA were precipitated into a white pellet by a 
further spin at lOOOOrpm for 2 minutes in a micrcentrifuge. The supernatant was 
discarded and the pellet rinsed twice with 1ml ethanol (70%). Residual ethanol was 
evapourated under vacuum for 2 -  3 minutes and the pellet resuspended in 30pl sterile 
water.
6.2.7 Restriction enzyme digestion
Onee the miniprep had been performed the cDNA probe had to be removed from the 
vector plasmid using an EcoRl digestion. The following were placed in a 
microcentrifiige tube;
lOpl DNA (from the mini-prep)
1.5 pi 10 X digest buffer Incubate @ 37°C for
1 1 hour -  overnight.Ipl EcoRl
2.5 pi DEPC water
6.2.8 Agarose GEL
The purpose of this next step was to determine the length of the insert. This was 
performed by running a sample of the DNA resulting from the EcoRl digest on an 
agarose gel alongside a standard marker ladder of known DNA sizes. The samples 
were prepared by adding 2pi loading buffer to the samples. The standard used was the 
A.DNA/EcoRl/Hind III marker because this was known to contain a fragment of 
similar length to that which we were trying to isolate. The standard (2pl) was prepared
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by adding 2pl loading buffer and 13 pi DEPC water. The samples and standards were 
loaded onto a 0.7% agarose gel and run at 125 -  150V (105mA) for V2 -  Ihour. TAE 
buffer was used as running buffer. Once the gel had run, it was stained by immersing it 
in TAE buffer containing ethidium bromide (0.5mg/l) and shaking for 10 minutes. The 
gel was washed continuously with R.O. water to remove background staining. It was 
visualised under UV light.
6.2.9 M a x ip r e p  OF DNA
Once the correct size band had been detected on the gel, a 'Maxiprep' was performed 
on the E. coli sample in order to produce a large amount of probe. This utilised 
Promega’s 'Wizard Maxipreps DNA Purification System'.
The overnight E.coli DNA culture (500ml) was centrifuged at 14000 x g for 
10 minutes in a Beckmann J6 centrifuge. The pellet of cells was then resuspended in 
Cell Resuspension Solution (15ml; 50mM Tris-HCl, pH 7.5 + lOmM EDTA + 
lOOpg/ml RNase A) and Cell Lysis Solution (15ml; 0.2M NaOH + 1 %  SDS) was 
added. The tube contents were mixed thoroughly by stirring or inverting and were left 
to stand for up to 20 minutes while the lysis took place. Lysis was complete when the 
solution became clear and viscous. Neutralisation Solution (15ml; 1.32M potassium 
acetate, pH 4.8) was added and the tubes mixed by inverting to stop the reaction. The 
tubes were centrifuged at 14000 x g  for 15 minutes at 4°C. The remaining supernatant 
was carefiilly decanted into a fi*esh tube, leaving behind a white precipitate of cell 
debris. To the supernatant 0.6 volumes isopropanol were added and mixed by 
inversion. The tubes were centrifuged at 14000 x g for 20 minutes at 4°C. This time 
the supernatant was discarded and the DNA pellet (not always visible) resuspended in 
TE buffer (2ml) to produce a cleared lysate.
DNA Purification Resin (10ml) was added to the lysate fi-om the above step and the 
solution mixed by swirling. This solution was placed in a Maxicolumn and a vacuum 
applied to pull the DNA/Resin into the column. To transfer all the DNA/Resin mix to 
the Maxicolumn, Column Wash Solution (13ml; 200mM NaCl + 20mM Tris-HCl, pH
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7.5 + 5mM EDTA + 55% ethanol) was added to the bottle that had contained the 
DNA/Resin mix. After mixing, this was applied to the Maxicolumn. A ftirther 12ml 
Column Wash was passed through the column. To rinse the Resin, 80% ethanol (5ml; 
v/v) was passed through the column. The resin within the column was then dried by 
placing the column inside a 50ml centriftige tube and centrifuging at 1300 x g for 5 
minutes. At the end of this time, the eluted liquid was decanted off and preheated 
water (65 -  70°C) was added to the column for 1 minute. To elute the DNA, the 
column was centrifuged at 1300 x g  for 5 minutes in a centrifuge with a swing out 
rotor. The Maxicolumn was removed and discarded and the eluted plasmid DNA 
stored at 4°C or -20°C until required.
6.2.10 DNA PURIFICATION
The complete sample of eluted DNA was loaded onto a large agarose gel and run out 
alongside a standard DNA marker to ensure the correct size of DNA had been 
prepared. The DNA-containing part of the gel was excised with a scalpel and placed in 
a microcentrifuge tube. The sample was centrifuged hard for several seconds to bring 
down the gel slice. A 'Prep-A-Gene' DNA purification kit (Bio-Rad) was then used to 
purify the DNA sample. Firstly the amount of matrix required to bind all the DNA 
present was calculated (5pi for each microgram DNA). Based on the volume of the 
gel slice plus the amount of Prep-A-Gene matrix required for total binding, 3 volumes 
of Prep-A-Gene DNA purification kit binding buffer (containing sodium perchlorate) 
was added and the mixture agitated gently to dissolve. The calculated amount of Prep- 
A-Gene matrix was added and the samples mixed gently by flicking or vortexing the 
tube. The mixture was then incubated at room temperature for 5 -  10 minutes. During 
this incubation frequent agitation assisted the DNA to Prep-A-Gene matrix binding. 
The DNA-containing Prep-A-Gene matrix was pelleted by centrifuging for 30 seconds 
in a microcentrifiige. The supernatant was removed with a pipette and the pellet rinsed 
by resuspension in the purification kit binding buffer (25 times the amount of matrix 
added originally was the approximate volume). Centrifugation for 30 seconds in a 
microcentrifiige pelleted the matrix and the supernatant was discarded. The Prep-A- 
Gene pellet was washed a further twice with a 25 x matrix volume of prepared wash
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buffer (containing 50% ethanol (v/v); pH 7.45) as described previously. After the last 
wash and centrifugation the supernatant was discarded and the sample centrifuged to 
pellet the matrix firmly and carefully remove all traces of liquid by removal of the 
supernatant. To elute the bound DNA the Prep-A-Gene matrix pellet was resuspended 
in at least one pellet volume of elution buffer and the sample incubated for 5 minutes at 
37 -  50°C. The sample was centrifuged for 30 seconds to make a solid pellet and the 
DNA-containing supernatant transferred to a clean tube. It was then centrifuged 
briefly to ensure complete removal of the matrix.
The cDNA probe was then ready for use and was stored at -20°C until being used in 
the work depicted in the following sections.
6.3 RESULTS
6.3.1 N o r t h e r n  b l o t  a n a l y sis
6.3.1.1 Detection o f rat LPL mRNA
The detailed methods are described in Chapter 2. Validation work of this technique 
firstly required repetition of previous work to strengthen confidence in the 
methodology. The first gel run was to assess the intra-assay variability using a 
standard rat sample of LPL mRNA extracted from the two epididymal fat pads of a 
young, healthy, male Wistar/Albino rat (University of Surrey strain). The 
concentration of the total RNA was calculated from spectrophotometric scanning of 
the rat standard at 260nm. Figure 6.3 shows an autoradiograph of a Northern blot 
probed with ^^P-labelled LPL. In the original gel all the lanes were loaded with lOpg 
total rat RNA. The intra-assay coefficient of variation was 16% for the 10 samples.
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10 lanes loaded with lOpg total RNA from a pooled rat standard
Figure 6.3 Autoradiograph of a Northern blot depicting an intra-assay 
coefficient of variation gel showing ten lanes all loaded with lOpg total rat RNA.
In order to assess the limit of detection of rat LPL mRNA, a standard curve using the 
rat standard was produced. Samples were loaded onto a gel at a concentration range 
of 2 -  20pg total RNA. The results are shown in Figure 6.4 and proved that detection 
of rat LPL mRNA was possible when only 2pg total RNA were loaded.
I r  5
_  3^ '
Figure 6.4 Autoradiograph of a rat standard curve gel showing LPL expression 
over a range from 2pg to 20pg total RNA.
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6.3.1.2 Detection o f Human LPL mRNA
Once an adipose tissue sample had been obtained and the RNA extracted, the RNA 
was scanned at 260nm to determine the amount of total RNA present. Northern blots 
were then performed to determine the limit of deteetion and variability of the 
measurement in human tissue. Tliis seetion outlines the results obtained.
The initial validation work with human samples involved running a standard curve to 
find the lower limit of deteetion possible with this method. A typieal human standard 
curve is shown in Figure 6.5. Although this depiets the visual detection of LPL mRNA 
down to 8pg and the densitometer could detect expression down to 2pg total RNA, 
the expression of human LPL mRNA is much lower than in rats. This ean be seen in 
Table 6.1 and Figure 6.6.
-
• 4M
Rat
standard
Figure 6.5 Autoradiograph of a human standard curve gel showing total LPL 
expression over a range of 2|ag to lOpg total RNA.
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Table 6.1 Scanning data from human and rat standard curves.
Rat Standard Curve Human Standard Curve
Amount of total 
RNA loaded (pg)
Total expression 
(Absorption at 
550nm)
Amount of total 
RNA loaded (pg)
Total expression 
(Absorption at 
550nm)
2 14420 2 800
2 15772 2 833
4 19669 5 1316
4 27878 5 1107
8 31975 8 2141
8 32714 8 2079
10 34310 10 2479
10 35706 10 2461
15 72897 15 4639
18 85300 15 4436
20 76950 18 6242
20 67699 18 4895
— — 20 6943
— — 20 6119
Sensitivity was defined as 2 standard deviations above mean background. The 
sensitivity of this method allowed scanning detection down to 264 (absorption at 
550nm). The level of human LPL expression was calculated to be only 6.3 ± 1.1% of 
the levels of rat expression.
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Figure 6.6 Total expression data of pooled samples comparing the rat and 
human standard curves of LPL mRNA.
It is clear that the ratio of LPL mRNA to total RNA is lower in humans compared to 
rats. However, it is possible to detect human adipose tissue LPL mRNA in individual 
samples as shown later. A coefficient of variation gel of a pooled human adipose tissue 
sample was also performed to determine the intra-assay variability. The blot is shown 
in Figure 6.7. The intra-assay coefficient of variation was 22%.
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Rat 
standard 10 lanes all loaded with lOgg of a standard total human RNA 
pool
Figure 6.7 Autoradiograph of an intra-assay coefficient of variation gel showing 
10 lanes loaded with lOpg human total RNA and one lane of rat standard for
comparison.
In order to further the validation work above the adipose tissue from two volunteers of 
different body composition was used to study the LPL expression in individual 
samples. One subject was male and had a BMI of approximately 20 and the other, a 
female volunteer, had a BMI of 30. Although it has been shown above that expression 
of a pool of human LPL mRNA is only 6% of rat expression it was still possible to 
determine LPL mRNA from individual human samples (see Figure 6.8).
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Rat standard 3 lanes showing lOpg 
total RNA from a lean 
subject (male)
3 lanes showing lOpg 
total RNA from an obese 
subject (female)
Figure 6.8 Autoradiograph of a blot showing the successful detection of LPL 
mRNA from adipose tissue biopsies of two human volunteers (one lean and one
obese).
The low expression of LPL mRNA in normal weight individuals becomes a problem if 
any human blots need to be stripped and reprobed or stained at a later date since there 
is considerable loss of RNA during stripping as shown in Figure 6.9 below. Therefore 
the methodology does not leave any room for errors (see Section 6.3.3). Nor does the 
method allow for normalisation of the results by checking for expression with a 
constitutively expressed protein such as actin. The process of stripping is designed to 
remove any radio labelled probe before storage of the blot or before reprobing with 
another probe to identify another gene. It involves shaking the blot while it is fully 
immersed in boiling 0.1% SDS for 30 minutes. This process is repeated a further 
twice. Although this is not reported to remove RNA there was a dramatic loss of RNA 
in the work depicted in Figure 6.9;
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Figure 6.9 Autoradiographs of rat standard curves before and after stripping 
with 0.1% SDS followed by reprobing.
6.3.2 The effects of altered meal frequency on LPL mRNA
A large study looking at the effects of altered meal frequency on postprandial 
lipoprotein metabolism was described in Chapter 3. As part of this study, subjects gave 
an adipose tissue biposy under local anaesthetic as described in Section 6.2.1. Two 
biopsies were taken throughout the study -  one at the end of each period of dietary 
intervention. A typical autoradiograph of results is shown in Figure 6.10.
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Unfortunately, very little LPL mRNA could be detected in the human samples and the 
only prominent band shows 1 Opg rat standard. The first time this blot was probed for 
LPL, the wrong conditions were used for hybridisation (42°C instead of 65°C) due to a 
misunderstanding. This meant the blots had to be washed and reprobed which led to 
loss of the RNA and therefore made detection harder. The current biopsy technique 
had been used to obtain the tissue for these gels and therefore there was not enough to 
repeat the work.
Rat
standard Samples of lOpg total RNA of each subject loaded here
Figure 6.10 Autoradiograph of a blot of human LPL mRNA showing the effects 
of meal frequency on human LPL gene expression -  depicting a clear rat 
standard but no human samples.
6.4 DISCUSSION
6.4.1 Assessment of methodology
Cracking extracts all nucleic acids from a colony of bacteria and is a quick way of 
determining whether there is an insert present in the plasmid vector. Following the 
cracking procedure a gel is run to compare the results to a DNA marker. Genomic 
DNA remains in the wells when rumiing a gel and plasmid DNA migrates down the gel. 
The major drawback of the methodology arises when the insert DNA is short 
compared to the total plasmid size. Then there would be no detectable difference in
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the distance travelled between those plasmids containing the insert and those not. 
However it is much quicker than using the miniprep method so in cases such as the one 
described in this chapter where the insert is relatively long (1.6kb) it is a useful 
diagnostic tool.
The Miniprep method can produce false positive results. There is always the danger of 
contamination by colonies from the atmosphere which are also ampicillin resistant. 
These colonies would then grow with the required bacteria and would mask the true 
Miniprep results. Other colonies which are not ampicillin resistant can contaminate the 
plates and survive by producing digestive enzymes which breakdown the ampicillin in 
the surrounding area in order to grow.
6.4.2 Reasons for not detecting LPL mRNA in human subjects
The results of the human work on two subjects prove that it is possible to detect 
human LPL mRNA using Northern blot analysis. However, LPL gene expression was 
only clearly visible in the obese subject, from whom it was possible to extract greater 
amounts of adipose tissue. When this method was used in a larger study we failed to 
detect LPL mRNA for a number of reasons.
The first problem with trying to detect LPL message in human adipose tissue is that the 
ratio of LPL mRNA to total RNA is very low in the human. This could be because the 
proportion of connective tissue compared to fat cells is smaller than in rats. When rat 
epididymal and human subcutaneous adipose tissues are compared under a microscope 
it is clear that there is far more connective tissue extracted alongside the fat in humans. 
Secondly, the subjects used in the meal frequency study were young healthy women 
who were consuming a habitual diet unusually low in fat compared to the general 
population. They would therefore be expected to have low LPL levels -  too low to 
detect using the methodology described in this chapter, especially as the blots had to be 
probed twice.
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6.4.3 Future WORK
The problems of sensitivity need to be overcome in order to be able to use Northern 
blotting in normal weight, healthy subjects. As discussed later, this is likely to involve 
changing the technique of measuring LPL mRNA once it has been extracted or 
improving the extraction of RNA from the tissue sample. Improving the efficiency of 
mRNA recovery or the recovery of more intact mRNA could be possibilities for future 
ways of improving this tecfmique. However, although the amounts of RNA extracted 
are low, degradation of RNA does not appear to be a problem since no products of 
degradation are identifiable on the gels. The primary problem is our inability to extract 
enough tissue from human subjects.
6.4. S. 1 Proposed method o f  adipose tissue biopsy
A pilot study needs to be performed to investigate the effects of anaesthetic on LPL 
mRNA and activity levels in biopsies. A new method employing a different technique 
for extracting adipose tissue from the site of interest could also be investigated in the 
hope of obtaining more tissue in one sample. This method would involve making a 
small incision in the skin with a scalpel following the administration of a local 
anaesthetic. The adipose tissue sample could then be removed simply from the 
subcutaneous deposits using forceps. It is proposed that this technique would result in 
the extraction of more tissue which is less fragmented.
There are two other methods which could be used in order to overcome the problem of 
the Northern blot methodology not being sensitive enough for human samples. The 
first is an RNase Protection assay. This involves hybridisation of target mRNA to a 
radio labelled antisense cDNA probe in solution. RNase is then added to remove any 
single-stranded, unhybridised mRNA. A phenol-chloroform extraction is performed to 
purify the mRNA and the reaction mixture is run on an agarose gel to define the 
contents. Quantification is acheived by running a serial dilution of a standard labelled 
mRNA alongside the sample of unknown quantity. The RNase protection assay is 
known to be approximately 10 times more sensitive than Northern Blotting because of 
better hybridisation of the probe to the target mRNA and because the background is
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digested away. However the main disadvantage of the RNase protection assay is the 
presence of the ^^P-labelled probe throughout the assay. The radioactive label is added 
at the beginning of the assay so the gel run to identify the assay products is also highly 
radioactive. This would mean all the stages would need to be run in a designated 
radioactivity area. The assay also puts the user at unnecessary risk of exposure when 
other viable techniques are now available.
The second method employs the reverse transcriptase-polymerase chain reaction (RT- 
PCR). RT-PCR is a powerful in vitro RNA amplification technique. The PCR 
reaction is based on oligonucleotide primers which are complementary to the target 
sequence. RT-PCR involves an initial reverse transcription step to produce the cDNA 
for the target RNA. The specimen cDNA, primers (one sense and one antisense) and 
Taq polymerase are combined with the reaction mixture buffer. Taq polymerase is 
used because it is a heat stable polymerase enzyme and can thus survive the high 
temperastures employed to split the DNA strands. The reaction mixture buffer 
contains single nucleotide bases and carefully controlled levels of ions (especially 
magnesium). The reaction mixture is heated to 95°C so that the specimen DNA 
denatures to single strands. The temperature is then reduced to 55°C to allow the 
primers to anneal to their complementary strand. The temperature is next raised to 
72°C which is the optimal temperature for Taq polymerase. This enzyme then extends 
the primers along the annealed strand using the appropriate nucleotide bases. The 
cycle is then repeated, starting by raising the temperature to 95°C, to separate the 
newly synthesised DNA strand fi"om its template which then becomes a template for the 
next reaction and so on. The reactions are depicted in Figure 6.11.
If PCR was 100% efficient, each reaction would produce double the number of copies 
of the target sequence. Therefore, in our application, small amounts of LPL mRNA 
fi’om a human biopsy could be amplified to reach detectable levels. The advantages of 
the RT-PCR reaction are that it involves no radioactivity and its higher sensitivity have 
made its development to measure LPL mRNA the next step in future work. Employing 
RT-PCR could mean either a smaller biopsy would be needed from each subject or it
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could enable other enzymes such as hormone-sensitive lipase to be specifically 
measured in one sample.
Single stranded RNA
Reverse transcriptase
Double stranded cDNA
Denature at 95°C
Single stranded DNA + Taq polymerase + primers
Anneal primers at 55°C then increase 
temperature to 72°Cfor extension
Double stranded DNA
Raise temperature to 95°C
Single stranded DNA
Repeat of cycles
Figure 6.11 Simplified diagram of the Reverse Transcriptase Polymerase Chain
Reaction
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7. FINAL DISCUSSION
The central theme of this thesis has been the enzyme lipoprotein lipase. This chapter 
sets out to draw together the findings with regard to LPL control and its role in lipid 
metabolism. There is evidence within this thesis that LPL is regulated by both 
pretranslational and posttranslational control. Alongside conclusions from each 
experimental Chapter are some thoughts relating to future work, given in the light of 
recent work on LPL.
The gastrointestinal hormones GIP and GLP-1 (7-36) amide have profound effects on 
stimulating insulin secretion via the enteroinsular axis and have direct effects on LPL 
activity in explants of rat adipose tissue. In Chapter 3 insulin and GIP stimulated LPL 
activity in explants. The glucagon-like peptides produced some unexpected results 
which were difficult to interpret in terms of their possible physiological effects on LPL 
activity. The cause for these findings may have been degradation of the hormones in 
the incubation medium or the possible binding of the hormone to more than one 
receptor. Some of the novel work in this section of the thesis, studying the effects of 
glucagon on LPL activity for example, provides the basis for future work. Since 
insulin and glucagon are known to act in opposition to one another, the ratio between 
the two hormones is important in such circumstances as the feed-starve cycle where the 
insulimglucagon ratio alters to affect glycogenolysis or gluconeogenesis in starvation 
or the fed state. Thus the suggestion of glucagon having a suppressive effect on 
adipose tissue LPL activity via its effect on NEFA concentrations (in Chapter 3) may 
have implications in times of nutritional stress, such as starvation or overfeeding, when 
the levels of NEFA available to the body for fuel or storage are fluctuating greatly.
The challenge for the future of LPL activity measurement in explants of adipose tissue 
needs to be in development of the work from the in vitro situation and towards in situ, 
in vivo experiments as well as expanding the work from laboratory animals into 
humans. Rat adipose tissue TAG is mostly synthesised de novo; in humans however, 
who consume much higher amounts of fat, more adipose tissue TAG is derived from
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dietary fat rather than from de novo lipogenesis. In order to further the in vitro work 
described in this thesis combinations of hormones must be investigated which would 
reflect more closely an in vivo situation. The explants used in this thesis were either 
taken from rat omental or epididymal adipose tissue depending on the study.
One step further than studying combinations of hormones would be to investigate the 
effects of the hormones on LPL activity in vivo. In the past three years, Frayn and his 
colleagues have described a technique for measuring arterio-venous differences across 
an adipose tissue site in humans. Based on this technique, the following method would 
enable the in vivo investigation of the effects of hormones on adipose tissue LPL 
activity in humans. The methodology involves the cannulation of three veins -  one in a 
vein draining a warmed hand, one in a vein draining a subcutaneous adipose tissue site 
and one used to infuse the hormone under investigation. The warmed hand vein 
samples arterialised blood, taken to represent blood supplying the adipose tissue and 
the vein in the site of study represents blood draining the adipose tissue. Blood flow 
through the tissue could be measured using a radioactive tracer.
The difference between the arterialised blood and the venous drainage blood then 
provides an overall picture of the changes occurring in the adipose tissue in situ with 
regards to fat storage and mobilisation. LPL activity within the blood samples could be 
measured according to the protocol described in Chapter 2. However Frayn has 
calculated a theoretical estimation of LPL activity, alongside hormone-sensitive lipase 
(HSL) measurement, using the arterio-venous difference in TAG levels since LPL is 
responsible for the metabolism of dietary TAG. Frayn and colleagues have studied the 
effects of insulin infusion on adipose tissue LPL and hormone-sensitive lipase levels 
(Frayn et a l 1994) but investigations into the effects of gastrointestinal hormones such 
as GIP and GLP-1 have not been studied. Similar work has been conducted in skeletal 
muscle with the purpose of comparing LPL, and TAG clearance, across muscle and 
adipose tissue in the fed and fasted states (Coppack et al. 1996). All this work 
provides detailed information about the differences in LPL regulation at the tissue level 
and therefore correlates well with the interest in LPL mRNA levels in tissues. This
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research could provide important novel findings in terms of the control of adipose 
tissue metabolism by gastrointestinal hormones.
It has been shown previously that a person's background diet affects the postprandial 
response to a standard test meal (de Bruin et al. 1988; Zampelas et al. 1994). Most 
people spend the majority of time in the postprandial state. Therefore the importance 
of studying postprandial responses must not be forgotten. The more efficiently people 
can clear lipid from the bloodstream and thus decrease exposure time to potentially 
atherogenic lipoprotein remnants, the lower the risk of CHD. High LPL activities are 
thought to be an advantage in terms of risk of chronic diseases such as atherosclerosis 
and CHD which are complications linked to non-insulin dependent diabetes. Few 
significant effects of meal frequency on postprandial lipaemia in young female subjects 
were reported in this work. The findings did not reflect previous work which 
suggested that nibbling is beneficial in reducing risk factors for CHD, diabetes and 
obesity. This study suggested that it is the composition of the diet that is more 
important in terms of postprandial lipaemia than the frequency with which the diet is 
consumed. However it must be stressed that the study was performed on young 
healthy women. Any changes due to altered meal frequency are perhaps more likely to 
be seen in older people who have raised fasting plasma TAG and LDL-cholesterol 
levels, lowered HDL-cholesterol levels and prolonged lipaemic responses to a standard 
test meal. This was the first postprandial study following a period of altered meal 
frequency. The study outline could be repeated, perhaps in a group more susceptible 
to the chronic diseases mentioned such as middle-aged men (who are likely to be at a 
higher risk of CHD). If a study in another subject group also produced negative results 
it would be fair to dismiss meal frequency as an important factor in certain disease risk. 
However a positive result would suggest that meal frequency is relevant to higher risk 
groups.
The macronutrient composition of the habitual diet has been shown to be important in 
determining postprandial lipaemia. The study described in Chapter 5 therefore 
investigated the effects of fatty acid intake on various parameters associated with lipid 
metabolism in young and adult rats. The study was designed to investigate the long­
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term changes in lipid metabolism in offspring bom to dams fed fish oils (n-3 PUFA) 
during gestation and lactation. Changes in tissue development during the life-cycle can 
have significant effects on metabolism within those tissues. For example, LPL activity 
levels in adipose tissue are changing for the first 30 days of rat life. Dietary fatty acid 
changes affected postprandial lipid and hormone levels in young rats sacrificed whilst 
consuming the test diets. However these effects did not, on the whole, persist into 
adulthood once the rats were fed normal chow. Nearly all the differences in hormones 
and metabolites found were between the young and adult animals, not between the two 
dietary groups. However, early diet affected LPL expression but not activity later in 
life. We hypothesised that enzyme and hormone levels may be set by an individual's 
habitual dietary intake. However fi"om this study there is little evidence for 
programming of enzyme levels early in life. The relevance of animal studies to the 
human in vivo situation can always be questioned. However, clearly ethical constraints 
prevent some research in the human situation if developmental studies are to be 
achieved. In the case of the early diet study, it was necessary to revert to the animal 
model to decipher some reasons for, and mechanisms behind, the changes that had been 
noted in humans by earlier workers.
Part of the work in this thesis has centred on LPL gene expression and the effects of 
dietary fatty acids on LPL expression. The hypothesis that LPL is controlled at a 
number of different levels has been confirmed by the work in this thesis. Most previous 
work studying dietary effects on LPL have used activity measurements; however, there 
is little understanding of the underlying mechanism to elucidate, for example, whether 
the effect is substrate or hormone driven. It has been shown in Chapter 5 that LPL 
activity is affected by dietary manipulation and that LPL mRNA levels are influenced 
by diet -  clearly substrate driven LPL control. However in Chapter 3 enzyme control 
is clearly hormone driven in rat adipose tissue explants. Although the measurement of 
postheparin plasma LPL activity is a good method of assessing total body activity at 
one point in time and heparin-releasable activity assesses newly synthesised LPL in 
tissue, the use of mRNA measurements gives an estimate of the total potential LPL 
activity. Our ongoing hypothesis is that if LPL mRNA levels are directly altered by 
dietary manipulation, (supported by findings in Chapter 5), and this change is
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transcribed into active enzyme, this could in turn influence an individuals’ capacity to 
clear dietary TAG. It is therefore important to measure the enzyme at a number of 
points including both LPL activity measurements and LPL mRNA levels to create an 
overall picture of the enzyme's production.
The notion that that fatty acids can rapidly regulate the transcription of specific genes is 
a relatively recent concept. The techniques of molecular biology allow the definition of 
nutrient needs and the outcomes of nutrient excesses in terms of events that govern 
gene transcription, mRNA processing, mRNA stability and mRNA translation of 
specific genes. The results of Chapter 5 support the view that diet can alter LPL 
through direct effects on gene expression. Clarke and Abraham published a thorough 
overview of the nutrient control of pre- and post-translational control of genes (Clarke 
& Abraham, 1992). They were the first group to report that fish oils had a direct effect 
on gene expression. Their studies looked at the regulation of fatty acid synthase gene 
expression in the rat liver and showed PUFA to suppress the expression through a 70 -  
90% reduction in the levels of fatty acid synthase mRNA. The kinetics of these 
changes in enzyme levels in response to alterations in dietary fatty acid intakes occur 
rapidly. Such rapid changes cannot therefore be explained by changes in membrane 
lipid composition and subsequent alterations in insulin signalling. Thus the effects of 
fish oils on LPL would be expected to be substrate rather than hormone driven. The 
work by Clarke and Abraham triggered the interest in our group to study the 
mechanism behind the stimulatory effects of fish oils on LPL.
There is much debate at the present time as to the mechanism behind the effects of n-3 
PUFA, especially fish oils, on postprandial metabolism. Fibrates -  lipid lowering 
drugs, which are synthetic fatty acids in structure, were mentioned briefly in Chapter 1 
with regard to increasing LPL activity. The current theory is that n-3 PUFA may act 
similarly to fibrates because of their closely related structure. The mechanism of action 
via a common liver regulatory pathway has been suggested because of the isolation of a 
specific receptor in hepatocytes (Sirtori et al. 1993). This receptor is known as the 
‘peroxisome proliferator activated receptor’ (PPAR). Fatty acids which act via the 
PPAR pathway are thought to cause enhanced fatty acid catabolism because the
190
Discussion
interaction with this hepatic receptor in turn triggers increased p-oxidation of fatty 
acids in liver cells, specifically in mitochondria in man and peroxisomes in rodents. 
This then results in reduced VLDL output fi"om the liver and increased circulating HDL 
levels. In the periphery the catabolism of fatty acids via this pathway would stimulate 
increased lipase activity in order to maintain a constant flow of lipid substrates to 
tissues. Alongside this fatty acid oxidation, certain n-3 PUFA such as EPA and DHA 
may actually inhibit triacylglycerol biosynthesis. This recent knowledge of the action 
of fish oils opens up a new pathway for the understanding of lipid regulation in man. 
Activation of the PPAR system might allow the body to dispose of excess fat in 
conditions of overload, by activation of these mitochondrial independent mechanisms 
(Schoonjans e/'a/. 1995).
The prospect of the ability to measure LPL mRNA levels using PCR and thus use less 
adipose tissue may enable the simultaneous measurement of other enzyme expressions 
such as hormone-sensitive lipase (HSL) -  also by PCR. HSL is the enzyme responsible 
for releasing NEFA stored as TAG in adipose tissue into the circulation in the fasted 
state. If both LPL and HSL were measured, an estimation of the changes in the 
LPL:HSL ratio in response to alterations in dietary fatty acids would be possible. The 
LPLiHSL ratio and its relation to the movement and storage of fatty acids in adipose 
tissue is important in terms of chronic diseases such as CHD and diabetes. There are 
many associations between fat metabolism and risk of CHD outlined in this thesis. 
There is also developing evidence that plasma NEFA concentration may alone play a 
central role in some of these associations. In a recent review Frayn suggested that 
raised NEFA levels postprandially may be associated with the development of a 
number of risk factors for CHD such as insulin resistance, hypertriacylglycerolaemia 
and high circulating apolipoprotein B levels (Frayn et al. 1996). Recent work has 
reported LPL gene expression to have a direct effect on HSL expression in mice 
(Shimada et al. 1995). Overexpression of LPL gene expression did not result in 
increased fat deposition, thought to be the result of a simultaneous increase in HSL 
gene expression. However the relevance of this to humans must be questioned until 
further work is performed. The technique of PCR has been employed recently to 
investigate the acute regulation by insulin of LPL gene expression in muscle.
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Following a 3 hour euglycaemic clamp, LPL mRNA in a human muscle biopsy was 
shown to be decreased by almost 50%, demonstrating the acute regulation by insulin 
on LPL as well as the application of the PCR methodology (La Ville et al. 1996).
There is growing evidence that LPL is a multifunctional protein, which not only affects 
lipolysis but also acts as a ligand for binding of lipoprotein particles such as 
chylomicron remnants to cell surfaces and hepatic receptors (Olivecrona et al. 1995). 
This could have important implications in terms of lipoprotein recognition by hepatic 
receptors and hence lipoprotein remnant clearance. Further studies on this enzyme and 
its relatively newly reported functions represent an exciting prospect for future work.
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APPENDIX I
QUESTIONNAIRE TO ASSESS COMPLIANCE OF 
SUBJECTS DURING THE DIETARY INTERVENTION 
PERIODS AND FEASIBILITY OF THE NIBBLING AND 
GORGING DIETS - See Chapter 3.
1) Please indicate your normal eating pattern
Breakfast, lunch, evening meal
Breakfast, mid-morning snack, lunch, mid-afternoon snack, evening
meal, supper
2 meals per day
Snacks throughout the day
Other (please specify)
2) Which meal pattern in the study did you find it easier to follow?
3) Why was this?
4) On the nibbling diet was the quantity of food
Too much 
Too httle 
O.K.
5) On the gorging diet was the quantity of food
Too much 
Too little 
O.K.
6) Were the suggested meal plans useftil?
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7) Any comments on meal plans?
8) How convenient did you find each diet?
very inconvenient very convenient
9) How hungry were you on each diet?
very hungry not at all hungry
10) How eompHant do you feel you were Avith eaeh diet?
not at all completely
11) Was there a particular time on each diet when comphance was more difficult? 
Why do you think that was?
12) On the gorging diet did you snack
Not at all 
Once a week 
Three times a week 
At weekends 
Other (please specify)
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13) On the nibbling diet did you stick to twelve meals a day
Everyday 
Five times a week 
Three times a week 
Not at all
Other (please specify)
14) On the nibbling diet did you think you ate more compared to your normal diet?
15) Do you think you ate more on the nibbling diet compared with the gorging diet?
16) On the gorging diet do you think you ate more compared to your normal diet?
17) How many hours exercise do you normally do in a week?
Of what nature is this exercise?
How mueh does this compare to your activity level whilst on each diet?
18) How many units of alcohol did you consume in a week while on each diet?
When during the week was this alcohol consumed?
Was this amount typical of one week?
19) Do you take any vitamin and mineral supplements?
20) Are you currently using oral contraceptives?
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